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Abstract 
Streptomyces are Gram-positive bacteria, usually found living within the soil and 
they are saphrophytes. Among this class of bacteria are some plant pathogenic 
species, which cause infection of the roots or the tubers of some plants. The model 
Streptomycete plant pathogen is Streptomyces scabies; this infects root crops, such as 
potato or radish and is a known cause of scab disease. Most Streptomyces species are 
producers of secondary metabolites, many of which possess important biological 
activities, such as antibacterial, iron-chelating, anticancer or immunosuppressant. 
One group of these secondary metabolites are called siderophores. These are small 
organic molecules, which can chelate ferric iron. The iron in the environment is 
mainly present as iron (III) hydroxide, which is not very water soluble and cannot, 
therefore, be taken up directly by microorganisms. Some bacteria solve this problem 
through production of siderophores. The siderophores are released into the 
environment by the microorganisms to chelate iron (III) from the environment and 
transport it into the cell across the cell membrane. Iron is required for many life 
processes.  
Analysis of the Streptomyces scabies genome sequence resulted in the identification 
of gene clusters predicted to direct the biosynthesis of known siderophores, e.g. 
desferrioxamines and pyochelin, as well as, potentially novel siderophores. A gene 
inactivation and comparative metabolic profiling approach has been employed to 
identify the metabolic products of these gene clusters. 
 
A PCR-targeting method was used to replace part of or whole genes in the S. scabies 
87.22 putative secondary metabolite gene clusters. An internal fragment of the 
scabichelin biosynthetic gene scab85471 and the putative S. scabies desC gene were 
deleted using this method. The scabichelin and desC gene mutants were subsequently 
analysed by LC-MS allowing confirmation of the function of the genes investigated. 
Production of scabichelin by S. scabies 87.22 wild type was analysed by comparing 
it with the authentic standard. The chemical and genetic complementation of the Δ 
desC mutant was carried out to establish the involvement of the desC gene in the 
biosynthesis of desferrioxamines. 
 
The S. scabies 87.22 cryptic tetronate biosynthetic gene cluster predicted to encode a 
novel agglomerin-like product, which could potentially be involved in plant 
pathogenicity was also investigated. The expression of the gene cluster was first 
analysed using reverse transcriptase PCR (RT-PCR) which was carried out on the 
total RNA isolated from the wild type S. scabies. Following this, an attempt was 
made to disrupt the scab63021 gene, a putative transcriptional activator of the cryptic 
tetronate-like cluster in the S. scabies genome. Transcriptional analysis of the wild 
type S. scabies and the putative Δscab63021 mutant genomes did not show any 
difference in the expression of the tetronate genes between the wild type strain and 
the Δ scab63021 mutant.  
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1.1 Streptomyces 
Streptomyces belong to the phylum of Actinobacteria and to the family of 
Streptomycetaceae (Kampfer, 2006). Streptomyces are Gram-positive bacteria, their 
genomes contain a high content of guanine and cytosine and they have a linear 
chromosome. They live mainly in soil, where they decompose organic matter to 
produce their characteristic earthy odour of which the main compound is volatile 
substance called geosmin (Meyer et al., 1996). Most Streptomyces species produce 
biologically active secondary metabolites and more than two thirds of clinically used 
antibiotics of microbial origin are produced by Streptomyces spp. The biological 
activities of secondary metabolites also include antimalarial, antifungal and 
antitumour, as well as some immunosuppressants (Kieser et al., 2000). Some 
Streptomyces spp. are pathogenic, for example, S. somaliensis and S. sudanensis 
cause mycetoma in humans (Lichon et al., 2006) ; and S. acidiscabies, S. 
turgidiscabies and S. scabies cause scab disease in plants (Bignell et al., 2010, 2). 
 
Streptomyces have a complex life cycle (Figure1.1). It begins with the single spore, 
which germinates to form several multi-nucleoid filaments. These filaments 
elongate, producing branches, which form hyphae known as vegetative mycelia. 
After several days the vegetative mycelia grow into air forming aerial hyphae. When 
the growth of the aerial hyphae is completed it undergoes septation and produces 
prespore compartments. The spores are assigned into chains and in this step, which is 
known as a stationary phase, secondary metabolites are produced. The mature spores 
are then released to start a new life cycle (Kieser et al., 2000). 
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Figure 1.1 The life cycle of Streptomyces (Angert, 2005). 
1.2 Streptomyces scabies 
There are over 900 Streptomyces species described to date (Labeda et al., 2012), and 
these include some plant pathogenic species. Three species are Streptomyces scabies 
and S. turgidiscabies and S. acidiscabies, which cause infection of root vegetables, 
such as potato or radish, known as scab disease (Loria and Kempter, 1986; Figure 
1.2). Streptomyces scabies was one of the first plant pathogens characterised and has 
a broad world distribution, whereas S. turgidiscabies and S. acidiscabies species 
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have been described more recently and have been found only in several isolated 
world areas (Bignell et al., 2010, 1). 
 
 Figure 1.2 Potato and radish with scab disease (http://www.cals.ncsu.edu, 
http://www.agroatlas.ru). 
 
Some of the secondary metabolites produced by S. scabies were known prior to the 
availability of its genome sequence, including thaxtomins and concanamycins (Kers 
et al., 2004, Natsume et al., 2005). 
One of the first reports of secondary metabolites produced by scab causing 
streptomycetes was thaxtomins, a family of phytotoxins isolated from S. scabies in 
1989 (King et al., 1989). It was also shown that S. scabies produces other 
phytotoxins, such as concanamycin A and B (Natsume et al. 1996, Natsume et al. 
1998), a macrolide antibiotic first isolated from Streptomyces diastatochromogenes 
S-45 (Kinashi et al., 1984). 
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1.3 Secondary metabolites of S. scabies 87.22  
1.3.1 Thaxtomins 
The plant pathogenic Streptomyces species produce the family of phytotoxins called 
thaxtomins (Figure 1.3; Loria et al., 2008, Fry and Loria, 2002; Johnson et al., 2009). 
These toxins, present in infected host tissue (Lawrence et al., 1990), are nitrated 
dipeptides biosynthesised from L-phenylalanine and L-tryptophan. The 4-nitroindole 
moiety is required for phytotoxicity (King and Calhoun, 2009). To date, eleven 
members of the thaxtomin family have been identified, which differ only in the 
presence or absence of an N-methyl group and the pattern of hydroxylation. 
Thaxtomin A is the most abundant member of the thaxtomin family (Figure 1.3 B) 
and is produced by all three plant pathogenic Streptomyces species, S. scabies, S. 
acidiscabies and S. turgidiscabies (Loria et al., 2008), whereas the main product of S. 
ipomeae is thaxtomin C (King et al., 1994). Thaxtomin A is essential for 
development of scab disease in plant tissue (King and Calhoun, 2009). The main 
mode of action of thaxtomins is inhibition of cellulose biosynthesis in growing plant 
tissue, causing hyperthropy of plant cells, tissue necrosis and cell death (Loria et al., 
2008). 
Thaxtomin is biosynthesised by non-ribosomal peptide synthetases (NRPSs) encoded 
by the txtA and txtB genes (Figure 1.3 A). TxtA and TxtB are responsible for 
producing the cyclic dipeptide from L-4-nitro-tryptophan and L-phenylalanine. The 
region close to the txtA and txtB genes indicated the presence of a gene highly 
homologous to the oxygenase domain of mammalian nitric oxide synthases (NOSs, 
Kers et al., 2004). This gene encodes the enzyme TxtD, which provides the nitric 
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oxide and a cytochrome P450, TxtE, uses it to nitrate L-tryptophan to give the 
precursor L-4-nitro-tryptophan (Figure 1.3 B; Barry et. al., 2012) A cytochrome 
P450 monooxygenase TxtC is responsible for post-cyclization hydroxylation steps 
on the thaxtomin precursor to yield thaxtomin A (Healy et al., 2002). 
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Figure 1.3 A- thaxtomin biosynthetic gene cluster and, B- thaxtomin A biosynthesis 
(Barry et al, 2012). 
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1.3.2 Concanamycins 
Concanamycins are macrolide antibiotics primarily isolated from S. 
diastatochromogenes (Kinashi et al., 1984), consisting of an 18-membered macrolide 
ring and a β-hydroxyhemiacetal side chain (Figure 1.4; Haydock et al., 2005). They 
have a broad range of biological activities, such as antiviral, antiprotozoal, 
antifungal, and antineoplastic (Kinashi et al., 1984; Omura et al., 1982; Seki-Asano, 
1994). Their activity is thought to be due to their inhibition of vacuolar ATP-ases (V-
ATP-ases; Drose et al., 1993), the role of which is to actively transport protons into 
the lumen of various cellular compartments such as endosomes, lysosomes and the 
vacuoles of plants and fungi (Mellmann et al., 1986; Nelson, 1995). Concanamycins 
inhibit the acidification of the lysosomes by binding to the V0 membrane component 
of the ATP-ase (Drose et al., 2001). Research into these compounds has increased 
since it was discovered that they may have some application in the treatment of 
osteoporosis, as V-type ATP-ases play a key role in osteoclast-mediated bone 
resorption (Laitala-Leinonen et al., 1999).
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Figure 1.4 Structure of concanamycin A (Haydock et al., 2005). 
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Concanamycins are produced by a variety of Streptomyces species, including S. 
diastatochromogenes, S. neyagawaensis, and S. graminofaciens (Kinashi et al., 1984; 
Haydock et al., 2005; Seki-Asano et al., 1994). They have also been found to be 
produced by S. scabies (Natsume et al., 1996) but have not been isolated from S. 
acidiscabies or S. turgidiscabies (Natsume et al., 1998). Analysis of the S. scabies 
87.22 genome indicated that it encodes a putative biosynthetic gene cluster (Figure 
1.5 A; Yaxley, 2009) similar to the S. neyagawaensis concanamycin biosynthetic 
cluster (Figure 1.5 B; Nelson, 1995). The S. scabies concanamycin biosynthetic 
cluster contains all the same genes as in the S. neyagawaensis concanamycin gene 
cluster (Yaxley, 2009). The concanamycin cluster in S. neyagawaensis is 100 kbp 
long and encodes 28 genes in total, including six polyketide synthases (PKS’s A-F). 
The 22 other genes present within the biosynthetic gene cluster encode proteins 
predicted to be involved in sugar biosynthesis, regulatory functions and genes for 
modification of the polyketide backbone. 
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Figure 1.5 Organization of the concanamycin biosynthetic gene cluster in: A- 
Streptomyces neyagawaensis ATCC 27449 (Kinashi et al., 1984). The genes 
functions are described in the text. B- S. scabies 87.22 (Yaxley, 2009). 
 
Concanamycin A contains deoxysugar moiety 4’-O-carbamoyl-2’-deoxyrhamnose, 
the biosynthesis and attachement of which is encoded for by seven genes ORF5*- 
ORF11*. ORF5* and ORF6* encode proteins with high homology to a TDP-glucose 
4, 6-dehydratase and TDP glucose synthase, respectively (Figure 1.5). ORFs 8*, 9* 
and 10* encode proteins with high homology to a dTDP-hexose 4-ketoreductase, d-
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TDP-sugar-3-ketoreductase and dTDP-sugar-2, 3-dehydratase respectively. ORF7* 
is highly homologous to carbamoyltransferases and ORF11* is homologous to 
glycosyltransferases. Assignment of the genes allows predictions to be made with 
regards to the biosynthetic route towards the deoxysugar moiety. ORF6* is proposed 
to activate glucose and ORF5* to catalyze 4, 6-dehydration of TDP glucose to form 
TDP-4-keto-6-deoxyglucose (Figure 1.6). ORF10* is then proposed to catalyse the 
formation of the 2-deoxy intermediate, which is in equilibrium with the 2, 4-diketo 
derivative. The ORFs 8*, 9* are then proposed to reduce each keto group at C3 and 
C4 to give the 2-deoxy derivative with the appropriate stereochemistry at the C3 and 
C4 positions. ORF7* is proposed to catalyse the addition of a carbamoyl unit to form 
4’-O-carbaomyl-2’-deoxyrhamnose. ORF11* is then predicted to catalyse the 
transfer of the sugar moiety to concanamycin A aglycone (Figure 1.6). 
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Figure 1.6 Proposed biosynthetic pathway for synthesis and addition of the sugar 
moiety 4′-O-carbamoyl-2′-deoxyrhamnose. 
 
 The regulatory functions are proposed to be encoded for by ORF’s 2, 3 and 17* 
(Haydock et al., 2005). ORF3 has high sequence homology to members of the LuxR 
regulatory family proteins, which are found in the secondary metabolite gene clusters 
of many Gram-positive bacteria, and ORFs 2 and 17* are similar to the regulatory 
genes in other PKS gene clusters. ORF17* has 33% identity to AfsR family regulator 
from Streptomyces griseus (Haydock et al., 2005). 
ORF1 is highly homologous to malonyl transferase enzymes and its function in the 
concanamycin A gene cluster is unclear. A putative ORF4B*, located between 
ORF4* and ORF5*, has no match to any other genes in the databases and its function 
is unknown. ORFs 18* and 19* encode proteins proposed to be involved in 
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biosynthesis of extender units. The enzymes are predicted to be a crotonyl-CoA 
reductase and a β-hydroxybutyryl-CoA reductase, respectively, which could both 
play a role in the biosynthesis of a butyrate extender unit for module 10. The 
extender unit selected for by modules 6 and 13 of the PKS could be a result of direct 
incorporation of methoxymalonyl-ACP.
 
ORF12*, is homologous to FkbG and may 
be involved in the biosynthesis of methoxymalonyl-ACP. ORF1* is homologous to 
FkbB, ORF2* to FkbJ, ORF3* to FkbI and ORF4* to FkbH. These proteins are 
predicted to catalyse the conversion of primary metabolites into methoxymalonyl-
ACP.  
The biosynthesis of the concanamycin A polyketide backbone in S. neyagawaensis is 
directed by the operon of six genes conA to conF (Figure 1.7), which encode the 
PKS enzymes CON1-6, respectively. CON1 (2841 aa, approx. 300 kDa) contains the 
loading module and module 1 for chain extension. CON2 (4825 aa, approx. 500 kDa) 
contains extension modules 2-4. CON3 (4970 aa, approx. 520 kDa) contains 
extension modules 5–7, CON4 (4490 aa, approx. 430 kDa) contains modules 8–9 
and CON5 (5599 aa, approx.530 kDa) contains modules 10–12. CON6 (2056 aa, 
approx. 215 kDa) contains the final condensation module 13 and a C-terminal 
thioesterase domain for cyclization and release of the polyketide chain (Figure  1.7; 
Haydock et al., 2005). More about PKSs family proteins is discussed in detail in 
section 1.8. 
 
PhD Thesis: Joanna Bicz                                                                     Chapter 1: Introduction 
 
 
13 
 
KS AT ACP KS
DH KR
ACP
KS AT KS
KR
ACP AT
KR
ACP KS AT ACP
KS AT KS
KR
ACP AT
KR
ACP KS AT
DH KR
ACP KS AT
DH KR
ACP ACPKS AT
DH ER KR
KS AT KS
KR
ACP AT
KR
ACP KS AT
DH KR
ACP
KS AT
DH KR
ACP TE
CON1 CON2
CON3 CON4
CON5 CON6
load
module 1 module 2 module 3 module 4
module 5
module 6
module 7 module 8
module 9
module 10
module 11
module 12 module 13 end
Figure 1.7 Domain organisation of concanamycin A PKS genes (Haydock et al., 
2005). 
 
1.4 Secondary Metabolites of S. scabies 87.22 Discovered by Genome 
Mining. 
S. scabies 87.22 is a model organism for studying plant pathogenicity in Gram-
positive bacteria (Lambert and Loria, 1989). The sequence of the genome of S. 
scabies became available through the S. scabies genome-sequencing project 
(www.sanger.ac.uk/Projects/S.scabies). The genome is 10.1 Mb long with a GC 
content of 72%. The availability of the genome sequence for S. scabies allowed 
comparative genomic analyses with other bacterial genomes, to identify several 
biosynthetic gene clusters proposed to encode either known (such as 
PhD Thesis: Joanna Bicz                                                                     Chapter 1: Introduction 
 
 
14 
 
desferrioxamines, pyochelin) or novel (agglomerin-like product, coronofacic acid-
like product) secondary metabolites 
(http://www.ncbi.nlm.nih.gov/nuccore/260644157, 
http://strepdb.streptomyces.org.uk).  
Some of the biosynthetic gene clusters identified were found to be conserved in the 
genomes of other Streptomyces species (e.g. des gene cluster in S. coelicolor A(3) 2) 
and other sequenced microbes (e.g. the pyochelin biosynthetic gene cluster in P. 
aeruginosa; Table 1.1; Yaxley, 2009). The products of some of secondary metabolite 
biosynthetic gene clusters are currently unknown; such clusters are referred to as 
‘cryptic’ biosynthetic gene clusters. 
Table 1.1 Overview of S. scabies known and putative natural product biosynthetic 
gene clusters (Yaxley, 2009). Yellow- biosynthetic gene clusters conserved both in S. 
coelicolor and S. avermitilis; white-biosynthetic gene clusters conserved either in S. 
coelicolor or in S. avermitilis; blue- clusters conserved in neither of the two species. 
 
Biosynthetic 
system 
Metabolite S. scabies gene 
cluster 
Estimated 
size/kb 
Conserv
ed in S. 
coelicol
or/S. 
avermiti
lis 
Bacterial type II 
PKS 
spore pigment ? 
     
scab43271 -
scab43341 
8 
 
both 
NRPS-independent 
siderophore 
synthetase 
siderophore ? 
 
scab24661-
scab24751 
16 
 
both 
NRPS-independent 
siderophore 
synthetase 
desferrioxamines 
? 
 
scab57921-
scab57981 
 
9 
 
both 
NRPS-independent 
siderophore 
synthetase 
siderophore ? scab18371-
scab18421 
 
7 
 
both 
PhD Thesis: Joanna Bicz                                                                     Chapter 1: Introduction 
 
 
15 
 
Ectoine synthase 
 
ectoine 
compatible solute  
scab70711-
scab70751 
4 
 
both 
Hopene/squalene 
synthase 
pentacyclic 
hopanoids 
scab12951-
scab13061 
14 both 
Phytoene/polyprenyl 
synthase 
carotenoid 
pigment 
scab5431-
scab5511 
12 both 
Sesquiterpene 
synthase 
geosmin? 
 
scab20121 
 
2 both 
Tyrosinase melanin pigment scab59231-
scab59241 
2 both 
Tyrosinase melanin pigment scab85681-
scab85691 
2 both 
Bacterial type III 
polyketide synthase 
germicidins? scab80171 
 
4 in S. 
coelicol
or 
NRPS-independent 
siderophore 
synthetase 
siderophore ? scab84501-
scab84521 
 
8 in S. 
avermiti
lis 
NRPS unknown scab72991 
 
4 in S. 
avermiti
lis 
Polysaccharide 
 
exopolysaccharide scab23341-
scab23551 
29 in S. 
coelicol
or 
NRPS pyochelin 
siderophore ? 
scab1411-
scab1571 
35 no 
NRPS NRPS 
siderophore? 
scab85431-
scab85521 
42 no 
NRPS lipopeptide? 
 
scab19681-
scab19731 
34 no 
NRPS unknown 
 
scab19681-
scab19731 
8 no 
NRPS thaxtomin 
 
scab31761-
scab31841 
19 no 
Hybrid NRPS/PKS 
system 
unknown 
 
scab62901-
scab63011 
14 no 
Hybrid NRPS/PKS 
system 
unknown 
 
scab78961-
scab78981 
8 no 
PhD Thesis: Joanna Bicz                                                                     Chapter 1: Introduction 
 
 
16 
 
Hybrid NRPS/PKS 
system 
unknown 
 
scab43961 
 
13 no 
Bacterial type I PKS 
 
macrolide 
phytotoxin ? 
scab83871-
scab84091 
95 no 
Bacterial type I PKS 
 
coronofacic acid 
derivative ? 
scab79581-
scab79721 
31 no 
Class II DAHP 
synthase/AfsA 
homologue 
butyrolactone ? 
 
scab12021-
scab12111 
 
12 no 
Lantibiotic 
 
lantibiotic ? 
 
scab31961-
scab32051 
14 no 
Mixed unknown 
 
scab63251-
scab63401 
8 no 
Mixed unknown 
 
scab69771-
scab69871 
13 no 
Other bothromycin scab56711- 
scab56591 
18 no 
1.4.1 Coronofacic acid 
Analysis of the S. scabies 87.22 genome sequence revealed the presence of a 
secondary metabolite gene cluster that is predicted to encode a compound 
homologous to coronofacic acid (CFA). CFA forms part of coronatine (COR), a 
phytotoxin produced by some plant pathogenic bacteria such as Pseudomonas 
syringae (Figure 1.8 A; Bignell et al., 2010, 2). In this strain COR is an important 
virulence factor and the cfa biosynthetic cluster is conserved in that strain as well as 
in the plant pathogen, Pectobacterium atrosepticum. Analysis of genomes of 
nonpathogenic Streptomyces (S. coelicolor, S. avermitilis, S. griseus) showed that 
they do not encode the cfa biosynthetic cluster. As cfa biosynthetic cluster is 
conserved amongst some plant pathogenic bacteria, it is possible that the S. scabies 
cfa cluster may also be important for virulence in this strain. 
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Figure 1.8 A-Structure of coronafacic acid (CFA) from Pseudomonas syringae and, 
B- A predicted structure for the CFA-like compound produced by S. scabies 87.22 
(Bignell et al., 2010, 2). 
 
The cfa biosynthetic cluster in S. scabies is 31 kb long and includes 15 genes (Figure 
1.9; Bignell et al., 2010, 2), nine of which are homologous to those in the 
Pseudomonas syringae and the Pectobacterium atrosepticum cfa clusters.  
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Figure1.9 A-The cfa-like biosynthetic gene cluster of Streptomyces scabies 87.22; B- 
the cfa biosynthetic cluster of Pseudomonas syringae pv. tomato DC3000; and C-the 
putative cfa biosynthetic cluster of Pectobacterium atrosepticum SCRI1043 (Bignell 
et al., 2010, 2). 
 
The genes cfa1-5 encode enzymes predicted to catalyse the synthesis of a CFA 
intermediate 2-carboxy-2-cyclopentenone (CPC; Rangaswamy et al., 1998). The 
genes cfa6 and cfa7 encode type-I PKSs catalysing the biosynthesis of the CFA 
backbone. The S. scabies Cfa6 and Cfa7 enzymes are similar to their Pseudomonas 
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syringae and Pectobacterium atrosepticum analogs, however, the enoyl reductase 
(ER2) domain in the S. scabies Cfa7 PKS is not present in the Pseudomonas 
syringae and Pectobacterium atrosepticum equivalent PKS (Bignell et al., 2010, 2). 
One more gene in the S. scabies cfa cluster that is homologous to the genes in the 
Pseudomonas syringae and Pectobacterium atrosepticum cluster is coronofactate 
ligase (cfl). Its function in Pseudomonas syringae is predicted to be ligation of CFA 
to coronamic acid (CMA) to produce coronatine (Figure 1.10). Although cfl is 
present in S. scabies and Pectobacterium atrosepticum these strains are not thought 
to produce coronatine as they do not encode genes for CMA biosynthesis (Bell et al., 
2004). 
  
                    
H3C
O
H H
O
NH
CH3
OH O
CFA CMA
 
 Figure 1.10 Structure of the Pseudomonas syringae coronatine (COR) phytotoxin 
consisting of coronafacic acid (CFA) linked to coronamic acid (CMA) (Bignell et al., 
2010, 2). 
 
 
The six other genes that are encoded in the S. scabies biosynthetic cluster and which 
have no homologues in Pseudomonas syringae or Pectobacterium atrosepticum 
clusters are: scab79581, scab79591, scab79681, scab79691, scab79711, scab79721. 
Scab79581 encodes a ~640 amino acid protein the function of which is unknown. It 
has low homology to other proteins from the BlastP database. It is 25% identical to a 
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UBA/ThiF-type NAD/FAD-binding fold protein from Nitrosospira multiformis 
(Bignell et al., 2010, 2). Scab79591 encodes a 266 amino acid protein with highest 
similarity to transcriptional regulators from Streptomyces antibiotic biosynthetic 
clusters (LuxR family). The genes scab79681 and scab79721 encode a putative 
oxidoreductase and a dehydrogenase/reductase, respectively. They are thought to be 
involved in the modification of the polyketide compound produced by S. scabies. 
Scab79691 encodes a protein with sequence similarity to P450 monooxygenases that 
are typically involved in introducing hydroxyl groups in synthesized polyketide 
products. Scab79711 encodes a putative 3-hydroxybutyryl-CoA dehydrogenase, 
which may have a role in the reduction of acetoacetyl-CoA to 3-hydroxybutyryl-
CoA, an intermediate in crotonyl-CoA biosynthesis. Crotonyl-CoA is a substrate for 
the crotonyl-CoA carboxylase/reductase (CCR), which converts Crotonyl-CoA into 
an ethylmalony-CoA extender unit (Chan et al., 2009). 
Analysis of the genes from the S. scabies cfa-like biosynthetic cluster suggests that S. 
scabies may produce a compound, which has similar structure to the coronofacic 
acid from P. syringae (Figure 1.8 B). Transcriptional studies indicated that the cfa-
like cluster is expressed in S. scabies in thaxtomin inducing media (Bignell et al., 
2010, 2). 
1.4.2 Bottromycin 
Bottromycin (Figure 1.11) is a macrocyclic peptide antibiotic that was originally 
isolated from Streptomyces bottropensis in 1957 (Waisvisz et al., 1957). It exhibits 
activity against Gram-positive bacteria and mycoplasma, including methicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci 
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(VRE; Kobayashi et al., 2010). Its antibacterial properties result from inhibiting 
bacterial protein synthesis by blocking an aminoacyl-tRNA binding to the A site of 
bacterial ribosomes (Otaka and Kaji., 1976; Otaka and Kaji., 1981; Otaka and Kaji., 
1983). It is comprised of a macrolactamidine, non-proteinogenic amino acids and a 
thiazole ring and its total synthesis was elucidated in 2009 (Shimamura et al., 2009). 
 
N
H
NH
N
HN
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R1
H
H
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H
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Ph
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O
R2
bottromycin A2 (R1 = Me, R2 = H)
bottromycin B2 (R1 = R2 = H)
bottromycin C2 (R1 = R2 = Me)  
Figure 1.11 Structure of bottromycin (Gomez-Escribano et al., 2012). 
 
Using a combination of high-throughput DNA sequencing, genetic manipulation and 
comparative metabolite profiling the bottromycin biosynthetic gene cluster was 
identified in S. bottropensis (Figure 1.12 A; Gomez-Escribano et al., 2012). 
Bioinformatic analysis of bottromycin biosynthetic gene cluster unveiled an almost 
identical gene cluster within the genome of S. scabies 87.22 (Figure 1.12 B; Crone et 
al., 2012). S. scabies had not been reported to produce bottromycin, consequently it 
was analysed for bottromycin production alongside S. bottropensis using LC-MS 
(Figure 1.13). This demonstrated that bottromycins are also produced by S. scabies 
(Gomez-Escribano et al., 2012; Crone et al., 2012).  
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Figure 1.12 Putative bottromycin biosynthetic gene clusters in S. bottropensis DSM 
40262 (Gomez-Escribano et al., 2012) and S. scabies 87.22 (Crone et al., 2012). 
 
Analysis of the S. bottropensis genome identified eleven putative biosynthetic genes 
(bmbA-K, Figure 1.12A), as well as, gene encoding a putative pathway specific 
regulatory protein (bmbR) and a gene encoding a putative exporter of the assembled 
product (bmbT). The gene cluster appears to be organised into two operons: bmbA-T 
and bmbB-K. The putative bottromycin biosynthetic gene cluster in S. scabies 
comprises of the genes scab56711 to scab56591, which were denoted btmA-M 
(Figure 1.12 B). The functions of bottromycin biosynthetic genes from S. 
bottropensis, as well as, their S. scabies homologs are listed in Table 1.2. 
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Table 1.2 Genes and proteins involved in bottromycin biosynthesis and their putative 
functions (adapted from Gomez-Escribano et al., 2012). 
Gene 
name 
S. scabies  
homolog 
Motifs Putative function 
bmbT Scab56711 
(btmA) 
putative integral membrane protein Bottromycin export 
and immunity 
bmbA Scab56701 
(btmB) 
Leucine carboxyl methyltransferase O-methylation of Asp 
residue 
bmbB Scab56691 
(btmC) 
B12 binding/Radical SAM β-methylation of 
Phe/Val/Pro residues 
bmbC Scab56681 
(btmD) 
Contains core peptide sequence 
GPVVVFDC 
Precursor peptide 
bmbD Scab56671 
(btmE) 
YcaO-like family Thiazoline 
formation? 
bmbE Scab56661 
(btmF) 
YcaO-like family (shows similarity to 
microcin B17 thiazoline/oxazoline 
synthetase McbD) 
Thiazoline formation 
bmbF Scab56651 
(btmG) 
B12 binding/Radical SAM O-methylation of 
Phe/Val/Pro residues 
bmbG Scab56641 
(btmH) 
Abhydrolase 1 family, alpha/beta 
hydrolase fold domain 
Peptidase involved in 
macrolactamidine 
formation 
bmbH Scab56631 
(btmI) 
Metal-dependent hydrolase    Peptidase involved in 
macrolactamidine 
formation 
bmbI Scab56621 
(btmJ) 
Cytochrome P450 Oxidative 
decarboxylation of 
thiazoline to form 
thiazole 
bmbJ Scab56611 
(btmK) 
B12 binding/Radical SAM β-methylation of 
Phe/Val/Pro residues 
bmbR Scab56601 
(btmL) 
DNA-binding domain of ArsR; 
DUF2087 
Putative 
transcriptional 
regulator 
bmbK Scab56591 
(btmM) 
Peptidase M17  cytosolic 
aminopeptidase family 
Removal of N-
terminal Met residue 
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Figure 1.13 EIC for m/z = 405.2200 and 412.2300 (corresponding to the [M+2H]
2+
 
ions for bottromycins A2 and C2, respectively) from LC-MS analyses of culture 
supernatants of S. bottropensis DSM40262 (top two traces) and EIC for m/z = 
405.2228 and 412.2314 (corresponding to the [M+2H]
2+
 ions for bottromycins A2 
and C2, respectively) from LC-MS analyses of culture supernatants of S. scabies 
(bottom two traces; Gomez-Escribano et al., 2012). 
Labelled precursor feeding experiments (Kellenberger, 1997) lead to the hypothesis 
that bottromycins are biosynthesised from a ribosomal precursor peptide containing 
the sequence GPVVVFDC. This undergoes several unusual posttranslational 
reactions, such as β-methylation of  the Phe, Pro and two Val residues, O-
methylation of the Asp residue, proteolytic lactamidine formation, and conversion of 
a thiazoline to a thiazole via hydroxylation of the Cys β-carbon followed by 
decarboxylation coupled with dehydration .  
Three putative methyl-cobalamin (MeCob)-dependent radical S-adenosylmethione 
(SAM) enzymes are encoded for by bmbB, bmbF and bmbJ. These are proposed to 
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catalyse β-methylation of the Phe, Pro and two of the three Val residues in BmbC 
(Figure 1.14). The putative SAM-dependent O-methyltransferase, encoded for by 
bmbB, is proposed to convert the carboxylic acid group of the Asp residue to the 
corresponding methyl ester (Figure 1.14). The protein similar to oxazoline/thiazoline 
synthetases (encoded for bmbC gene) is involved in the biosynthesis of many other 
heterocycle-containing ribosomal peptides (Dunbar et al., 2012). It is hypothesised 
that BmbE forms a complex with BmbD, similar to oxazoline/thiazoline synthetases, 
which then catalyses ATP-dependent thiazoline formation. Proteases thought to be 
encoded for by bmbG, bmbH and bmbK are proposed to catalyse the removal of the 
N-terminal N-formyl-Met residue and the 35 amino acids located downstream of the 
Cys residue. Removal of the N-terminal N-formyl-Met residue enables nucleophlic 
attack of the Gly amino group on the carbonyl group of the appropriate β-methyl-Val 
residue with subsequent collapse of the resulting intermediate with loss of water, 
which results in macrolactamidine formation. This reaction is proposed to be 
catalysed by the third protease. The putative cytochrome P450 is encoded for by 
bmbI and it is thought to catalyse the conversion of the thiazoline to a thiazole via 
hydroxylation of the β-carbon of the Cys residue, followed by elimination of water 
and subsequent decarboxylation. The final reaction in the biosynthetic pathway is 
proposed to be the epimerisation of the Asp β-carbon, yielding bottromycin A2. It is 
not known whether this reaction is catalysed by a specific enzyme or is spontaneous. 
Bottromycins B2 and C2 arise from the same pathway, except that C-methylation of 
the Pro residue is skipped in the biosynthesis of the former and occurs twice in the 
assembly of the latter. bmbT encodes a putative integral membrane protein that may 
be involved in the export of bottromycin. bmbR is proposed to encode a negative 
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transcriptional regulator of the bottromycin biosynthetic gene cluster, as it has 32% 
identity to ArsR of Roseiflexus castenholzii (Gomez-Escribano et al., 2012). 
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Figure 1.14 Proposed pathway for bottromycin biosynthesis in S. bottropensis and S. 
scabies (Gomez-Escribano et al., 2012). 
1.5 Siderophores 
Siderophores are low molecular weight organic molecules produced by bacteria and 
fungi (Neilands, 1995). The iron is present in the environment mainly in the ferric 
form, for example as iron (III) hydroxide, which is not very soluble in water at 
neutral pH; therefore, it cannot be taken up directly by microorganisms.To overcome 
this many bacteria secrete siderophores into the environment, where they strongly 
chelate iron (III). The iron complex is then actively transported back into the cell 
(Kraemer, 2005).
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The ability of the siderophore to chelate iron results from formation of stable 
multidentate (e.g. hexadentate) complexes with iron (III). This is possible due to the 
presence of iron-chelating ligands in the siderophores structure. The most commonly 
observed are one to several bidentate oxygen ligands, such as hydroxamates (e.g. in 
desferrioxamine E), catecholates (e.g. in enterobactin), or α-hydroxycarboxylates 
(e.g. in achromobactin; Figure 1.15; Miethke and Marahiel, 2007). Some 
siderophores contain oxygen and nitrogen heterocyclic structures to chelate ferric 
iron (e.g. pyochelin; Figure 1.15; Miethke and Marahiel, 2007). 
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Figure 1.15 Structures of several siderophores (chelating atoms are highlighted in 
blue; Miethke and Marahiel, 2007). 
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Iron is required for many mammalian cell processes, such as gene regulation, DNA 
synthesis, oxygen transport, respiration and lipid metabolism to name a few 
(Recalcati et al., 2006). To perform these functions iron is incorporated into 
haemoglobin, myoglobin and cytochromes. It is also a part of non-haeme structures, 
e.g.iron-sulfur motifs found in the prosthetic groups of some proteins (Meyer, 2008). 
In plants, iron is required for chlorophyll formation and for metabolism (Marsh et al., 
1963). Iron is also essential for bacterial growth. Iron acquisition, through the 
production and release of siderophores, is necessary for the succesful infection of 
mammalian hosts by bacterial pathogens (Miethke and Marahiel, 2007). For 
example, mycobactin, a siderophore produced by M. tuberculosis, is able to extract 
iron from macrophages (Luo et al., 2005). Siderophore-mediated iron acquisition can 
be inhibited by the mammalian host protein siderocalin, which binds to siderophores 
released by the pathogen. However, some bacteria have developed a way to 
circumvent this defense mechanism through the production of siderophores, to 
which, siderocalin cannot bind. An example of this resistance mechanism is found in 
Vibrio cholera, which produces the siderophore vibriobactin (Li et al., 2012). 
1.5.1 Siderophores Biosynthesised via NRPS-Dependent Pathways 
Many siderophores are biosynthesised by enzymes belonging to the family of 
nonribosomal peptide synthetases (NRPSs; Challis, 2005). They catalyse the 
condensation of amino acids to form biologically-active peptides. These molecules 
commonly possess structural features, such as non-proteinogenic amino acids, 
hydroxy acids, heterocyclic rings and other unusual modifications in their backbone. 
Products of NRPSs include not only siderophores but other pharmacologically 
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significant compounds, for example the antibiotics penicillin (Smith et al., 1990), 
vancomycin (Wageningen et al., 1998), gramicidin (Kessler et al., 2004) and 
immunosuppressive agents such as cyclosporine (Finking and Marahiel, 2004).  
NRPS enzymes consist of a number of repeat units referred to as modules. Each 
module is generally responsible for the extension of the growing peptide chain by 
one amino acid residue, as well as any modifications to be made to the selected 
amino acid. The number and order of amino acids in the peptide being synthesized 
corresponds to the order of modules in the NRPS, with exceptions, such as 
coelichelin (Barona-Gomez, 2006). 
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Figure 1.16 Steps of nonribosomal peptide biosynthesis, domains: A – adenylation, T 
(PCP) – thiolation, C – condensation, TE – thioesterase. 
 
Each module consists of a set of different domains. Each NRPS chain elongation 
modules usually contains adenylation (A), thiolation (T) (also known as the peptidyl 
carrier protein-PCP), and condensation (C) domains (Figure 1.16; Challis and 
Lautru, 2004). These chain elongation modules may also contain additional or 
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alternative domains such as epimerisation (E), methylation (M), and 
heterocyclization (Cy), which introduce modifications to the amino acid incorporated 
by the module into the biosynthesized polypeptide chain. Another two modules 
usually present in the NRPS are a loading module, consisting only of A and T 
domains; and a chain terminating module containing the thioesterase (TE) domain 
(Figure 1.16). 
The adenylation (A) domain is considered to have a primary role in substrate 
selectivity of the module. During nonribosomal peptide biosynthesis (Figure 1.16), 
the A domain firstly recognises the amino acid being incorporated, activates it as an 
amino acyl adenylate and then transfers it to the adjoining T domain (Figure 1.17). 
The activated amino acid is linked to the T domain via a covalent bond as a thioester 
to the 4’-phosphopantetheinyl (4’Ppant) arm of the T domain. The 4’Ppant is 
posttranslationally attached to a conserved serine of the T domain. This reaction is 
carried out by a broad specificity phosphopantetheinyl transferase, which catalyses 
the attack of a conserved serine residue in the T domain on the diphosphate group of 
coenzyme A. 3', 5'-adenosine diphosphate (ADP) is released and the T domain with a 
phosphopantetheine thiol group is generated (Figure 1.18; Walsh et al., 1997).  
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Figure 1.17 The A domain reaction catalysis: the activation of the amino acid 
substrate through the formation of an aminoacyl adenylate followed by the covalent 
binding via a thioester bond to the 4’Ppant cofactor of the PCPdomain. 
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Figure 1.18 Reaction catalysed by PPTases. The apo is the inactive form, lacking the 
phosphopantetheinyl arm and the holo is the active form. 
 
Elongation of the growing peptide chain is then carried out by the condensation (C) 
domain, which joins the amino acid attached to the T domain of its module with an 
amino acid attached to the T domain of the downstream module. This is achieved by 
the nucleophilic attack of α-amino group of the peptidyl chain, tethered to the 
downstream T domain, on the thioester carbonyl group of the the amino acid bound 
to the upstream T domain (Figure 1.19; Challis and Lautru, 2004). 
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Figure 1.19 The catalytic mechanism of condensation (C) domains. 
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The final step of polypeptide biosynthesis is release of the peptide from the NRPS, 
which is usually catalysed by a TE domain located at the C terminal end of the last 
module of the NRPS. The first structure of a TE domain was solved in 2002 
(Brunner et al., 2002). It showed that TE domains contain the catalytic residues 
Ser80, His207 and Asp107, which catalyse the cleavage of the peptidyl thioester 
bond resulting in the formation of a peptidyl-O-TE intermediate. This intermediate 
can be attacked by an external nucleophile, usually a water molecule (hydrolysis) or 
by an intramolecular nucleophile (cyclization) resulting in the release of the peptide 
(Figure 1.20; Donadio et al., 2007; Challis and Lautru, 2004).  
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Figure 1.20 The release of peptide from NRPS catalysed by TE domain. 
1.5.1.1 NRPS siderophore pathway-Enterobactin Biosynthesis 
 
One of the earliest and most comprehensive studies of an NRPS pathway is the 
biosynthesis of catecholate siderophore enterobactin (Oves-Costales et al., 2009). 
The discovery of enterobactin (also named enterochelin) was first reported in 1970 
and this compound was found to be a metabolite produced by Escherichia coli. The 
biosynthesis of enterobactin and its ferric complex uptake mechanism have since 
been elucidated. The total chemical synthesis of enterobactin was reported in 2003 
PhD Thesis: Joanna Bicz                                                                     Chapter 1: Introduction 
 
 
33 
 
(Raymond et al., 2003). The three catecholate moieties in the enterobactin structure 
allow it to form a very stable ferric complex. 
The entABCDEF gene cluster of E. coli encodes the enzymes responsible for 
enterobactin biosynthesis. Chorismate, a precursor in aromatic amino acid 
biosynthesis, is converted into 2, 3-dihydroxybenzoic acid (2, 3-DHB) by EntA, 
which is the N-terminal domain of EntB and EntC (Rusnak et al., 1990). The three 
molecules of 2,3-DHB are joined with three molecules of L-serine via three amide 
and three ester linkages to form enterobactin (Figure 1.21; Liu et al., 1990; Rusnak et 
al., 1989). EntE is a stand-alone adenylation (A) domain catalysing the acylation of 
the C-terminal thiolation (T) domain of EntB with 2, 3-DHB (Rusnak et al., 1989; 
Reichert et al., 1992).
 
The EntF protein contains C, A and T domains and a TE 
domain is also present at its C-end. The adenylation (A) domain of EntF catalyses 
the adenylation of the carboxyl group of L-serine and subsequent acylation of the T 
domain of EntF. The EntF condensation (C) domain catalyses the formation of an 
amide bond between the amino group in the L-serinyl thioester with the DHB–EntB 
thioester to form a 2, 3-DHB-L-serinyl-EntF thioesters (Figure 1.21). This is then 
transacylated with the active Ser residue of the EntF thioesterase (TE) domain to 
form a 2, 3-DHB-L-serinyl-TE ester (Reichert et al., 1992). 
The formation of second 2, 3-DHB-L-serinyl thioester is catalysed by EntF 
condensation domain and then the TE domain catalyses its condensation with the 2, 
3-DHB-L-serinyl-TE ester (Figure 1.22; Shaw-Reid et al., 1999). In this way the 
dimeric ester is formed. The same process is repeated to form a trimeric ester, which 
then undergoes macrocyclisation catalysed by the EntF TE domain to release 
enterobactin (Figure 1.22). 
PhD Thesis: Joanna Bicz                                                                     Chapter 1: Introduction 
 
 
34 
 
TE
OH
O
HN O
HO
HO
HO
S
TC
SH
TICL +TE
OH
O
NH2
HO
S
TCTICL + A
S O
HO
HO
TICL
S O
HO
HO
TICL
SH
O
HO
HO
HO
TE
OH
O
NH2
HO
S
TC A
A
EntE
ATP
EntB EntB
EntF
ATP
TE
OH
SH
TC A
EntF
O
NH2
HO
OH
EntF EntFEntBEntB
A
 
Figure 1.21 Biosynthetic pathway of enterobactin. Reactions catalysed by EntE and 
EntF enzymes in the assembly of an L-N-(2, 3-dihydroxybenzoyl) serinyl thioester 
intermediate (Oves-Costales et al., 2009). ICL (EntA)-Isochorismate lyase. 
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Figure 1.22 Biosynthetic pathway of enterobactin. Oligomerization and 
macrocyclization reactions catalyzed by the TE domain of EntF from the L-N-(2, 3-
dihydroxybenzoyl) serinyl thioester intermediate (Oves-Costales et al., 2009). 
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1.5.2 Siderophores Assembled via NRPS-Independent Siderophore (NIS) 
Pathway 
Siderophores containing dicarboxylic acid and diamine building blocks are 
biosynthesised by a structurally distinct family of synthetases, the NRPS-
independent siderophore synthetases (NISs). In the last two decades over 40 species 
of bacteria were found to contain genes encoding for NIS synthetases, which are 
involved in biosynthesis no less than ten different siderophores (Challis, 2005). The 
first characterised NIS pathway was the aerobactin biosynthetic pathway (Neilands 
1986).
 
Following on from this discovery, several more NIS-derived siderophores 
were identified including rhizobactin, alcaligin, desferrioxamines, vibrioferrin, 
staphylobactin, anthrachelin and achromobactin. Genetic studies demonstrated that 
all these siderophore biosynthetic gene clusters encode at least one enzyme with high 
sequence similarity to the aerobactin siderophore synthetases. Biosynthesis of 
siderophores via an NIS pathway involves the activation of carboxylic acid 
substrates to their corresponding acid adenylates. The NISs can be divided into three 
subtypes depending on which type of carboxylic acid substrate is recognised and 
activated (Berti and Thomas, 2009). Type A NISs are specific for citrate, type B for 
α-ketoglutarate and type C for ester or amid derivatives of carboxylic acid (Oves-
Costales et al., 2009).
  
The type A NISs are homologs of the IucA synthetase, type B 
are homologs of IucD and the type C enzymes are similar to IucC. All of which are 
present in the aerobactin biosynthetic pathway. 
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1.5.2.1 Aerobactin Biosynthesis- an archetypal NIS pathway. 
Aerobactin is a virulence factor produced by a number of Gram-negative species, 
including Escherichia coli, Shigella, Yersinia and Salmonella (Warner et al., 1981).
 
This siderophore forms a stable hexadentate complex with ferric iron using its 
carboxylate and hydroxamate groups (Figure 1.23). 
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Figure 1.23 Proposed pathway for aerobactin biosynthesis. A-Biosynthesis of N6-
acetyl-N6-hydroxylysine (AHL) from L-lysine catalysed by IucB and IucD. B-
biosynthesis of aerobactin catalysed by IucA and IucC (Challis, 2005). 
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The aerobactin biosynthetic gene cluster was first identified on the pColV-K30 
plasmid in E. coli. It consists of five genes, of which four (iucABCD) direct 
aerobactin biosynthesis (Figure 1.24), while the fifth (iutA) encodes an outer-
membrane receptor protein involved in the uptake of the ferric-aerobactin complex 
(Challis, 2005). The iucD and iucB genes encode a FADH2-dependent 
monooxygenase and an acetyl-CoA-dependent acyltransferase, respectively. They 
catalyse the first two steps of aerobactin biosynthesis (Figure 1.23 A). IucD catalyses 
the conversion of L-lysine to L-N6-hydroxylysine and IucB catalyses the conversion 
of L-N6-hydroxylysine to L-N6-acetyl-N6-hydroxylysine (AHL; Carbonetti and 
Williams, 1984; Cox, 1982). The iucA is proposed to encode a synthetase catalysing 
the condensation of the α-amino group in L-N6-acetyl-N6-hydroxylysine with one of 
the prochiral carboxyl groups of citric acid to form N6-acetyl-N2-citryl-N6-hydroxy-
L-lysine (Figure 1.24). The iucC is proposed to encode a homologue of IucA 
synthetase, which catalyses the condensation of the product of the IucA-catalysed 
reaction with a second molecule of L-N6-acetyl-N6-hydroxylysine to form 
aerobactin (Challis, 2005; Figure 1.23). 
 
Figure 1.24 Aerobactin biosynthetic gene cluster. 
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1.6 Investigations of Cryptic Siderophore Biosynthetic Pathways 
encoded for in the S. scabies 87.22 genome. 
Not much is known about the significance of siderophores in bacterial plant 
pathogenicity. Investigations into siderophore mediated iron acquisition and its role 
in plant pathogenicity has only been explored in Gram-negative bacteria known to be 
plant pathogens. For example, the siderophore pyoverdine plays a key role in the 
infection of tobacco by Pseudomonas syringae pv. tabaci 6605 (Sriyosachati and 
Cox, 1986). The presence of iron aids the transcription of virulence genes during 
speck disease in tomato by Pseudomonas syringae pv. tomato DC3000 (Kim et al., 
2009). However, to date, siderophore-mediated iron uptake and its role in plant 
pathogenicity has not been explored as extensively in Gram-positive bacteria. One 
Gram-positive strain, where studies into this have been undertaken, is the plant 
pathogen S. scabies 87.22.  
1.6.1 Pyochelin  
Analysis of the S. scabies 87.22 genome (http://strepdb.streptomyces.org.uk/) 
uncovered a putative gene cluster for the biosynthesis of pyochelin, a previously 
characterised siderophore. Pyochelin (Figure 1.25) produced by the mammalian 
pathogen Pseudomonas aeruginosa (Cox et al., 1981)
 
is known to be a virulence 
factor in these bacteria, as it plays an important role in the infection in mice (Cox, 
1982). This is because pyochelin is able to take up iron from transferrin and 
lactoferrin present in the blood serum of mammals and use it for bacterial growth 
(Akenbauer et al., 1995). 
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Figure 1.25 Structure of pyochelin (Cox, 1982). 
1.6.1.1 Pyochelin Biosynthesis in P. aeruginosa 
Pyochelin is a siderophore that contains a thiazoline/thiazolidine moiety and its 
biosynthesis in Pseudomonas aeruginosa, has been fully characterised (Cox, 1982; 
Takase et al., 2000). The pyochelin biosynthetic gene cluster in P. aeruginosa 
(Figure 1.26) encodes seven proteins PchABCDEFG, which are required for 
pyochelin biosynthesis (Figure 1.27; Cox et al., 1981; Reinmann et al., 2001). 
 
Figure 1.26 Organization of the pyochelin biosynthetic gene cluster in P. aeruginosa 
PAO1. 
 
PchA and PchB catalyse the biosynthesis of salicylate from chorismate (Serino et al., 
1995). A stand-alone A domain, PchD, then adenylates salicylate and subsequently 
loads it onto the thiolation domain of PchE NRPS multienzyme (Figure 1.27). The A 
domain of PchE catalyses the acylation of cysteine onto the C-terminal T domain, 
and the Cy (heterocyclization) domain catalyses condensation of the cysteinyl 
thioester with the salicylic thioester to form a peptide bond. An MT-like domain 
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embedded within the A domain of PchE is then proposed to catalyse the 
epimerization of the α-carbon of the resulting thioester (Patel et al., 2003). The Cy 
domain, then, catalyses the cyclodehydration to yield a 2-hydroxyphenyl-thiazolinyl 
thioester intermediate.  
The A domain of PchF catalyses the cis loading of cysteine onto its T domain, and 
the Cy domain of PchF catalyses amide bond formation between the cysteinyl 
thioester and the 2-hydroxyphenyl-thiazolinyl thioester on PchE. Subsequent 
cyclodehydration results in a formation of a bis-thiazolinyl thioester intermediate. 
PchG catalyses NADPH-dependent reduction of one of the thiazoline rings to the 
corresponding thiazolidine and an MT domain in PchF catalyzes the S-
adenosylmethionine (SAM)-dependent N-methylation of the thiazolidine. The TE 
domain of PchF catalyses hydrolysis of the thioester bond in the resulting 
intermediate yielding pyochelin (Reinmann et al., 2001; Serino et al., 1995; Serino et 
al., 2003). 
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Figure 1.27 Biosynthesis of pyochelin. NRPS domains: T-thiolation, Cy-
heterocyclization, A-adenylation, MT-methyltransferase, TE-thioesterase (Reinmann 
et al., 2001; Serino et al., 1995; Serino et al., 2003). 
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1.6.1.2 Sequence Analysis of the S. scabies Pyochelin Biosynthetic Gene Cluster. 
The pyochelin biosynthetic gene cluster (PBGC) in S. scabies contains 12 genes 
(Figure 1.28; Cox, 1982). Six of these genes encode proteins (Scab1381, Scab1411, 
Scab1421, Scab1461, Scab1471 and Scab1481) that are proposed to be analogous in 
function to the pyochelin biosynthetic proteins PchABCDEFG from P. aeruginosa 
(Patel and Walsh, 2001; Quadri et al., 1999; Serino et al., 1997).
 
 
Figure 1.28 Organisation of pyochelin biosynthetic gene clusters in S. scabies 87.22, 
P. aeruginosa PAO-1and P. fluorescens Pf-5 (Seipke et al., 2011; Youard et al., 
2007). 
 
Scab1381 encodes for a putative salicylate synthase and it contains an anthranilate 
synthase domain. Scab1411 is predicted to be AMP-ligase, which contains putative 
active site residues that are highly similar to the active site residues of MbtA, an 
AMP-ligase from Mycobacterium tuberculosis. MbtA catalyses the adenylation of 
salicylate in mycobactin biosynthesis (Challis et al., 2000; Quadri et al., 1998; 
Rausch et al., 2005). Two genes scab1481 and scab1471, encode proteins with 
putative functions analogous to PchF and PchE, respectively, both of which are 
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NRPS enzymes in P. aeruginosa (Figure 1.28). Scab1481, which is analogous to 
PchE, is proposed to catalyse the formation of a 2-hydroxyphenylthiazolinyl 
thioester from the salicyl adenylate and Scab1471 adds a second molecule of the 
cysteine to the thioester to form 2-hydroxyphenylbis-thiazolinyl thioester attached to 
the T domain of Scab1471 in a manner analogous to PchF (Figure 1.27). Scab1461 is 
predicted to encode a reductase enzyme homologous to PchG. It is proposed to 
catalyse the reduction of one of the thiazoline rings in the thioester. N-methylation of 
the reduced thiazoline ring and the release of the pyochelin by the N-terminal 
thioesterase domain is catalysed by Scab1471 (Patel and Walsh, 2001). Scab1421 
protein is predicted to be a homolog of PchC, a proofreading thioesterase, which 
catalyses removal of wrongly charged molecules from the PchE and PchF thiolation 
domains (Reinmann et al., 2004). The analysis of the S. scabies genes indicates that 
they encode proteins, which have identical properties to the pyochelin biosynthetic 
proteins PchABCDEFG from P. aeruginosa and indicates that S. scabies may be a 
producer of pyochelin. 
Other genes from the putative pyochelin gene cluster, such as scab1401 encodes a 
pathway specific regulator homologous to PchR, a pyochelin-responsive repressor 
protein in P. aeruginosa and Scab1401 is a TetR family transcriptional regulator. 
Analysis of the transcription of the PBGC revealed that scab1371 is a positive 
transcriptional regulator of the cluster and it is co-transcribed with the scab1381, 
predicted to encode salicylate synthase. Putative transport proteins are encoded for 
by scab1431, scab1441 and scab1451. 
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There are also some differences between the biosynthetic proteins in P. aeruginosa 
and S. scabies. Formation of salicylate from chorismate is catalysed in P. aeruginosa 
by two proteins PchA and PchB (Serino et al., 1995) while in S. scabies 87.22 a 
single protein, Scab1381, is predicted to catalyse the same reaction. Another 
difference is that the S. scabies pyochelin gene cluster does not contain an ortholog 
of the P. aeruginosa fptX gene encoding the inner membrane pyochelin permease. 
The gene is not encoded anywhere else in the S. scabies genome and therefore, it is 
speculated that one of the putative transport proteins Scab1431, Scab1441 or 
Scab1451 within the cluster may be used for the import of ferric-pyochelin in S. 
scabies (Seipke et al., 2011). 
1.6.1.3 Biosynthesis of Enantio-Pyochelin in Pseudomonas fluorescens  
Pyochelin is biosynthesised from salicylate and two molecules of cysteine. During 
thiazoline ring formation in P. aeruginosa, the α-carbon of the first cysteine residue 
undergoes epimerisation, which results in the conversion of cysteine to its D-
isoform, whereas the second cysteine remains as L-isoform (Figure 1.27). This 
results in the formation of two pyochelin diastereoisomers with the stereochemistry 
4’R, 2’’R, 4’’R for pyochelin I and 4’R, 2’’S, 4’’R for pyochelin II (Youard et al., 
2007). Other closely related strains P. fluorescens Pf-5 and CHA0 were found to 
produce an enantiomer of pyochelin named enantiopyochelin (Figure 1.29). 
Enantiopyochelin was found to facilitate growth under iron-deficient conditions in P. 
fluorescens and to induce the expression of its biosynthetic genes, however, it did not 
promote growth in P. aeruginosa. On the other hand, pyochelin from P. aeruginosa 
did not promote growth, nor induce the expression in P. fluorescens. Comparison of 
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the pyochelin biosynthetic gene cluster between P. aeruginosa and P. fluorescens 
(Figure 1.28) highlighted three main differences. Firstly, in P. aeruginosa the 
biosynthetic genes are organised in two operons, while in P. fluorescens the genes 
are in one operon. Secondly, PchE in P. fluorescens does not contain the 
epimerisation domain and finally the predicted function of PchK in P. fluorescens is 
not homologous to PchG in P. aeruginosa. PchG is a thiazoline reductase and PchK 
is predicted to have reductase and/or epimerase function. The amino acid sequences 
of other of P. aeruginosa and P. fluorescens pch genes are between 35 and 60% 
identical (Youard et al., 2007). 
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Figure 1.29 Stereoisomers of pyochelin (P. aeruginosa) and ent-pyochelin (P. 
fluorescens).  
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1.6.2 Desferrioxamines. 
Desferrioxamines are a group of siderophores containing three hydroxamic acid 
ligands, which form a hexadentate complex with ferric iron (Miller, 1989).
 
Desferrioxamines include the linear trimer desferrioxamine G1, the hetero-oligomer 
desferrioxamine B and the 33-membered macrocyclic desferrioxamine E (Figure 
1.30). They are biosynthesised by several Streptomyces species (Bickel et al., 1960). 
S. coelicolor has been shown to produce desferrioxamine G1 and E (Imbert et al., 
1995) and S. viridosporus has been shown to produce desferrioxamine B and E 
(Imbert et al., 1995). S. pilosus has been found to take up ferrioxamines B and E, S. 
lividans B and G1 and S. viridosporus B, E and G1 (Muller and Raymond, 1984, 
Imbert et al., 1995).
 
Desferrioxamine B is used clinically for the treatment of iron 
poisoning in human body. 
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Figure 1.30 Structure of desferrioxamines E, B and G1. 
 
Analysis of the S. coelicolor M145 genome sequence identified a cluster of six genes 
(desEFABCD) that direct the biosynthesis of desferrioxamines E and B (Figure 
1.31). The Des cluster is also conserved in S. avermitilis and S. ambofaciens 
(Barona-Gomez et al., 2004).  
Analysis of the S. scabies 87.22 genome sequence resulted in the identification of a 
cryptic biosynthetic gene cluster, which includes the protein coding sequences 
Scab57921–Scab57981 (Figure 1.31). These proteins are homologs of proteins 
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encoded for by genes in the desferrioxamine biosynthetic gene cluster of S. 
coelicolor A(3)2 (Table 1.3). Preliminary LC-MS analysis of S. scabies culture 
supernatants indicated that S. scabies also produces desferrioxamines (Song and 
Challis, unpublished data). 
 
Figure 1.31 Organistation of the gene cluster directing desferrioxamine biosynthesis 
and ferrioxamine uptake in S. coelicolor M145 and in S. scabies 87.22. 
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Table 1.3 Putative proteins function encoded by the desferrioxamine biosynthetic 
gene cluster in S. scabies 87.22 
 
S. scabies 
gene 
desferrioxamine 
biosynthesis protein (Des) 
Sequence similarity with S. 
coelicolor A3(2) des cluster (%) 
scab57921 DesD hypothetical protein SCO2785 (81%) 
 
scab57931 DesC aceytltranferase        SCO2784 (79%) 
 
scab57941 DesB monooxygenase        SCO2783 (80%) 
 
scab57951 DesA pyridoxal-dependent  
decarboxylase           SCO2782 (86%) 
scab57961 IS630 family insertion 
sequence 
no similar  protein  
scab57971 DesE hypothetical protein SCO2781 (75%) 
 
 
The first steps of desferrioxamine biosynthesis were investigated in Streptomyces 
pilosus, and involved elucidation of reactions catalysed by the enzymes DesA and 
DesB (Schupp at al., 1987, 1988), which have high sequence identity to PLP-
dependent amino acid decarboxylases and FAD-dependent amine monooxygenases, 
respectively. DesA and DesB are involved in the first two steps of desferrioxamine 
biosynthesis to form N-hydroxycadaverine from L-lysine (Figure 1.32 A).  
Investigations into the roles of DesC and DesD were carried out in the 
desferroxamine E biosynthetic pathway of S. coelicolor. The desC gene encodes an 
enzyme similar to acyl-CoA-dependent acyl transferases (Kadi et al., 2007)
 
and is 
proposed to catalyse the N-acylation of N-hydroxycadaverine (N. Kadi and G. L. 
Challis, unpublished data). DesC is predicted to have relaxed substrate specificity in 
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those bacteria, which also produce desferrioxamine B, catalysing acylation of N-
hydroxycadaverine with acetyl-CoA as well as succinyl-CoA, giving N-hydroxy-N-
acetylcadaverine (HAC) and N-hydroxy-N-succinylcadaverine (HSC), respectively 
(Figure 1.32 A; Barona-Gomez et al., 2004).  
The gene desD encodes a protein that has a high percentage sequence similarity to 
IucA and IucC from the aerobactin biosynthetic pathway, the first NIS enzymes to be 
characterised. Purified recombinant DesD was shown to catalyse the ATP-dependent 
conversion of chemically-synthesized HSC to desferrioxamines G1 and E. DesD 
catalyses the ATP-dependent trimerisation and macrocyclisation of HSC to yield 
desferrioxamine E (Figure 1.32 B) and the ATP-dependent condensation of two units 
of HSC with one unit of HAC to yield desferrioxamine B (Figure 1.32C; Barona-
Gomez et al., 2006). 
DesE is similar to ferric-siderophore
 
lipoprotein receptors and has been shown to 
bind ferrioxamines with high affinity and selectivity (Patel et al., 2010). DesF is 
similar to ViuB, which is
 
proposed to be a hydrolase involved in the release of iron 
from
 
ferric-vibriobactin. However, more recent sequence analyses suggest it is a 
ferric-siderophore reductase (Barona-Gomez et al., 2006). 
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Figure 1.32 Proposed pathways for desferrioxamine E and B biosynthesis. Proposed 
pathway for the biosynthesis of AHC and HSC. B-Biosynthesis of desferrioxamine E 
by DesD. C- Biosynthesis of desferrioxamine B by DesD (Kadi et al., 2007). 
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1.6.3 Novel Putative Hydroxamate Siderophore 
A novel tris-hydroxamate iron-chelating metabolite was originally discovered in 
Streptomyces antibioticus NBRC 13838 by Dr Shinya Kodani and coworkers 
(Shizuoka University, Japan), collaborators of the Challis group. Analysis of the S. 
scabies 87.22 genome sequence unveiled a cryptic NRPS biosynthetic gene cluster 
(Figure 1.33), which includes the protein coding sequences from Scab85431 to 
Scab85521, suggesting that it may encode an NRPS that directs the production of a 
hydroxamate-containing metabolite. All of these proteins, present within the NRPS 
biosynthetic gene cluster, are homologous to proteins encoded for by genes within 
the coelichelin biosynthetic gene cluster from S. coelicolor M145 (Table 1.4) 
(http://www.ncbi.nlm.nih.gov/nuccore/260644157).
 
 
Figure 1.33 Organization of the scabichelin biosynthetic gene cluster in S. scabies 
87.22. 
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Table 1.4 Putative proteins function encoded by the putative novel hydroxamate 
siderophore biosynthetic gene cluster in S. scabies 87.22. 
Protein Putative function  Homolog; origin Similarity/ 
identity 
(%) 
Scab85431 ABC transporter 
permease/ATPase component 
CchI; S. coelicolor 53/38 
Scab85441 ABC transporter 
permease/ATPase component 
CchG; S. coelicolor 58/46 
Scab85451 Ferric-siderophore 
lipoprotein receptor 
CchF; S. coelicolor 53/38 
Scab85461 
 
MbtH-like protein CchK; S. coelicolor 72/57 
Scab85471 Nonribosomal peptide 
synthetase 
CchH; S. coelicolor 60/48 
Scab85481 ABC transporter permease 
component 
CchC; S. coelicolor 65/47 
Scab85491 ABC transporter permease 
component 
CchD; S.coelicolor 60/45 
Scab85501 ABC transporter ATPase 
component 
CchE; S. coelicolor 74/60 
Scab85511 Formyl-tetrahydrofolate-
dependent formyl transferase 
CchA; S. coelicolor 85/76 
Scab85521 Flavin-dependent 
monooxygenase 
CchB; S. coelicolor 73/60 
 
The genes Scab85511 and scab85521 encode proteins homologous to CchA and 
CchB from S. coelicolor, respectively. CchA and CchB are involved in the 
biosynthesis of the non-proteogenic amino acid residues hydroxyornithine (hOrn) 
and formylhydroxyornithine (fhOrn), which are take part in the biosynthesis of 
PhD Thesis: Joanna Bicz                                                                     Chapter 1: Introduction 
 
 
55 
 
coelichelin. An NRPS multienzyme is encoded for by scab85471 and is proposed to 
be involved in the biosynthesis of a putative novel hydroxamate siderophore (Figure 
1.34; Lautru and Challis, 2004). 
Bioinformatic analysis of the functional domains of the NRPS encoded for by 
scab85471 revealed it contains 17 enzymatic domains assembled into 5 modules 
(Figure 1.34). Each module contains an adenylation (A), a thiolation (T) and a 
condensation domain (C) (http://www.nii.res.in/searchall.html). The final 
termination module of scab85471 also contains an epimerisation/condensation 
domain (Figure 1.34) suggesting that the stereochemistry of the peptide is L-L-L-L-
D. It is hypothesised that product of the scab85471 gene would be a pentapeptide, as 
it contains 5 modules. The substrate specificity of the adenylation domains in each 
module was predicted using the NRPS predictor online tool (Table 1.5; Raush et al., 
2005). 
 
It was predicted that modules 1, 2 and 3 of the NRPS probably have 
specificity for a L-N5-acyl-N5-hydroxyornithine, a L-Ser and a L-N5-
hydroxyornithine, respectively. The substrate specificity for the modules 4 and 5 
could not be predicted, indicating that unusual substrates may be used by these 
modules. Modules 1 and 3 of the NRPS contain N-methyltransferase (MT) domains 
suggesting that residues 1 and 3 could be N-methylated.  
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Figure 1.34 Organisation of modules and domains of the NRPS encoded by 
scab85471. 
 
Table 1.5 Predicted substrate specificity of adenylation domains in the Scab85471 
protein. 
 
Module number Substrate specificity Residue position 
1 hforn DVWILGAT 
2 ser DVWHLSLV 
3 horn DMENLGLI 
4 ? DGEDLGLS 
5 ? DAQXXXLV 
 
1.7 Products of Other Cryptic Pathways 
A family of polyketide natural products, which all contain a five-membered tetronate 
ring are known to have apoptotic and antibacterial properties (Hamaguchi et al., 
1995).
 
All these
 
natural products were found to be biosynthesised by both Gram-
negative and Gram-positive bacteria, including various Streptomyces species. 
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Examples of tetronate containing natural products are RK-682 (Figure 1.35) from 
Streptomyces sp. 88-68 and agglomerin antibiotics (Figure 1.35) from the Gram-
negative Pantoea agglomerans (Sun et al., 2010). 
 
O
OO
HO
OH
RK-682
O
OO
HO
agglomerin A  
Figure 1.35 Structures of tetronate polyketides. 
 
The common structural feature of tetronate natural products is the tetronic acid ring 
(Coloured blue in Figure 1.35). The mechanism of tetronic acid formation was 
elucidated during investigations into the biosynthesis of RK-682. This is proposed to 
involve an FabH-like protein, which is an enzyme belonging to a family of fatty acid 
synthases (Sun et al., 2010). 
Another common feature of these natural products is a polyketide backbone, which is 
assembled by enzymes belonging to the family of polyketide synthases (PKSs). 
Polyketides comprise a major group of structurally and functionally diverse natural 
products that include a broad range of clinically important compounds, such as 
antibiotics, immunosuppressants, antitumour, antifungal and antiparasitic agents 
(McMurry and Begley, 2005). Polyketides are biosynthesized by the condensation of 
extender units malonyl-, methylmalonyl- or ethylmalonyl-CoA with an acyl-CoA 
starter unit and are classified according to their structure into three types. Type I 
PKSs contain multiple catalytic domains for each reaction in the polyketide chain 
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assembly and are classified into modular and iterative systems. In type I modular 
PKSs each module is used only once to catalyse the elongation of the polyketide 
chain by a malonate extender unit, whereas in iterative systems the PKS modules are 
used for more than one elongation step. Type II PKSs are a group of monofunctional 
proteins where each protein catalyses a different reaction in the chain assembly. 
Type III PKSs are homodimers of identical keto synthase (KS) domains that do not 
use ACP domains in the polyketide chain assembly. They posses a single active site 
to catalyse different types of reactions, such as decarboxylations, condensations and 
cyclisations (Austin and Noel, 2002).  
Type I PKSs are involved in tetronate polyketide chain assembly. In a type I PKS the 
loading module contains an acyl transferase (AT) and an acyl carrier protein (ACP) 
A chain extension module consists of a minimum of three domains: an acyl 
transferase (AT), an acyl carrier protein (ACP) and a β-ketoacyl synthase (KS). In 
the first stage, the AT domain of the loading module loads the acyl-CoA starter unit 
and then transfers it to the adjacent ACP domain (Figure 1.36 A; McMurry and 
Begley, 2005). During chain extension the malonate extender unit is loaded onto the 
AT domain of the module 1 and then transferred onto the ACP domain within the 
same module (Figure 1.36 B; McMurry and Begley, 2005). The KS domain of 
module 1 then catalyses the decarboxylative Claisen condensation between the ACP 
bound acyl thioester of the module 1 with the acyl-ACP of the upstream loading 
module to extend the chain forming a β-ketothioester (Figure 1.37; McMurry and 
Begley, 2005). Additional domains, such as a ketoreductase (KR), a dehydratase 
(DH) and an enoyl reductase (ER) may be present in some extension modules. The 
KR domain catalyses the NADPH-dependent reduction of the β-carbon to form a β-
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hydroxy thioester (Figure 1.38; McMurry and Begley, 2005). The DH domain 
catalyses the conversion of the β-hydroxy thioester to an α, β-unsaturated thioester 
by removal of water (Figure 1.39; McMurry and Begley, 2005). The ER domain 
catalyses the NADPH-dependent reduction of the α, β-unsaturated double bond to 
form a saturated bond (Figure 1.40; McMurry and Begley, 2005). 
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Figure 1.36 Reaction catalysed by AT domains. A-loading, B-chain extension  
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Figure 1.37 Reaction catalysed by KS domain. 
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Figure 1.38 Reaction catalysed by KR domain. 
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Figure 1.39 Reaction catalysed by DH domain. 
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Figure 1.40 Reaction catalysed by ER domain. 
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1.7.1 RK-682 
RK-682 (3-hexadecanoyl-5-hydroxymethyl-tetronic acid; Figure 1.35) is a model 
tetronate containing polyketide, originally isolated from Streptomyces sp. 88-682 
(Hamaguchi et al., 1995). It is an inhibitor of protein phosphatases and of HIV-1 
proteinase. The RK-682 biosynthetic gene cluster was heterologously expressed in 
Saccharopolyspora erythraea JCB2, which does not produce erythromycin, thus 
allowing the production of RK-682, to be easily detected (Sun et al., 2010).
 
Nine genes, RkA-RkI, were identified in the RK-682 biosynthetic gene cluster in 
Streptomyces sp. 88–682 (Figure 1.41). The genes from this cluster code for the 
following proteins: rkI-TetR-family transcriptional regulator; rkH- antibiotic efflux 
protein; rkA- palmitoyl-CoA synthetase; rkB and rkF- acyl carrier proteins; rkC, 
modular PKS containing KS, AT and ACP domains; rkD-FabH-like protein; rkE- 
FkbH-like glyceryl-S-ACP synthase; rkG -type II thioesterase (TEII). It was 
determined that expression of all nine genes from the RK-682 cluster from the 
original host is required for similar production levels in Saccharopolyspora 
erythraea. The putative Rk proteins were later expressed and purified from E. coli 
allowing the steps of the RK-682 biosynthetic pathway to be reconstituted in vitro 
(Sun et al., 2010). 
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Figure 1.41 RK-682 biosynthetic gene cluster in Streptomyces sp. 88-682 (Sun et al., 
2010). 
 
RkA, which is a putative acyl-CoA synthetase, would activate palmitic acid and load 
it onto the stand-alone ACP, RkB, forming a palmitoyl-S-RkB complex (Figure 
1.42). The chain would then be elongated by the PKS, RkC, which catalyses the 
incorporation of one malonyl-CoA unit, resulting in the formation of 3-oxo-stearoyl-
S-RkC. In parallel, RkE would catalyse both the transfer of D-1,3-
bisphosphoglycerate to RkF, a second stand-alone ACP, and its subsequent 
dephosphorylation, to form glyceryl-S-RkF. RkD, which is a putative 3-oxoacyl-
ACP synthase (FabH-like), would then catalyse the condensation of glyceryl-S-RkF 
and 3-oxo-stearoyl-S-RkC to yield RK-682.  RkD is proposed to to catalyse the C-C 
and C-O tetronate bond formation in RK-682 (Sun et al., 2010).
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Figure 1.42 Proposed biosynthetic pathway of RK-682 (Sun et al., 2010). 
 
1.7.2 Agglomerins 
Agglomerins A (Figure 1.43), B, C and D were originally extracted from the culture 
broth of a bacterial strain, identified as Pantoea agglomerans PB-6042 (formerly 
Enterobacter agglomerans), in the late 80’s by Shoji and co-workers (Shoji et al 
1989). P. agglomerans belong to a family of Gram-negative aerobic bacteria, known 
as Enterobacteriaceae. This strain can either be commensal or pathogenic to plants 
and is commonly found in diverse environments, including water, soil or sediments 
(Cruz et al., 2007; Shoji et al., 1989). Several strains of P. agglomerans are used 
comercially in the United States as biological control agents, against the fire blight 
pathogen (Erwinia amylovora) on apple trees (Wodzinski et al., 1994; Johnson and 
Stockwell et al., 1998). This species is currently also considered as an opportunistic 
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human pathogen due to several clinical reports of local or systemic infections in 
immunocompromised patients (Cruz et al., 2007). 
Analysis of the biological properties of agglomerins indicated its activity is 
predominantly against a broad range of anaerobic Gram-positive and Gram-negative 
bacteria, for example Clostridium difficile, Bifidobacterium bifidum, Eubacterium 
aerofaciens, and to a lesser extent against aerobic Gram-positive bacteria, for 
example Streptococcus pneumoniae and Staphylococcus aureus (Shoji et al., 1989). 
Agglomerins are structurally similar to RK-682. 
 
O
OO
HO
agglomerin A  
Figure 1.43 Structure of agglomerin A (Shoji et al., 1989). 
 
1.8.3 Cryptic Tetronate Biosynthetic Gene Cluster in S. scabies 87.22.  
Analysis of the S. scabies 87.22 genome revealed that it encodes a number of 
secondary metabolite biosynthetic gene clusters (Table 1.2; Yaxley, 2009). The 
products of some of these secondary metabolite biosynthetic gene clusters are 
currently unknown; such clusters are referred to as ‘cryptic’ biosynthetic gene 
clusters. One of the cryptic secondary metabolite biosynthetic gene clusters 
identified in S. scabies 87.22 (Figure 1.44) is predicted to encode proteins for the 
biosynthesis of a novel tetronate-like secondary metabolite similar to RK-682 from 
Streptomyces sp. 88-682 and to agglomerin antibiotics from Pantoea agglomerans 
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(Figure 1.43). It encodes genes with high sequence similarity to those present in the 
RK-682 biosynthetic gene cluster, such as a type I PKS, an acyl-CoA 
synthetase/dehydrogenase, an ACP, a FabH-like protein, and an FkbH-like protein. 
 
Figure 1.44 Cryptic polyketide tetronate biosynthetic gene cluster in S. scabies 87.22 
(Challis, unpublished). 
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Table 1.6 Putative proteins function encoded by the putative tetronate biosynthetic 
gene cluster in S. scabies 87.22. 
Protein Putative function  Homolog; origin Identity (%) 
 
scab62881 FkbH-like protein 
 
RkE; Streptomyces sp.88-682     66.1 
scab62891 Unknown 
 
                       -        - 
scab62901 Acyl-CoA synthetase 
 
RkA; Streptomyces sp.88-682     66.4 
scab62911 
 
Acyl-CoA dehydrogenase Acyl-CoA dehydrogenase,  
S. clavuligerus ATCC 27064 
 
     83 
scab62921 Acyl-CoA dehydrogenase 
 
Acyl-CoA dehydrogenase,  
S. clavuligerus ATCC 27064 
 
    85 
scab62931 Acyl carrier protein 
 
RkB; Streptomyces sp.88-682     63.9 
scab62941 Type I modular PKS 
 
RkC; Streptomyces sp.88-682     67.9 
scab62951 FabH-like protein 
 
RkD; Streptomyces sp.88-682     71.7 
scab62961 Acyl carrier protein 
 
RkF; Streptomyces sp.88-682      64.8 
scab62971 Acyl transferase (ChlD3-
like protein) 
 
Acyl transferase,  
S. clavuligerus ATCC 27064 
 
      82 
scab62981 PPtase                                                                   
 
PPtase, S. clavuligerus ATCC 
27064 
 
      83 
scab62991 α,β-hydrolase (ChlD4-
like protein) 
α,β-hydrolase, S. clavuligerus 
ATCC 27064 
 
      86 
 
Based on the sequence analysis of the RK-682 biosynthetic gene cluster and the S. 
scabies 87.22 putative tetronate biosynthetic gene cluster it is likely that the S. 
scabies tetronate metabolite is assembled in a way analogous to RK-682. 
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The starting point of the S. scabies tetronate assembly would be the activation of an 
acyl group by the putative acyl-CoA synthetase, Scab62901, followed by loading 
onto the ACP, Scab62961, to form an acyl-S-ACP intermediate (Figure 1.44). The 
chain would then be elongated by the putative PKS, Scab62941, which would result 
in the formation of a β-ketothioester. In parallel, an FkbH-like protein, Scab62881, 
would catalyse the transfer of 3-bisphosphoglycerate to the ACP, Scab62931 and 
dephosphorylation by the same enzyme yields the glyceryl-S-ACP intermediate. 
Scab62951, which is a FabH-like protein, would then catalyse the condensation of 
the glyceryl-S-ACP intermediate with the polyketide chain attached to Scab62941, to 
form the tetronate ring. A further two steps are likely to be involved in S. scabies 
tetronate product formation, which are not present in RK-682 biosynthesis. These are 
reactions catalysed by a putative acyl-transferase, Scab62971, (ChlD3-like), and by a 
putative hydrolase, Scab62991, (ChlD4-like). 
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Figure 1.45 Proposed biosynthetic pathway for cryptic tetronate product in S. scabies 
87.22 (Challis, unpublished). 
PhD Thesis: Joanna Bicz                                                                     Chapter 1: Introduction 
 
 
68 
 
1.8 Aims of the Project 
The aim of this project is to investigate cryptic secondary metabolite biosynthetic 
gene clusters in S. scabies 87.22. 
S. scabies 87.22 has become a model organism for studying plant-microbe 
interactions among Gram-positive plant pathogenic bacteria and the genome 
sequence for this strain is now published (GenBank Accession no. FN554889). Three 
out of four of the biosynthetic gene clusters investigated in this work are responsible 
for the production of the siderophores pyochelin, scabichelin and desferrioxamines, 
which are iron-chelating molecules. Iron acquisition through the use of siderophores 
is crucial for the development of infection in the mammalian host by pathogenic 
bacteria (Miethke and Marahiel, 2007). Studies of iron uptake were mostly 
conducted in Gram negative bacteria, whereas investigations into iron acquisition by 
Gram positive plant pathogens remained limited. Analysis of the S. scabies 
secondary metabolite biosynthetic gene clusters and its metabolic products is 
important to increase the understanding of its potential role in plant pathogenicity. 
For example, several genes encoding for the biosynthesis of plant toxins in these S. 
scabies secondary metabolite biosynthetic gene clusters, were found to be significant 
virulence factors. Awareness of these virulence factors can be used in the future in 
the agrochemical development to prevent infection by that pathogen potentially 
saving important agricultural crops from damage. 
 
The first objective of this project was to confirm that pyochelin is the product of the 
putative pyochelin biosynthetic gene cluster in S. scabies. Analysis of the pyochelin 
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gene cluster mutants was planned to determine if the gene knockouts affected the 
production of pyochelin either by abolishing (deletion of NRPS scab1471) or 
upregulating production (deletion of scab1401). Comparisons of the compound from 
the pyochelin overproducing mutant, ∆scab1401, with pyochelin and 
enantiopyochelin authentic standards from P. aeruginosa were planned. 
The second objective was to investigate whether the cryptic NRPS cluster in S. 
scabies directs the production of the putative hydroxamate siderophore, by creation 
of a partial cryptic NRPS gene deletion (scab85471) using a PCR targeting strategy. 
The mutant strain would also be examined for the production of scabichelin by 
comparisons of the S. scabies NRPS product with an authentic standard from S. 
antibioticus. 
The third objective was to confirm that the putative desferrioxamine biosynthetic 
gene cluster in S. scabies directs desferrioxamine production and to investigate the 
role of the desC gene in desferrioxamine biosynthesis. The aim was to create a desC 
gene deletion in S. scabies using PCR targeting technology and to examine 
desferrioxamine production in the desC mutant. The function of the desC gene in the 
mutant would then be restored via genetic complementation by introducing another 
copy of desC gene into the mutant genome. The complemented mutant could then be 
analysed for restoration of desferrioxamine production. 
The final objective was to investigate the expression of the cryptic tetronate-
containing polyketide biosynthetic gene cluster in S. scabies. The role of the SARP 
family of proteins encoded for within the gene cluster in the regulation of expression 
of the cluster was also investigated by performing reverse transcriptase PCR 
reactions on the total RNA isolated from wild type S. scabies.  
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Results and Discussion I: Investigation of 
siderophore biosynthetic gene clusters in S. scabies. 
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2. Pyochelin as a Product of Pyochelin Biosynthetic Gene 
Cluster in S. scabies. 
2.1 Analysis of the Pyochelin Biosynthetic Gene Cluster in S. scabies 
87.22. 
The pyochelin biosynthetic gene cluster (PBGC) in S. scabies contains 12 genes 
(Figure 2.1). Six of these genes encode proteins (Scab1381, Scab1411, Scab1421, 
Scab1461, Scab1471 and Scab1481) that are proposed to be analogous in function to 
the pyochelin biosynthetic proteins PchABCDEFG from P. aeruginosa (Patel and 
Walsh, 2001; Quadri et al., 1999; Serino et al., 1997).
 
Scab1381 is proposed to encode for a putative salicylate synthase and it contains an 
anthranilate synthase domain. Scab1411 is predicted to be AMP-ligase since it 
contains putative active site residues that are highly similar to the active site residues 
of MbtA, an AMP-ligase from Mycobacterium tuberculosis, which adenylates 
salicylate in mycobactin biosynthesis (Challis et al., 2000; Quadri et al., 1998; 
Rausch et al., 2005). Two genes scab1481 and scab1471 encode proteins with 
putative functions analogous to PchF and PchE, respectively, both of which are 
nonribosomal peptide synthetase (NRPS) enzymes in P. aeruginosa (Figure 2.1). 
Scab1481, being similar to PchE, is proposed to catalyse assembly of a 2-
hydroxyphenylthiazolinyl thioester from the salicyl adenylate and Scab1471, 
analogously to PchF, adds a second  molecule of cysteine to the thioester to form 2-
hydroxyphenylbis-thizaolinyl thioester attached to the T domain of Scab1471 (Figure 
2.2). Scab1461 encodes a reductase enzyme homologous to PchG and it is predicted 
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to catalyse the reduction of one of the thiazoline rings in the thioester. Scab1471 
catalyses N-methylation of the reduced thiazoline ring, followed by the release of 
pyochelin by its N-terminal thioesterase domain (Patel and Walsh, 2001).
 
Scab1421 
gene is proposed to encode for a putative thioesterase analogous to PchC. PchC can 
catalyse removal of wrongly charged molecules from the thiolation domains of PchE 
and PchF (Reinmann et al., 2004).
 
 
Figure 2.1 Organization of the PBGCs in S. scabies 87.22 and P. aeruginosa PAO1. 
 
 Other genes from the putative pyochelin gene cluster include scab1401, which 
encodes a pathway specific regulator homologous to PchR, a pyochelin-responsive 
repressor protein in P. aeruginosa. Scab1401 belongs to the TetR family of 
transcriptional regulators. Analysis of the transcription of PBGC revealed that 
Scab1371 is a positive transcriptional regulator of the cluster and it is co-transcribed 
with the predicted salicylate synthase gene scab1381. Scab1431, scab1441 and 
scab1451 encode putative transport proteins. Proposed functions of the proteins 
encoded by the S. scabies 87.22 pyochelin biosynthetic gene cluster are displayed in 
the Table 1.7 (Seipke et al., 2011). 
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Table 1.7 Putative proteins function encoded by the putative pyochelin biosynthetic 
gene cluster in S. scabies 87.22 (adapted from Seipke et al., 2011). 
Protein Putative function  Homolog; origin Identity 
(%) 
Scab1371 AfsR-family regulator 
 
AfsR; S. coelicolor 40 
Scab1381 Salicylate synthase 
 
TrpE; Saccharopolyspora 
erythraea 
51 
Scab1391 Unknown 
 
Sav760; S. avermitilis 72 
Scab1401 
 
TetR-family regulator OrfH2; S. griseoruber 55 
Scab1411 Salicyl-AMP-ligase 
 
DhbE; B. subtilis 50 
Scab1421 Thioesterase 
 
PchC; P. fluorescens 44 
Scab1431 ABC transporter permease/ 
ATPase 
Nfa28020; Nocardia 
farcinica 
66 
Scab1441 ABC transporter permease/ 
ATPase 
Nfa28010; N. farcinica 65 
Scab1451 Major facilitator 
superfamily protein 
Fraal6304; Frankia alni 46 
Scab1461 Thiazoline reductase 
 
Strop2818; Salinispora 
tropica 
49 
Scab1471 
 
Nonribosomal peptide 
synthetase 
PchF; P. fluorescens 45 
Scab1481 
 
Nonribosomal peptide 
synthetase 
Pst2602; P. syringae 40 
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Figure 2.2 A proposed pathway for pyochelin biosynthesis in S. scabies 87.22 based 
on analysis of biosynthesis by orthologous proteins from P. aeruginosa (Seipke et 
al., 2011). 
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2.2 Creation of Pyochelin Mutants in S. scabies 87.22. 
Mutants of S. scabies 87.22 were created using PCR-targeting REDIRECT 
technology (Gust et al., 2003) in the lab of Rose Loria (Cornell University). 
 
As 
discussed in section 2.1
 
scab1401 is a gene encoded for in the putative pyochelin 
biosynthetic gene cluster (PBGC) in S. scabies 87.22 wild type strain. Analysis of 
pyochelin production in the wild type strain and in the scab1401 mutant revealed 
that Scab1401 is a transcriptional repressor of the S. scabies PBGC (Seipke et al., 
2011). The scab1401 mutant contains a cassette consisting of oriT and an 
apramycin resistance gene from pIJ773 in place of the scab1401 gene (Gust et al., 
2003) Deletion of scab1401 induces expression of the putative pyochelin 
biosynthetic gene cluster (confirmed by RT-PCR analysis in Loria lab; Figure 2.3; 
Seipke et al., 2011). 
 
Figure 2.3 RT-PCR analysis of ΔScab1401 mutant strain showing that Scab1401 
represses transcription of S. scabies 87.22 pyochelin biosynthetic genes. Lane 1- S. 
scabies wild-type cDNA, 2- ΔScab1401, 3- ΔScab1401 with pAU3-45 or 4- 
pRFSRL34 (plasmids containing the copy of scab1401 gene) grown in liquid 
minimal medium+100 mM FeCl3 was used as template for PCRs. The murX gene -a 
loading control (Seipke et al., 2011). 
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scab1471 encodes a putative NRPS multienzyme complex homologous to PchF in 
the P. aeruginosa PBGC, involved in catalysing the assembly of pyochelin. The 
scab1471 mutant contains a cassette with oriT and a hygromycin B resistance gene 
from pIJ10700 plasmid, in place of scab1471 (Gust et al., 2003). Deletion of 
scab1471 was created to investigate the effect on pyochelin production in S. scabies. 
scab1471 was also replaced with a gene conferring resistance to hygromycin B in the 
Δscab1401 mutant, creating the double mutant Δscab1401-Δscab1471 by the group 
of Rose Loria. The creation of the double mutant was required for investigations into 
the function of Scab1471 NRPS under conditions giving constitutive expression of 
the S. scabies PBGC. 
 
2.3 Analysis of Pyochelin Production in S. scabies  
The production of pyochelin in S. scabies wild type and mutant strains scab1401, 
scab1471 and Δscab1401-Δscab1471 was examined by growing the strains in a 
liquid iron deficient medium (IDM) and then analysing the culture supernatants for 
the presence of pyochelin by LC-MS. Iron deficient media is a liquid minimal media 
in which all traces of iron are removed by Chelex resin (section 7.1.6.1; Barona-
Gomez et al., 2004). 
LC-MS analyses of the scab1401 mutant supernatant unveiled the presence of a 
compound with m/z of 325.0669 and a retention time of 23.5 min (Figure 2.4 A). 
This m/z correlates with the m/z for the [M+H]
+
 ion of pyochelin. This compound 
from the Δscab1401 mutant culture supernatant was also compared with the 
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simulated mass spectrum of pyochelin, with the molecular formula of 
C14H17N2O3S2
+
. It indicated that the m/z for each isotopic isomer of S. scabies 
compound correlates and agrees with the predicted m/z values for pyochelin. The 
relative abundances of these isotopic isomers in both the measured and the simulated 
spectra also agree with each other. 
LC-MS analysis of the scab1471 mutant and of scab1401-1471 double mutant 
culture supernatants revealed that pyochelin was not produced (Figure 2.5). 
The stereochemistry of the compound produced by S. scabies was also investigated. 
Research recently unveiled that the plant pathogen P. fluorescens, which is a Gram-
negative bacterium, produces diastereoisomers of pyochelin, referred to as 
enantiopyochelins (ent-pyochelin I and II; Figure 2.4 C; Youard et al., 2007). 
Comparison of the scab1401 mutant culture supernatant by LC-MS using chiral 
stationary phase with the synthetic standards of pyochelin and ent-pyochelin 
(standards kindly provided by Cornelia Reinmann) proved that S. scabies produce 
pyochelin, not enantiopyochelin (Figure 2.4 B).  
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Figure 2.4 A- Measured mass spectrum of pyochelin from Δscab1401 supernatant 
(top panel), pyochelin standard (middle panel), and ent-pyochelin (bottom panel). 
 
 
Figure 2.4 B- Extracted Ion Chromatograms (EICs) at m/z=325 from analyses of ent-
pyochelin standard (top trace), pyochelin standard (middle trace) and S. scabies 
pyochelin (bottom trace).  
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Figure 2.4 C- Pyochelin and ent-pyochelin stereoisomers. Metal induced shift at C-
2’’ results in isomerisation of pyochelin (Ino, and Murabayashi, 2001; Schlegel et al., 
2004). 
 
 
Figure 2.5 EICs at m/z= 325 from analyses of supernatants from the Δscab1401 
mutant (bottom trace) and theΔscab1401–Δscab1471 mutant (top trace). 
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2.4 Discussion 
Pyochelin production by Gram-negative bacterial pathogens has been reported 
previously (Cox et al., 1981; Thomas, 2007; Castignetti, 1997).  S. scabies is the first 
Gram-postive plant pathogen, which has been found to produce pyochelin. Mining of 
the S. scabies genome for putative secondary metabolite clusters identified a putative 
PBGC. Five genes from that cluster scab1411, scab1421, scab1461, scab1471 and 
scab1481 are predicted to encode proteins homologous to well characterised 
pyochelin biosynthetic proteins PchCDEFG from P. aeruginosa. The main 
differences between the S. scabies PBGC and the P. aeruginosa pyochelin 
biosynthetic gene cluster are in the organisation of the genes and in the regulation of 
transcription of the gene clusters. 
Expression studies of the S. scabies PBGC, conducted by the research group of our 
collaborator professor Rose Loria revealed that it is transcribed as two operons. One 
of these is ~19 kb in size and includes the pyochelin biosynthetic genes, and the 
other smaller operon, which is ~3kb, consists of scab1371 and the salicylate synthase 
gene scab1381. The two genes scab1391 and scab1401 are not transcribed in either 
operon and RT-PCR did not give any PCR products for scab1391-scab1401 region. 
Scab1401 is a member of the TetR family of proteins and represses the transcription 
of the large biosynthetic operon during growth in high iron conditions. The other 
regulator Scab1371 protein is an AfsR-family regulator, which activates transcription 
of the large operon if the availability of iron is low (Seipke et al., 2011). 
 
In contrast, 
the pyochelin cluster in P. aeruginosa is regulated by the AraC-family protein PchR 
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and the ferric uptake protein, Fur (Heinrichs and Poole, 1993, 1996; Michel et al., 
2005). 
Pyochelin biosynthesis differs slightly between S. scabies and P. aeruginaosa. The 
synthesis of salicylate, a substrate for pyochelin biosynthesis in the S. scabies PBGC 
is thought to be catalysed by one protein Scab1381, while in P. aeruginosa the 
biosynthesis of salicylate is catalysed by two proteins PchA and PchB (Serino et al., 
1995). 
LC-MS analysis of the ∆scab1401 mutant indicated the presence of a compound with 
an m/z value corresponding to that of pyochelin. The compound with the same m/z 
was not consistently detected in the supernatants of wild type S. scabies when grown 
in iron deficient conditions. Pyochelin should have been produced consistently in the 
wild type strain in iron deficient media as the pyochelin biosynthesis genes have 
been found to be expressed under these growth conditions. LC-MS analyses of the 
∆scab1401-1471 mutant culture supernatant, in which the pyochelin biosynthetic 
gene is deleted, revealed that pyochelin is not produced, further confirming that 
pyochelin is the product of the putative pyochelin biosynthetic gene cluster identified 
in S. scabies. Further LC-MS analysis of the ∆scab1401 mutant culture supernatant 
alongside authentic standards of pyochelin and enantiopyochelin confirmed that S. 
scabies produces pyochelin and not its enantiomer enantiopyochelin. 
Plant assays were used (by Prof R. Loria’s group at Cornell University; Seipke et al., 
2011) to analyse the importance of pyochelin in plant pathogenicity. Incubation of 
the scab1471 mutant (scab1471 codes for one of the NRPS enzymes from the 
pyochelin biosynthetic pathway) and of  the S. scabies 87.22 wild type strain, both 
on potato tissue and radish seedlings, showed tissue necrosis by both wild type and 
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scab1471 mutant strains indicating that pyochelin is not required for pathogenicity 
of potato tissue and radish. One conclusion that can be drawn from these results is 
that iron may not have been essential for S. scabies growth in these assays. The 
genome of S. scabies possesses several more biosynthetic gene clusters coding for 
other siderophores, such as putative genes for the biosynthesis of desferroxamines 
(scab57921–scab57951). To determine which iron-chelating metabolites produced 
by S. scabies are required for plant pathogenicity, analysis of a desferrioxamine 
mutant and other siderophore mutants in S. scabies is needed, as well as, in planta 
transcriptional analysis of the pyochelin, desferrioxamine and other putative 
siderophore biosynthetic gene clusters. 
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3. Investigation of a Putative Hydroxamate Siderophore 
Biosynthetic Gene Cluster in S. scabies 87.22 
3.1 PCR Targeting Strategy 
Mutagenesis of S. scabies, to create gene knockouts, was achieved using a PCR 
targeting protocol (Gust et al., 2002; Gust et al., 2003). This strategy allows the 
replacement of a genomic DNA sequence, located in the cosmid genomic library of 
S. scabies, with a cassette containing an apramycin resistance gene. This cassette is 
amplified by PCR using primers, which have 39 nt 5’ regions homologous to the 
regions adjacent to the targeted gene. The cassette also contains the origin of transfer 
(oriT) allowing for the transfer of the PCR targeted cosmid from an E. coli strain to 
S. scabies via conjugation. 
Plasmid pIJ773 (Figure 3.1) was used for obtaining the resistance cassette. The 
plasmid containing an apramycin gene and oriT was digested using restriction 
enzymes HindIII and EcoRI resulting in two fragments. The fragment of 1.4 kb, 
containing the apramycin resistance gene and oriT, was purified from an agarose gel 
and subsesquently used as a PCR template. 
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Figure 3.1 Map of pIJ773 (Gust et al., 2003). 
 
The PCR primers for amplification of the disruption cassette were 59 nt (upstream 
primer) and 58 nt (downstream primer). The sequence of each set of primers had at 
the 5’ end, 39 nt homologous to the S. scabies DNA region adjacent to the gene to be 
inactivated and at the 3’ end, 19 or 20 nt same as the right or left end of the 
resistance cassette (Figure 3.2). 
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Figure 3.2 Design of PCR primers for making a gene replacement (Gust et al., 2002). 
 
The cosmid with the gene to be disrupted was transferred into E. coli BW25113, 
which contains the recombination plasmid pIJ790. The apramycin cassette was then 
introduced into cosmid by electroporation. The resulting apramycin resistant colonies 
were ones in which a double cross over between the target sequence in the cosmid 
and the cassette has occurred. These colonies were subsequently analysed by 
restriction digest and PCR, using a pair of test primers. These test primers were 18-
20 nt long and were designed to prime approximately 100 bp outside of the region of 
the gene disruption. The size of the resulting PCR products makes it possible to 
distinguish between the presence of the wild type gene in the cosmid and the 
disruption cassette. 
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Figure 3.3 Creation of a gene deletion in the cosmid via homologous recombination 
of the disruption cassette with cosmid DNA and then conjugation from E. coli into S. 
scabies and double homologous recombination resulting in a replacement of the gene 
of interest with the disruption cassette creating an S. scabies mutant. Yellow gene – 
apramycin resistance, orange region – origin of transfer (oriT), green regions = FRT 
sites. 
 
The cosmid with the replaced gene was then introduced via transformation into E. 
coli ET12567/pUZ8002, which is a DNA non-methylating strain (Figure 3.3). It is 
necessary to use this strain as S. scabies carries a methylated DNA-sensing 
restriction system, which degrades methylated DNA from ordinary E. coli strains. 
The mutagenised cosmid was then transferred from E. coli ET12567/pUZ8002 to S. 
scabies via conjugation. This was completed by mixing the E. coli 
ET12567/pUZ8002 cells containing the mutagenised cosmid with S. scabies spores, 
and then plating a dilution series on SFM plates. Following an overnight incubation 
PhD Thesis: Joanna Bicz                        Chapter 3: Results and Discussion 
87 
 
the plates were overlaid with nalidixic acid, killing only the E. coli, and with 
apramycin, which selectively kills the Streptomyces that did not contain introduced 
cosmid. As a result of the conjugal transfer of cosmid, the apramycin resistant S. 
scabies colonies on the SFM plates should have the target gene replaced with the 
resistance cassette by double crossover. The double cross over was recognized by 
apramycin resistance (cassette contains apramycin) and kanamycin sensitivity (the 
cosmid backbone containing kanamycin resistance gene has been lost during cross 
over). The replacement of the gene was confirmed by PCR and Southern blot 
hybridization. 
 
3.2 Investigation of Putative Hydroxamate Siderophore Production 
in S. scabies 
The aim of this work was to examine whether the putative hydroxamate siderophore 
(Figure 3.4) is present in culture supernatants of S. scabies 87.22 grown under iron 
deficient conditions. It has been reported by our collaborators Kodani and co-
workers that the siderophore was isolated from the culture supernatants of S. 
antibioticus NBRC 13838 (the strains that they used in their work). That siderophore 
is also proposed to be the product of a cryptic NRPS enzyme encoded by scab85471, 
discovered by genome mining of S. scabies 87.22. 
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3.2.1 Isolation and Structure Elucidation of the Hydroxamate 
Siderophore 
Analysis of the culture supernatants of S. antibioticus NBRC 13838, via HPLC by 
our collaborators, Dr Shinya Kodani and his co-workers, indicated that this strain 
produces a putative siderophore that was named scabichelin. Our collaborators also 
carried out the structural characterisation of scabichelin. The metabolite was 
converted into a complex with Galium before the NMR analysis, which helped signal 
dispersion and aided stereochemical analysis. The Ga-scabichelin complex structure 
was elucidated by H NMR AND 2D NMR. The NMR spectra analysis indicated that 
the compound consists of the five amino acids: N-methylated hydroxy-formyl-
ornithine, serine, N-methylated hydroxy-ornithine, ornithine and cyclic hydroxyl-
ornithine. The mass spectrum had a parent ion present for scabichelin at the m/z 
648.3671, which agreed well with the calculated value of 648.3675 corresponding to 
[C26H50N9O10]
+
. The stereochemistry of scabichelin was determined by chemical 
analysis using Marfey method (Marfey, 1984)  and 3D modelling (Deeth, 2001) as 
LLLLD. 
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Figure 3.4 Structure of a novel siderophore scabichelin. 
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3.2.2 Scabichelin Biosynthetic Gene Cluster 
Analysis of the S. scabies 87.22 genome sequence unveiled a cryptic NRPS 
biosynthetic gene cluster, which includes the protein coding sequences from 
Scab85431 to Scab85521 (Figure 3.5). All of these proteins, present within the 
NRPS biosynthetic gene cluster, are homologous to proteins encoded for by genes 
within the coelichelin biosynthetic gene cluster from S. coelicolor M145 (section 
1.7.3; Table 3.1; http://www.ncbi.nlm.nih.gov/nuccore/260644157).
 
 
 
Figure 3.5 Organization of the scabichelin biosynthetic gene cluster in S. scabies 
87.22. 
Bioinformatic analysis of the functional domains of the NRPS encoded for by 
scab85471 revealed it contains 17 enzymatic domains organized into 5 modules 
(Figure 3.6 B). Each module contains an adenylation (A), a thiolation (T) and a 
condensation domain (C) (http://www.nii.res.in/searchall.html). The final 
termination module of scab85471 also contains an epimerization/condensation 
domain (Figure 3.6 B) suggesting that the stereochemistry of the peptide is L-L-L-L-
D. It is hypothesised that product of the scab85471 gene would be a pentapeptide, as 
it contains 5 modules. 
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Two genes from the putative scabichelin biosynthetic cluster, scab85511 and 
scab85521, encode proteins homologous to CchA and CchB from S. coelicolor 
M145, respectively. These enzymes have sequence similarity to formyl transferase 
and NADH/FAD-dependent monoxygenases, respectively. CchB catalyses the 
hydroxylation of L-ornithine (L-Orn) to yield L-N5-hydroxyornithine (L-hOrn) and 
CchA subsequently formylates it yielding L-N5-formyl-N5-hydroxyornithine (L-
fhOrn; Pohlman and Marahiel, 2008). These two non-proteinogenic amino acids are 
later incorporated into coelichelin. Analogous reactions are predicted to be catalysed 
by Scab85511 and Scab85521 in the biosynthesis of the novel hydroxamate 
siderophore in S. scabies (Figure 3.6 A). 
The amino acids, which are the building blocks for the putative S. scabies product 
are loaded onto the thiolation (T) domains by the adenylation (A) domains of the 
NRPS encoded by scab85471 (Figure 3.6 B).  
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Figure 3.6 A-Proposed role of the enzymes encoded by scab85521 and scab85511 in 
the biosynthesis of the amino acids L-N5-hydroxyornithine (L-hOrn) and L-N5-
formyl-N5-hydroxyornithine (L-fhOrn). B-Organisation of modules and domains of 
the NRPS encoded by scab85471. The residues attached to the thiolation domains 
(black circles) of module 1, 2, 3 are the aminoacids predicted to be incorporated into 
scabichelin by each A domain. The substrates loaded by A domains of the modules 4 
and 5 could not be unambiguously predicted.  
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3.2.3 Creation of a scab85471 Mutant 
The scab85471 disruption was obtained using the PCR targeting REDIRECT 
technology. In this method the cosmid S57 (a clone from an S. scabies supercos1 
genomic library containing scab85251 to scab85521 provided by Prof R Loria of 
Cornell University) containing an insert with the scab85431-scab85521 gene cluster 
was used. A 3 kb fragment internal to scab85471, which encodes an entire NRPS 
module 2 (Figure 3.7) was selected to be deleted, thus disrupting its function. This 
internal fragment of scab85471 was chosen as this is a coding region for one of the 
domains of the Scab85471 NRPS. It was assumed that deletion of the sequence 
encoding one of the protein domains, rather than inactivation of any random region 
of scab85471, would ensure the inactivation of the target gene was achieved. The 
internal fragment to be deleted was chosen so that a region flanking either side of the 
deletion remained. Sufficient flanking sequences on both sides of target sequence 
would ensure that homologous recombination would occur. 
Before creating the scab85471 disruption both ends of the insert in the cosmid were 
sequenced to determine from which gene of the S. scabies biosynthetic cluster the 
insert starts and at which gene the insert ends. For this 20 nt forward and reverse 
sequencing primers in the insert were created. The primers were designed approx. 
100 bp before the ends of the insert and going out from the insert towards the cosmid 
backbone (section 7.1.5). 
The integrity of the wild type scab85471 containing cosmid was also analysed by 
restriction digest with BamHI, NcoI, PstI and NotI restriction enzymes (Figure 3.8). 
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The band pattern of each digest on the gel was consistent with the pattern shown by a 
virtual digestion program (Figure 3.9).  
 
Figure 3.7 The enzymatic domains of scab85471. The fragment deleted is module 2. 
 
Figure 3.8 Restriction analysis of the wild type S57 cosmid. Lanes from left to 
right:M- 1kb DNA molecular size marker, BamHI, PstI, NotI, NcoI digests. 
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Figure 3.9 Restriction digest pattern of scabichelin cosmid (S57) with BamH, PstI, 
NotI and NcoI restriction enzymes (the band sizes in bp that are displayed red in the 
diagram indicate bands present on the gel picture in figure 3.8). 
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Figure 3.10 Restriction analysis of wild type vs mutagenised S57 cosmid 
(S57::scab85471::apr-OriT. Lanes: M- 1kb DNA molecular size marker, WT- wild 
type S57 cosmid BamHI cut, Δ- cosmid + oriT-apramycin cassette BamHI cut. 
 
The oriT- apramycin cassette from the pIJ773 plasmid was amplified by PCR using 
primers, which have 39 nt 5’ extensions homologous to the regions adjacent to the 
targeted internal fragment of scab85471 (3233 bp encoding C, A and T domain of 
module 2). The cosmid containing scab85471 was transferred into E. coli BW25113, 
which carries recombination plasmid pIJ790. Following this the apramycin resistance 
cassette was introduced into the cosmid via electroporation. The apramycin resistant 
colonies are ones in which the double cross over between the regions adjacent to the 
target sequence in the cosmid and the cassette has occurred. These colonies were 
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analysed by restriction digest (Figure 3.10) and PCR with a pair of test primers 
(Figure 3.11). These primers were 18-20 nt long (Section 7.1.5) and were designed to 
prime approximately 100 bp outside of the region of the gene disruption. The size of 
the PCR allowed for comparison between the wild type gene in the cosmid and the 
gene in the disruption cassette. The test primers generated the expected ~1.6 kb 
fragment after gene disruption (1.4kb-the size of apramycin cassette plus ~ 200bp 
distance of primers from the cassette and approximately 3kb for the wild type -
Figure 3.11). 
 
 
Figure 3.11 PCR analyses of the wild type and the mutagenised S57 cosmid with the 
test primers. Lanes: M- 1kb DNA molecular size marker, WT gDNA- PCR band for 
the wild type S. scabies DNA, WT cos- PCR band for the wild type S57cosmid, Δ 
cos-PCR band for the S57 cosmid + oriT-apramycin cassette.  
 
The cosmid with replaced gene was introduced by transformation into E. coli 
ET12567/pUZ8002, which is a DNA non-methylating strain. The mutagenised 
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cosmid was then transferred from E. coli ET12567/pUZ8002 to S. scabies by 
conjugation where a double cross over between the homologous regions in S. scabies 
genomic DNA and scab85471 on cosmid would occur, yielding a mutant with 
inactivated scab85471. The replacement of the gene was confirmed by PCR and 
Southern blot hybridization. The test primers (Test_fw and Test_rv; Table 7.6) were 
used to analyse replacement of the target sequence in the genome by PCR (Figure 
3.12). The mutant was named S. scabies W1000. 
 
Figure 3.12 PCR analysis of the genomic DNA from the putative scabichelin mutant. 
Lanes: M- 1kb DNA molecular size marker, WT cos- PCR band for the wild type 
scabichelin cosmid, Δ cos-PCR band for the scabichelin cosmid with OriT-
apramycin cassette, Δ gDNA- PCR for the for the scabichelin mutant genomic DNA. 
 
Southern blot hybridization analysis was carried out to analyse the position of the 
resistance cassette within the S. scabies W1000 genome. Genomic DNA and the 
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cosmid containing mutagenised scabichelin gene were digested by BamHI. A DIG-
labelled mutagenised scabichelin cosmid was used as a probe, which was hybridised 
to the digested DNA. Comparisons could then be made between the wild type and 
mutant on an X-ray film. Bands that could be seen on the x-ray film were highlited in 
white, red or green (Figure 3.13).  
  
Figure 3.13 Southern blot hybridization using labelled S57::oriT-apr cosmid as a 
probe confirming the nature of S.scabiesW100 mutant with 3 kb fragment deleted 
within scab85471 gene. Bands in white colour are all present in the S.scabies wild 
type and the mutant. Band 7827 bp in green is only present in the wild type strain. 
Bands 1412 bp and 7575 bp coloured in red are characteristic for the mutant.  
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The mutant was also analysed by sequencing using Test_fw and Test_rv primers 
(Section 7.1.5), which confirmed the presence of the apramycin resistance gene in 
the S. scabies W1000 genome.  
3.2.4 LC-MS Analysis of Scabichelin Mutant 
LC-MS analysis of the W1000 scabichelin mutant culture supernatant compared with 
that of wild type culture supernatant, with the ferric iron added before analysis, 
indicated the presence of a ferric complex in S. scabies 87.22 but not in the W1000 
mutant (Figure 3.14). This complex had identical retention time (Figure 3.14) and 
MS/MS fragmentation pattern (Figure 3.15) to scabichelin isolated and purified from 
S. antibioticus (provided by our collaborators), which was used as an authentic 
standard. These data conclusively proves that scabichelin is the metabolic product of 
the Scab85471 NRPS in S. scabies 87.22. 
 
Figure 3.14 EICs at m/z=351.14 (corresponding to the [M+2H]
2+
 ion for the ferric-
scabichelin) from analyses of the culture supernatant of S. scabies 87.22 (top panel), 
Fe-scabichelin purified from S. antibioticus (middle panel) and the culture 
supernatant of S. scabies W1000 (bottom panel). 
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Figure 3.15 MS/MS spectra of ferric-scabichelin purified from S. antibioticus (top 
panel) and from ferrated supernatants from iron-deficient cultures of S. scabies 87.22 
(bottom panel). 
 
3.2.5 Discussions  
Analysis of the S. scabies 87.22 genome sequence unveiled a cryptic NRPS 
biosynthetic gene cluster, which includes the protein coding sequences from 
scab85431 to scab85521 (Figure 3.17 A). All of these proteins, present within the 
NRPS biosynthetic gene cluster, are homologous to proteins encoded for by genes 
within the biosynthetic gene cluster from S. coelicolor M145 (Table 3.1),
 
which is a 
producer of tris-hydroxamate siderophore coelichelin (Figure 3.16; Lautru et al., 
2005). It was, therefore, hypothesised that the biosynthetic cluster encoded by S. 
scabies may direct the production of a hydroxamate-containing metabolite named as 
scabichelin (Figure 3.16).  
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Figure 3.16 Structures of coelichelin and a novel siderophore scabichelin. 
 
PCR targeting method (Gust et al., 2003) was used to create a mutant of S. scabies 
87.22 in order to investigate the role of the cryptic nonribosomal peptide biosynthetic 
gene cluster in scabichelin biosynthesis. The mutant, named as S. scabies W1000, 
was obtained via replacement of an internal fragment of the scab85471 gene with an 
oriT-apr cassette. LC-MS/MS analyses of culture supernatants of the 87.22 and 
W1000 strains grown in an iron-deficient medium, to which ferric iron was added 
before analysis, indicated the presence of a ferric complex that is produced by S. 
scabies 87.22, but not the W1000 mutant. LC-MS retention time and MS/MS 
fragmentation pattern of ferri-scabichelin are the same for S. scabies 87.22 
compound and the authentic standard. The experimental data confirm that 
scab85431-scab85521 gene cluster is involved in the production of scabichelin. 
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The hydroxymate siderophore coelichelin, a product of S. coelicolor, similarily as 
scabichelin, was predicted to be produced from bioinformatic analysis of S. 
coelicolor genome (Challis and Ravel, 2000). It was later isolated and structurally 
characterised (Lautru et al., 2005). The coelichelin biosynthetic gene cluster encodes 
11 proteins (Figure 3.17 B; Challis and Ravel, 2000), of which one is a trimodular 
NRPS (CchH) that catalyse the condensation of, in total, four amino-acid residues to 
form a tetrapeptide. Structure-based sequence comparisons allowed predicting the 
substrates for modules 1, 2 and 3 as N-formyl-N-hydroxyornithine (L-hfOrn), L-
threonine (L-Thr) and N-hydroxyornithine (L-hOrn), respectively (Figure 3.17 B). 
 
Figure 3.17 A-putative scabichelin biosynthetic gene cluster. B-Organisation of the 
coelichelin biosynthetic gene cluster and the module and domain organisation of the 
NRPS encoded by cchH. The residues attached to the thiolation domains (black 
circles) of module 1, 2, 3 are the aminoacids predicted to be incorporated into 
coelichelin by each A domain. 
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Unlike the proposed biosynthesis of scabichelin, where C domains of five modules 
of the NRPS are predicted to catalyse condensation of five amino acyl thioesters, 
coelichelin biosynthetic model (Figure 3.18) involves iterative usage of module 1 to 
incorporate two molecules of N-formyl-N-hydroxyornithine into the peptide (Lautru 
et al., 2005). In the first step, the A domains of modules 1, 2, 3 activate the three 
substrates, L-hfOrn, L-Thr and L-hOrn as aminoacyl adenylates and subsequently 
transfer them onto the adjacent T domains to form the corresponding aminoacyl 
thioesters (Figure 3.18; 1). The α-carbons of the thioesters undergo epimerization 
catalysed by E domains of module 1 and 2. In the second step, the C domains of the 
module 2 and 3 catalyse sequential condensation of the thioesters of the three 
substrates, L-hfOrn, L-Thr and L-hOrn to form a tripeptide tethered to the T domain 
of module 3 (Figure 3.18; 2). In the third step, a second molecule of L-hfOrn is 
loaded onto T domain of module 1 and the α-carbon of the resulting thioester is 
epimerized by the module 1 E domain (Figure 3.18; 3). In the fourth step the C 
domain of either module 2 or module 3 catalyses the condensation of the module 3 
attached tripeptide thioester with the module 1 attached hOrn thioester yielding 
tetrapeptide thioester attached to the T domain of module 3 (Figure 3.18; 4). In the 
final stage, the tetrapeptide thioester is released from the NRPS by hydrolysis 
catalysed by CchJ (Figure 3.18, 5), a protein encoded by one of the genes in the cch 
biosynthetic cluster. Usually the C-terminal TE domain is used by NRPS for the 
cleavage of the assembled peptide and the CchH was not found to contain one. 
However, the examination of other genes in the cch cluster identified an orthologue 
of an esterase, which catalyses hydrolytic cleavage of an enterobactin siderophore 
into smaller subunits in order to release iron from the ferric-enterobactin complex 
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(Brickman and McIntosh, 1992). Subsequent genetic knockouts of cchJ from S. 
coelicolor chromosome confirmed the role of CchJ as the free standing thioesterase 
that is involved in the release of the NRPS assembled tetrapeptide (Lautru et al., 
2005).  
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Figure 3.18 Proposed coelichelin biosynthetic pathway (Lautru et al., 2005). The 
stages 1-5 are described in the text. The domains active in each step are shaded gray. 
The black circles are the thiolation domains in each module of CchH. 
 
In scabichelin biosynthesis the putative NRPS Scab85471 also lacks the TE domain. 
However, none of the other gene in the putative scabichelin biosynthetic gene cluster 
encodes the hydrolase protein. 
The coelichelin biosynthetic model shows the iterative use of the A, T and E domain 
of module 1 and the C domain of either module 2 or 3 and some domains in the 
second assembly are skipped. Iterative module use and module skipping is the 
unique trait of coelichelin biosynthesis and the predicted assembly of scabichelin, a 
putative hydroxamate siderophore of S. scabies, does not follow that pattern. 
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Two genes from coelichelin biosynthetic cluster cchA and cchB encode the enzymes 
with sequence similarity to formyl transferase and NADH/FAD-dependent 
monoxygenases, respectively. CchB catalySe the hydroxylation of L-Orn to yield L-
hOrn and CchA subsequently formylates it yielding L-fhOrn (Figure 3.19 A). These 
two non-proteinogenic amino acids are later incorporated into coelichelin. The role 
of both enzymes was experimentally confirmed in the biosynthesis of coelichelin 
(CchB) and rhodochelin (CchA; Pohlmann and Marahiel, 2008; Bosello et al., 2012). 
 
Bioinformatic analysis of the functional domains of the NRPS encoded for by 
scab85471 revealed it contains 17 enzymatic domains organised into 5 modules 
(Figure 3.19 B), hence the product of the scab85471 gene would be a pentapeptide. 
On the basis of prediction of the substrate specificity of the adenylation domains in 
each module it was identified that modules 1, 2 and 3 of the NRPS likely select for a 
L-N5-acyl-N5-hydroxyornithine, a L-Ser and a L-N5-hydroxyornithine, respectively. 
The substrate specificity for the modules 4 and 5 could not be, however, 
unambiguously predicted. 
Two genes from the putative scabichelin biosynthetic cluster, scab85511 and 
scab85521, encode proteins homologous to CchA and CchB from S. coelicolor 
M145, respectively. Scab85521 is proposed to encode the flavin-dependent 
monooxygenase that catalyse N5 hydroxylation of L-Orn to form L-N5-
hydroxyornithine (L-hOrn). Scab85511 encodes the putative formyl-
tetrahydrofolate-dependent formyl transferase that catalyses N5-formylation of L-
N5-hydroxyornithine to form L-N5-formyl-N5-hydroxyornithine (L-fhOrn; Figure 
3.19 A). These reactions are predicted to be analogous to the reactions catalysed by 
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CchA and CchB, enzymes involved in the biosynthesis of non-proteogenic amino 
acid residues hOrn and fhOrn that are utilised in the biosynthesis of coelichelin 
(Pohlmann and Marahiel, 2008). The amino acids, which are the building blocks for 
the putative S. scabies product are loaded onto the thiolation (T) domains by the 
adenylation (A) domains of the NRPS encoded by scab85471 (Figure 3.19 B). The 
methylation (MT) domains of the NRPS are proposed to catalyse the N-methylation 
of the aminoacyl thioesters attached to the T domains within module 1 and 3. The 
epimerization (E) domain within module 5 is proposed to catalyze α-carbon 
epimerization of the L-hOrn residue attached to the T domain of module 5 and the 
condensation (C) domains of modules 2 to 5 are proposed to catalyse peptide bond 
formation between the T domain-bound aminoacyl thioesters to yield pentapeptidyl 
thioester attached to the T domain of module 5 before it is finally released from the 
NRPS (Figure 3.19 B).  
 
 
PhD Thesis: Joanna Bicz                        Chapter 3: Results and Discussion 
107 
 
A MT C A C A MT
S S
O
HN
MeHN
Module 1 Module 2 Module 3
85471
S
O
N
MeHN
OHO
H
O
H2N
OH
HO
C A
S
Module 4
O
H2N
H2N
C A
S
Module 5
H2N
HN
OH
E
NHMe
HN
O
N
O
HO
NHMe
N
OHO
H
OH
O
HNNH
N
OHO
O
NH2
O
HO
O
N
H2N
OHO
H
HO
O
HN
H2N
OH
HO
O
H2N
H2N
85521 85511
FAD
NADH
O2
fTHF
L-Orn L-hOrn L-fhOrn
A
B
-5H+
 
Figure 3.19 A-Proposed role of the enzymes encoded by scab85521 and scab85511 
in the biosynthesis of the amino acids L-N5-hydroxyornithine (L-hOrn) and L-N5-
formyl-N5-hydroxyornithine (L-fhOrn). B-Organisation of modules and domains of 
the NRPS encoded by scab85471. The residues attached to the thiolation (T) 
domains (black circles) of the five modules are the aminoacids proposed to be 
incorporated into scabichelin. 
 
There are two hypothetical ways of scabichelin release from the NRPS. One of them 
is via intramolecular addition of the δ-hydroxylamino group of the D-hOrn residue to 
the carbonyl group of the thioester, and subsequent deprotonation and release of the 
resulting product (Figure 3.19 B). This mechanism for peptide chain release is 
analogous to that proposed for another putative siderophore called amychelin (Figure 
3.21) from Amycolatopsis sp. AA4 (Seyedsayamdost et al., 2011). Both amychelin 
and scabichelin, contains D-cyclo-hOrn residue and both of the putative siderophore 
NRPSs lack the C-terminal thioesterase (TE) domain, which is responsible for chain 
release in nonribosomal peptide biosynthesis. In amychelin that reaction is proposed 
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to be catalysed by AcmB, a putative standalone α, β-hydrolase (Figure 3.20). 
Scabichelin biosynthetic gene cluster, however, does not encode a protein with 
sequence similarity to an α, β-hydrolase. Therefore, the reaction may be catalysed by 
α, β-hydrolase encoded elsewhere in the S. scabies genome. Some epimerization 
domains may also be involved in the peptide release. The epimerization (E) domain 
of module 5 of the scabichelin NRPSs may not only catalyse the epimerization of the 
module 5 bound L-hOrn residue, but it may also catalyse the subsesquent cleavage of 
the assembled peptide. In vitro experiments are required to elucidate the peptide 
release mechanisms. 
Further work, in collaboration with Dr. Bignell (former member of professor R. 
Loria group at Cornell University) and co-workers, would be to examine the effect of 
scabichelin biosynthetic gene inactivation on plant pathogenicity and would involve 
the use of a plant assay to compare the necrotic effect of S. scabies 87.22 and W1000 
strains grown in parallel on tuber and root vegetables such as potato and radish, 
respectively. 
 
Figure 3.20 Amychelin biosynthetic gene cluster in Amycolatopsis sp. AA4 
(Seyedsayamdost at al., 2011).  
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The amychelin biosynthetic gene cluster is 35.2 kb in size and consists of 16 genes 
(SSMG_02531 to SSMG_02546). It includes four NRPS genes (amcDEFG), amino 
acid tailoring genes (amcKP), chain initiation and termination genes (amcBCHL) and 
transport genes (amcAIJMON). AmcK is 61% identical to CchB in S. coelicolor a 
flavin-dependent monooxygenase and amcP is encoded outside of the amc gene 
cluster and it encodes a protein that is 74% identical to CchA the formyltransferase 
in coelichelin biosynthetic pathway. Thus, AmcK and AmcP are proposed to catalyse 
formation of the two nonproteinogenic precursor amino acids N-hydroxyornithine 
(hOrn) and N-hydroxy-N-formylornithine (hfOrn), respectively. 
AmcL is proposed to encode salicylate synthase that catalyses the salicylate from 
chorismate in proposed amychelin biosynthesis (Figure 3.21; Seyedsayamdost et al., 
2011). AmcH is proposed to encode hydroxybenzoyl-AMP ligase, which likely 
catalyses adenylation of salicylate and its subsequent loading onto the aryl carrier 
protein (ArCP) domain of AmcG. The substrate specificity of A domain in AmcG is 
predicted to be cysteine, though the serine is incorporated. The cyclisation domain 
(Cy) in AmcG is then proposed to catalyse oxazoline ring formation and the chain is 
then transferred to AmcF. The two A domains of AmcF have substrate specificity for 
serine and after the incorporation of second serine the E domain in AmcF catalyzes 
epimerization of second serine α-carbon. The chain is then passed on to AmcD, 
where it is condensed with another serine and with N-hydroxy-N-formylornithine 
(hfOrn) residue, a substrates predicted to be selected by the A domains of AmcD. 
The E domain in AmcD generates D form of hfOrn. The A domain of the final NRPS 
AmcE is predicted to select for glutaminic acid. After condensation of hfOrn and 
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epimerization of its α-carbon the peptide is proposed to be released from the AmcE 
by AmcB a putative α, β hydrolase encoded in amc cluster. AmcE does not contain 
the C-terminal TE domain and the amychelin release mechanisms resembles that of 
coelichelin, where free standing esterase performs that function (Seyedsayamdost et 
al., 2011). 
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Figure 3.21 Proposed biosynthesis of amychelin (Seyedsayamdost at al., 2011).
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4. Desferrioxamine production in S. scabies 87.22 
4.1 The Aims of This Work 
Desferrioxamines are a group of ferric iron binding molecules consisting of 
hydroxamic acid ligands (Challis and Kadi, 2009). Unlike pyochelin and scabichelin, 
which are synthesised by multidomain NRPS enzymes, desferrioxamines are 
synthesised via an NRPS-independent pathway (Challis and Kadi, 2009). 
Desferrioxamines are produced by a broad range of bacteria including many 
Streptomyces species (Bickel et al., 1960) and analysis of the S. scabies genome 
unveiled a putative desferrioxamine biosynthetic gene cluster.  
The aim of this work was to establish if the putative desferrioxamine biosynthetic 
gene cluster in S. scabies directs the biosynthesis of desferrioxamine and to 
investigate the role of the desC gene in desferrioxamine biosynthesis. This was 
achieved by creating a desC gene deletion in S. scabies using the PCR targeting 
technology and examining the production of desferrioxamine in the desC mutant 
strain. Subsequent chemical complementation of the desC mutant by the introduction 
of a precursor from the desferrioxamine biosynthetic pathway into desC mutant 
liquid culture was analysed to establish if desferrioxamine production could be 
restored. The desC mutant in S. scabies was also genetically complemented by in 
trans expression of the desC gene from the integrative plasmid pOSV556. 
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4.2 Putative Desferrioxamine Biosynthetic Gene Cluster in S. scabies  
Analysis of the S. scabies 87.22 genome sequence identified a cryptic biosynthetic 
gene cluster, which includes the protein coding sequences Scab57921-Scab57981 
(Figure 4.1). These proteins are homologs of proteins encoded by genes in 
desferrioxamne biosynthetic gene cluster of S. coelicolor A (3)2 (Table 4.1). 
 
Figure 4.1 Putative desferrioxamine biosynthetic gene cluster in S. scabies 87.22. 
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Table 4.1 Putative proteins functions encoded by the desferrioxamine biosynthetic 
gene cluster in S. scabies 87.22. 
 
S. scabies 
gene 
desferrioxamine 
biosynthesis protein (Des) 
Sequence similarity with S. coelicolor 
A3(2) des cluster (%) 
scab57921 DesD hypothetical protein SCO2785 (81%) 
 
scab57931 DesC aceytltranferase SCO2784 (79%) 
 
scab57941 DesB monooxygenase SCO2783 (80%) 
 
scab57951 DesA pyridoxal-dependent decarboxylase 
SCO2782 (86%) 
scab57961 IS630 family insertion 
sequence 
no similar  protein  
scab57971 DesE hypothetical protein SCO2781 (75%) 
 
scab57981 DesF secreted protein SCO2780 (73%) 
 
 
 
The desC gene, which is of interest, encodes for an enzyme responsible for 
catalysing the acylation of N-hydroxycadaverine to form N-hydroxy-N-
succinylcadaverine, a precursor in desferrioxamines biosynthesis in Streptomyces 
coelicolor (Kadi amd Challis, unpublished data; Figure 4.2). 
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al., 2007). 
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4.3 Construction of desC Mutant in S. scabies 87.22 
The desC mutant was previously made with S. scabies ATCC 49173 (Loria group, 
unpublished data). However, before continuing with the desC complementation 
experiment, it has been decided that the desC mutant should be made again in S. 
scabies 87.22, which is the wild type strain used by our collaborators at Cornell 
University. The reason for making desC mutant in S. scabies 87.22 was to investigate 
function of that gene and desferrioxamine production in this strain. Specifically after 
the desC mutant of S. scabies 87.22 has been made, the complementation of this 
mutant was attempted. 
The desC mutant in S. scabies 87.22 was created using the same strategy as that used 
to create the scabichelin mutant i.e. PCR targeting and subsequent conjugation to the 
wild type S. scabies 87.22 strain.  The cosmid containing the whole des cluster with 
the oriT-apramycin resistance cassette in place of the desC gene, which is only 555 
bases in length, was used for the construction of the mutant (the sequence of des 
cluster and the cosmid was obtained from our collaborators). This cosmid was 
introduced into E. coli ET12567 by electroporation and then transferred by 
conjugation from E. coli ET12567 to S. scabies 87.22. The kanamycin sensitive, 
apramycin resistant Streptomyces colonies were then selected and their genomic 
DNA was isolated and analysed by PCR. The PCR (Figure 4.3) was performed using 
18 nt long test primers (Table 7.6) designed within 100 bp region upstream and 
downstream of desC gene in S. scabies 87.22 genome.  
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Figure 4.3 PCR analysis of genomic DNA from the putative desC mutant colony. 
Lanes: M1- Middle Range DNA molecular size marker; M2- 1kb DNA molecular 
size marker, a, b, c- desC mutant genomic DNA; Tm= 57, 61, 63,respectively; d, e, f- 
desC cosmid with apramycin cassette; g, h, i- wild type S. scabies 87.22 genomic 
DNA. 
 
A PCR product of approximately 1.7 kb in size was obtained in the mutant strain. 
This size for the mutant corresponds to the apramycin cassette of 1.4 kb plus the 
primers priming about 150 base pairs downstream and upstream of the cassette. This 
PCR product was excised and purified from the gel and sent for sequencing analysis. 
The sequencing results confirmed that the PCR product contains the apramycin 
resistance gene. The size of the PCR product for the wild type desC gene was 855 
bp. 
Southern blot hybridization analysis was carried out to determine if the resistance 
cassette was inserted in the correct position in the genome. The DIG-labeled des 
cluster cosmid was used as a probe. Genomic DNA and the cosmid containing the 
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des cluster were digested using SacI. The probe was hybridized to the digested DNA 
and the different pattern of bands for the wild type and mutant were present on X-ray 
film (Figure 4.4). 
 
Figure 4.4 Southern blot hybridization using labeled des::oriT-apr cosmid as a probe 
confirming the nature of S.scabies desC mutant. Band 14716 bp in green is only 
present in wild type strain. Bands 1412 bp and 7575 bp coloured in red are 
characteristic for the mutant.  
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4.3.1 LC-MS Analysis of desC Mutant 
The metabolic profile of the desC mutant was analysed by LC-MS. The desC mutant 
strain was grown in 50 ml  Minimal Liquid Medium (SMM) in parallel with 50 ml 
SMM culture of S. scabies 87.22 wild type at 30° C, 180 rpm for 5 days. The culture 
extracts were then analysed via LC-MS for the presence of ferrioxamine B and E. 
Analysis of the extracted ion chromatograms for the m/z of 614 (ferrioxamine B; 
Figure 4.5 A) and 654 (ferrioxamine E; Figure 4.5 B) indicated that these compounds 
are present in cultures of the wild type strain. However, compounds with the same 
m/z and retention time could not be seen in the desC mutant (Figure 4.5 A, B). 
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Figure 4.5 A – EIC (m/z = 614) for ferrioxamine B from LC-MS analyses of 
acidified organic extracts from the S. scabies wild type (green) and S. scabies desC 
mutant (blue). B – EIC (m/z = 654) for ferrioxamine E from LC-MS analyses of 
acidified organic extracts from the S. scabies wild type (red) and S. scabies desC 
mutant (green). 
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4.4 Chemical Complementation of desC Mutant 
The aim of this work was chemical complementation of the S. scabies desC mutant 
to illustrate that reintroduction of the N-hydroxy-N-succinylcadaverine (HSC) 
precursor (Figure 4.6) into the desferrioxamine biosynthetic pathway would restore 
the production of desferrioxamines in this mutant. This was carried out by setting up 
three tubes with 5 ml of SMM medium each. Two were inoculated with the desC 
mutant spores, and S. scabies 87.22 wild type strain was used to inoculate the third. 
The HSC precursor was added to one of the cultures in which the desC mutant was 
growing. The other culture with desC mutant and the one with wild type S. scabies 
remained as the controls with no HSC added to either one. Following 72 hours 
incubation the culture supernatants were analysed by LC-MS. The analysis indicated 
restoration of desferrioxamine B production in the culture of desC mutant chemically 
complemented with HSC (Figure 4.7). However, desferrioxamine E (m/z=654) was 
not detected in the culture of desC mutant chemically complemented with HSC. 
Desferrioxamine was not detected in the culture supernatant of desC mutant with no 
HSC added (Figure 4.7).  
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Figure 4.6 Pathway for the biosynthesis of desferrioxamines B, G1 and E (Kadi et 
al., 2007).A-reactions catalysed by DesA, DesB enzymes and reaction proposed to 
be catalysed by DesC enzyme. B-Reaction catalysed by DesD enzyme. yielding 
desferrioxamine B, G1 and E. 
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Figure 4.7 EIC (m/z = 614) for ferrioxamine B from LC-MS analyses of acidified 
organic extracts from the S. scabies wild type (top trace), S. scabies desC mutant 
(middle trace) and Δ desC mutant + HSC (bottom trace). 
 
4.5 Genetic Complementation of desC Mutant 
Genetic complementation of the desC mutant by in trans expression of the deleted 
gene from the integrative plasmid pOSV556 (Figure 4.8), in addition to the chemical 
complementation, confirmed that reintroduction of the desC gene restores the 
production of desferrioxamines in S. scabies. desC gene complementation in S. 
scabies was carried out by cloning the desC gene into pOSV556 plasmid, which is 
under the control of the constitutive ermE* promoter. The plasmid contains 
ampicillin resistance gene (for selection in E.coli) and the hygromycin resistance 
gene (for selection in Streptomyces). It also contains oriT, allowing for the conjugal 
transfer of the plasmid from E. coli to Streptomyces. Additionally, an integrase 
encoded within pOSV556 allows its integration into the Streptomyces chromosome. 
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It occurs through site-specific recombination between the attP site within the vector 
and the attB site within the chromosome (Raynal et al., 2002). 
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Figure 4.8 Map of pOSV556 plasmid. 
 
To clone the desC gene into pOSV556 PCR cloning primers were designed (section 
7.1.5). The forward primer included an artificial conserved ribosome binding site 
(RBS; 5’-AGGAGG-3’) followed by the 6 bp upstream of the start codon and the 
first 7 bp of the coding sequence (Strohl, 1992). Reverse primers were designed to 
anneal approximately 100 bp downstream of the stop codon of the gene. The forward 
primer contained a HindIII restriction site and the reverse primer contained an XhoI 
site. The amplified desC gene was then cloned in the multiple cloning site of 
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pOSV556. The resultant PCR product was digested with HindIII and XhoI restriction 
enzymes and subsequently ligated with the similarly digested pOSV556. 
Electrocompetent E. coli DH5α were then transformed with the ligation mixture and 
colonies were selected for on LB agar containing ampicillin. Correct insertion of the 
PCR product into the vector was then confirmed by restriction digest and by PCR 
using the cloning primers (Figure 4.9). The size of a product was 699 bp. The E. coli 
ET12567/pUZ8002 were transformed with the correctly identified plasmid clone, 
which was subsequently transferred by conjugation from E. coli ET12567/pUZ8002 
to S. scabies strain and a single hygromycin resistant exconjugant was chosen for 
further analyses. DNA was isolated and analysed by PCR for the insertion of the 
desC gene copy from the pOSV556 by the cloning primers (Table 7.6; Figure 4.9). 
 
Figure 4.9 Left- a- an XhoI-HindIII restriction digest and b- PCR analysis with desC 
gene cloning primers of pOSV556::desC plasmid. Right-PCR analysis with desC 
gene cloning primers of: c- S. scabies wild type chromosomal DNA, d- S. scabies 
ΔdesC mutant DNA and e- S. scabies ΔdesC::pOSV556::desC complemented 
mutant. M- 1 kb molecular DNA ladder. 
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4.5.1 LC-MS Analysis of Complemented Δ desC Mutant 
 
The LC-MS analysis (Figure 4.10) indicated restoration of desferrioxamine B 
production in the culture of the desC mutant complemented with pOSV556::desC, 
however, this is at a lower level when in comparison to the S. scabies 87.22 wild 
type strain. Desferrioxamine B (m/z=654) was not detected in the culture of the desC 
mutant complemented with pOSV556::desC. Desferrioxamine was not detected in 
the culture supernatant of desC mutant (Figure 4.10).  
 
 
Figure 4.10 EICs (m/z = 614) for ferrioxamine B from LC-MS analyses of acidified 
organic extracts from the S. scabies wild type (top trace), S. scabies desC mutant 
(middle trace) and Δ desC ::pOSV556/63021::apr (bottom trace). 
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4.6 Discussion 
The PCR-targeting method was used to create a deletion of the desC gene within the 
des cluster of S. scabies (Gust et al., 2002). The desC gene in S. scabies genome was 
replaced with an apramycin resistance cassette containing oriT. The constructed 
mutant was analysed via PCR and Southern blot hybridisation methods. 
LC-MS analysis of the S. scabies wild type strain and the S. scabies ΔdesC mutant 
strain liquid cultures was undertaken. Before analysis, the supernatants of the wild 
type and the mutant strain were incubated with ferric iron to obtain the ferric 
complexes with desferrioxamines, which were then examined via LC-MS. The 
results indicated that wild type S. scabies produced desferrioxamines, whereas the 
ΔdesC mutant S. scabies strain did not, indicating that disruption of the desC gene in 
S. scabies abolished desferrioxamine production.  
Chemical complementation was carried out to further analyse the function of desC 
gene within the des cluster in S. scabies. The DesC enzyme is thought to catalyse the 
acylation of N-hydroxycadaverine to form precursors in desferrioxamine E and B 
biosynthesis in S. coelicolor (N. Kadi and G. L. Challis unpublished data; Figure 
4.6).  
Chemical complementation using HSC restored desferrioxamine B production in the 
S. scabies desC mutant, although to a lower level than in a wild type S. scabies 
strain. The lower level of desferrioxamine B production in S. scabies desC 
chemically complemented strain could have been due to the amount of HSC 
precursor added to desC mutant liquid culture. The concentration of HSC in desC 
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mutant culture was only 1µmol/ml. The reason for the small concentration of HSC 
was that it was not readily available during the experiment. Had more HSC been 
available the chemical complementation of S. scabies desC mutant could have been 
repeated several times to validate the LC-MS analysis results and optimise the 
concentration needed. 
The introduction of desC copy from pOSV556 vector into the ΔdesC mutant S. 
scabies genome was confirmed by PCR and LC-MS analyses. The LC-MS of 
complemented ΔdesC mutant strain indicated restoration of desferrioxamines 
biosynthesis. 
Investigation into the role of DesC was carried out in S. coelicolor (N. Kadi and G. 
L. Challis, unpublished data). The desC gene encodes an enzyme similar to acyl-
CoA-dependent acyl transferases (Kadi et al., 2007),
 
and catalyses the N-acylation of 
N-hydroxycadaverine (Figure 4.6; N. Kadi and G. L. Challis, unpublished data). In 
those organisms that also produce desferrioxamine B, DesC has relaxed substrate 
specificity, allowing acylation of N-hydroxycadaverine with acetyl-CoA as well as 
succinyl-CoA, giving N-hydroxy-N-acetylcadaverine (AHC) and N-hydroxy-N-
succinylcadaverine (HSC), respectively (Figure 4.6; Kadi et al., 2007). To prove 
directly that DesC catalyses these reactions the DesC enzyme purified from S. 
coelicolor was incubated with succinyl coenzyme A and with N-hydroxycadaverine 
substrate in one reaction and with acetyl coenzyme A and with N-hydroxycadaverine 
in another reaction (Kadi and Challis, unpublished data). LC-MS analysis of the 
reaction mixture with succinyl coenzyme A and another with acetyl coenzyme A 
showed respectively the presence of the peaks, which had the same m/z and retention 
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times as the authentic standards of the products HSC and AHC (Kadi and Challis, 
data not shown).  
In conclusion, desC gene in S. scabies is involved in desferrioxamine biosynthesis as 
its deletion resulted in the abolition of desferrioxamine production. Chemical 
complementation of the desC mutant with HSC restored to some level 
desferrioxamine biosynthesis (Figure 4.10) suggesting that the DesC protein in S. 
scabies catalyses the acylation of N-hydroxycadaverine to yield HSC, which is 
utilised in subsequent reaction catalysed by DesD to yield desferrioxamine B. 
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Results and Discussion II: Investigation of Tetronate-
like Biosynthetic Gene Cluster in S. scabies 87.22. 
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5. Investigation of Tetronate-like Biosynthetic Gene Cluster 
in S. scabies 87.22. 
5.1 Cryptic Polyketide Tetronate Biosynthetic Gene Cluster in S. 
scabies 87.22 
S. scabies 87.22 was found to encode a cryptic tetronate biosynthetic gene cluster 
(Figure 5.1). It contains genes homologous to the genes in the RK-682 biosynthetic 
cluster, such as a type I polyketide synthase, an Acyl-CoA synthetase, an Acyl 
carrier protein, a FabH-like protein and a FkbH-like protein. The metabolic product 
of this gene cluster has not yet been identified. It is hypothesised to be a novel 
compound with a structure similar to that of RK-682 and agglomerins, and with a 
potential role in plant pathogenicity. 
 
Figure 5.1 Cryptic tetronate polyketide biosynthetic gene cluster Figure in S. scabies 
(Challis, unpublished). 
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5.2 Transcriptional Analysis of Cryptic Tetronate Biosynthetic Gene 
Cluster in S. scabies 
The aim of this work was to determine if the genes from the putative tetronate-like 
cluster in S. scabies are expressed under laboratory conditions. Currently the 
metabolic products of this cluster have not been identified. To check the expression 
of the putative tetronate-like cluster in S. scabies reverse transcriptase PCR (RT-
PCR) was carried out on the total RNA isolated from wild type S. scabies. 
 PCR primers approximately 20 bp in length were designed to amplify a 500-600 bp 
regions of several genes found within the putative tetronate biosynthetic gene cluster, 
such as scab62881 (encoding a FkbH-like protein), scab62951 (encoding a FabH-
like protein), scab62971 (encoding a ChlD3-like protein), scab62991 (encoding a 
ChlD4-like protein) and also from the hrdB gene (an essential gene encoding sigma-
like transcription factor) as a positive control. The total RNA was isolated from S. 
scabies mycelium grown for 3, 5, 7 and 14 days. The RNA was then analysed using 
agarose gel electrophoresis (Figure 5.2) and treated with DNAse to remove all traces 
of DNA from the RNA samples. RT-PCR was carried out on a purified RNA with 
the hrdB, scab62881, scab62951, scab62971 and scab62991 primers (Section 7.1.5) 
to examine the transcription of the genes (Figure 5.3).  
The first step in RT-PCR involves the use of reverse transcriptase polymerase and a 
primer to anneal and extend the targeted mRNA sequence. The mRNA is transcribed 
to a complementary strand of DNA (cDNA), which is subsequently amplified with 
primers and DNA polymerase in a standard PCR. The PCR products are analysed 
using agarose gel electrophoresis. If a band of the desired molecular weight is 
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present, then the mRNA was present in the sample, consequently the associated gene 
is expressed.  
The figure 5.3 B shows the molecular band present for the hrdB control PCR was the 
correct size. Analysis of the RT-PCR for the tetronate genes scab62881 and 
scab62951 indicates that the tetronate-like cluster is expressed as bands of the correct 
size were present (Figure 5.3 C, D). However, the PCR results for scab62991 and 
scab62971 are inconclusive (data not shown). The RT-PCR product obtained for 
scab62991 was not the correct size and in the control reaction, PCR on genomic 
DNA, multiple bands could be seen, thus indicating that the primers for this gene are 
not specific enough and did not anneal to the correct RNA sequence. 
 
 
Figure 5.2 The 1% agarose gel of total RNA extracted from wild type S. scabies. 
Lanes 1-4: 1- RNA extracted from 3 days old mycelium; 2- RNA extracted from 5 
days old mycelium; 3- RNA extracted from 7 days old mycelium; 4- RNA extracted 
from 14 days old mycelium.23S and 16S are two bands of total RNA. 
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Figure 5.3 RT-PCR analysis of S. scabies wild type RNA. A- the putative tetronate 
gene cluster in S. scabies 87.22; B- RT-PCR: 1- with hrdB primers (positive control); 
2- with scab62881 primers; 3- with scab62951 primers. 3, 5, 7, 14- the S. scabies 
cells were grown for 3, 5, 7 and 14 days before the RNA extraction. 
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5.3 Mutagenesis of scab63021 to Determine the Effect on Expression 
of Putative Tetronate-like Gene Cluster in S. scabies. 
5.3.1 SARP Family 
Scab63021 is proposed to encode for a transcriptional activator containing some 
sequence homology to the SARP (Streptomyces Antibiotic Regulatory Proteins) 
family of genes. SARP genes are pathway-specific regulatory genes that are 
associated with individual biosynthetic gene clusters and they were the first pathway-
specific regulatory proteins to be discovered (Wietzorrek and Bibb, 1997). Proteins 
of the SARP family are transcriptional activators. Examples include RedD and ActII-
orf4, which regulate the production of undecylprodigiosin and actinorhodin, 
respectively, in Streptomyces coelicolor (Fernandez-Moreno et al., 1991; Narva and 
Feitelson, 1990). It is proposed that SARPs activate transcription by binding to a set 
of sequences of heptameric repeats located in the proximity of the cognate promoters 
of biosynthetic clusters, which are controlled by SARPs (Garg and Parry, 2010). 
When the SARPs are bound to the promoters it is proposed that the mechanism of 
transcription initiation involves binding of RNA polymerase to the appropriate sites 
(Tanaka et al., 2007).  
5.3.2 Mutagenesis of scab63021 Gene 
The scab63021 gene is situated approximately 1500 bp downstream of the S. scabies 
tetronate-like biosynthetic gene cluster. It has been proposed that it is involved in the 
regulation of the tetronate-like biosynthetic gene cluster acting as a transcriptional 
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activator. To prove this hypothesis the gene was disrupted in S. scabies using PCR 
targeting protocol (section 7.6.5).  
In this method the cosmid containing the target gene is usually used. However, the 
cosmid containing scab63021 was not available. Instead, primers were designed to 
encompass the start and stop codons of the target gene and to amplify it by PCR from 
S. scabies 87.22 genomic DNA. The amplified scab63021 gene would be then 
cloned into plasmid vector and that construct could subsequently be used to 
transform E.coli BW25113/pIJ790 strain. From then on the further steps in the 
construction of the mutant would be carried as in a standard PCR Redirect protocol.  
According to the above the cloning primers were designed to amplify scab63021 
gene via PCR. These were designed in the same way as the primers used to clone the 
S. scabies desC gene into pOSV556 plasmid (section 4.6), however, the PCR with 
primers designed to amplify the scab63021 gene did not yield a product with the 
correct molecular weight. For that reason the scab63021 gene was not cloned into 
plasmid vector. As the alternative, the scab63021 gene was synthesised by a gene 
synthesis company (Genewiz). The whole scab63021 gene was synthesised and 
cloned into pUC57 plasmid by Genewiz (Figure 5.4).  
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Figure 5.4 Map of pUC57/scab63021. Legend: oriT-origin of replication, ampR-
ampicillin resistance gene. 
 
E.coli BW25113/pIJ790 was electrotransformed with the obtained pUC57/ 
scab63021 construct. A 1 kb internal fragment of scab63021 was chosen to be 
replaced. To disrupt the scab63021 gene (size 2781 bp) in S. scabies, specific 
primers (Section 7.1.5) were designed and used to amplify the oriT-apramycin 
cassette obtained from the pIJ773 plasmid. The priming sequences (39 nt) used were 
taken from 880 bp after the start codon and about 740bp before the stop codon of the 
targeted gene i.e., within the scab63021. Each primer had at the 5’ end 39 nt 
homologous to the S. scabies sequence adjacent to the targeted 1 kb sequence inside 
of the scab63021 and at the 3’ end 19 or 20 nt matching the right or left end of the 
disruption cassette (section 3.1). The E. coli BW25113/pIJ790 bacteria containing 
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the pUC57 scab63021 construct were electrotransformed with the PCR amplified 
OriT-apramycin cassette resulting in a double cross-over recombination between the 
ends of the amplified resistance cassette and the homologous regions within 
scab63021. To determine if the desired gene replacement had occurred correctly, the 
pUC plasmid was isolated and analysed by PCR using test primers, which were 
designed to anneal ~100 bp upstream/downstream of the region in the  scab63021 
gene to be replaced. The expected band for mutagenised plasmid was 1770 bp, and 
for wild type plasmid 1440 bp. As it is illustrated in Figure 5.5 the PCR for the wild 
type plasmid did not work very well but it showed a band with a size of about 1700 
bp for the mutated plasmid had been amplified as expected. This band was purified 
from the gel and sent for sequencing, which indicated the presence of the apramycin 
resistance gene. The replacement of the scab63021 gene fragment in the plasmid was 
also confirmed via restriction enzymes digestion patterns of the mutated plasmid 
with the wild type plasmid (examples of digestion with SacI, which cuts twice within 
the oriT-apr cassette generating a specific 752 bp band indicative of the presence of 
the cassette, and BamHI enzymes are shown in Figure 5.6).  
 
Figure 5.5 PCR analysis of genetically-engineered pUC57/scab63021 plasmid with 
test primers. Lanes: M-b. M- 1 kb molecular weight marker; a- PCR band for 
unmutagenised pUC57/scab63021; b- PCR for pUC57/scab63021::oriT-apra. 
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Figure 5.6 Agarose gel electrophoresis analysis of restriction enzymes digest of 
genetically-engineered pUC57/scab63021 plasmid used to disrupt the scab63021 in 
the S. scabies genome within putative tetronate-like cluster. Lanes M-d: M- 1kb 
molecular weight marker; a- undigested pUC57/scab63021::oriT-apra; b- digestion 
with EcoRI; c- digestion with BamHI d- digestion with SacI. 
 
The correctly modified plasmids were introduced into S. scabies by intergenic 
conjugation from E. coli ET12567/pUZ8002. Apramycin resistant, Streptomyces 
exconjugants were analysed by PCR to confirm that a double cross-over gene 
replacement had taken place (Figure 5.7). The first PCR using genomic DNA from 
the scab63021 mutant colonies and with the primers annealing inside of the oriT- 
apramycin cassette, confirmed the presence of the oriT-apramycin cassette in place 
of the scab63021 internal fragment in the genome of the mutant. The expected size 
of the PCR product was ~400 bp, which was then compared to the PCR of the 
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mutagenised plasmid pUC/scab63021::apr, which also gave band of ~400 bp 
(Figure 5.7 A). This indicate that introduction of oriT-apramycin cassette into the 
genome of putative scab63021 mutant was successful. They do not prove, however, 
that a double cross-over between scab63021 and cassette had occured. The putative 
scab63021 mutant genomic DNA was further analysed with the test primers (Section 
7.1.5) designed to anneal ~100 bp upstream and downstream of the replaced internal 
fragment within scab63021. The expected band size was ~1.5 kb for the wild type S. 
scabies genomic DNA, and 1.8 kb for scab63021 mutant. The PCR results showed 
no band for wild type, however, the expected band was present for the mutant strain 
(only mutant band is displayed-Figure 5.7 B). 
 
Figure 5.7 A- PCR analysis of genetically-engineered pUC57/scab63021 plasmid 
and genomic DNA of scab63021 mutant with oriT- apramycin casette internal 
primers; M-1 kb molecular weight marker, a –PCR of genomic DNA of Δscab63021 
mutant; b- pUC57/scab63021::apra plasmid with apramycin internal primers. B-PCR 
analysis of putative scab63021 mutant genomic DNA with test primers. 
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5.4 RT-PCR on Wild Type S. scabies and the Δscab63021 Mutant 
RNA 
Although the mutation of the scab63021 gene had not been proved conclusively, 
analysis of the wild type S. scabies and the putative scab63021 mutant genomes has 
been carried out to allow for comparisons in the patterns of expression of the genes 
in the putative tetronate-like gene cluster. 
The RT-PCR was carried on wild type and mutant S. scabies purified RNA using the 
same method previously described (section 5.3). The RNA was extracted from 
mycelia 3, 5, 7 and 14 days old.  In this experiment the expression was analysed only 
for two genes from S. scabies tetronate-like cluster; scab62881 (encoding a FkbH-
like protein), and scab62951 (encoding a FabH-like protein) as the RT-PCR in wild 
type S. scabies yielded specific bands only for these two genes within the cluster. 
The RT-PCR with the scab62881 primers yielded specific as well as unspecific 
bands. The right size for the specific band of RT-PCR product on wild type RNA 
was 617 bp for the scab62881 primers. The ~20 bp PCR primers designed for the 
previous analysis to amplify regions of scab62881 and scab62951 approximately 600 
bp in length were used in this experiment. The hrdB gene RT-PCR was again used as 
a positive control.  
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Figure 5.8 RT-PCR analysis of S. scabies wild type and Δscab63021 RNA, A: RT-
PCR control, 1317bp product size (hrdB primers); B: RT-PCR with scab62951 
primers, 615 bp product size; C: RT-PCR with scab62881 primers, 617 bp product 
size. 
5.5 Discussion 
The PCR analysis and sequencing of the Δscab63021 mutant genomic DNA has 
confirmed the presence of the resistance cassette in the mutant genome. However, 
this did not enable us to conclude that the cassette was in the correct position within 
the genome. For that Southern blot hybridisation was carried out. However, findings 
were inconclusive due to a high amount of background on the X-ray film. 
The expression pattern does not illustrate any differences between the wild type 
strain and the Δscab63021 mutant indicating that scab63021 does not have any effect 
on the expression of genes within the putative tetronate biosynthetic gene cluster. 
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An alternative method could have been employed to construct the Δscab63021 
mutant. The scab63021 gene could have been obtained within a cosmid, which could 
subsequently be used as a template for PCR. The cosmid would be more useful as the 
insert is bigger and the PCR primers could be designed to anneal outside of the 
scab63021 gene and the sufficient flanking sequences on both sides of the target 
sequence would ensure that the homologous recombination between the investigated 
gene and the resistance cassette PCR product ends would occur. 
Further work would be to carry out the comparative analysis of the S. scabies wild 
type strain and Δscab63021 mutant culture supernatants via LC-MS to find the 
putative tetronate product. If there would be no differences between the metabolic 
profiles of the two strains, the Δscab63021 mutant could be constructed again by 
another method. Alternatively, the deletion of the scab62941, encoding for a putative 
PKS within the S. scabies tetronate-like gene cluster could be obtained and the 
metabolic profile of the wild type strain and the mutant could be compared again via 
LC-MS in search of the cryptic tetronate metabolite. 
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6.1 Results and Discussion I: Investigation of Siderophore 
Biosynthetic Gene Clusters in S. scabies. 
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Figure 6.1 Structures of investigated siderophores. 
6.1.1 Investigation of Pyochelin Biosynthetic Gene Cluster in S. scabies 
87.22. 
Putative functions for most of the twelve genes within the putative pyochelin 
biosynthetic gene cluster (PBGC) in S. scabies 87.22 have been proposed (Seipke et 
al., 2011) and a biosynthetic pathway for pyochelin has been suggested on the basis 
of bioinformatics and experimental studies. However, the regulation of pyochelin 
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production was not fully understood. Scab1401 was found to encode a pathway 
specific regulator, which was predicted to repress transcription of PBGC in iron rich 
conditions. To determine the function of scab1401, the gene was replaced with the 
oriT-apramycin cassette creating Δscab1401 mutant by our collaborators (Loria’s 
group; Seipke et al., 2011). The mutant was then analysed via LC-MS for pyochelin 
production in iron deficient conditions. To prove that pyochelin is a product of S. 
scabies PBGC the putative NRPS encoding gene scab1471 in Δscab1401 mutant was 
replaced with oriT-hygromycin resistance cassette creating a scab1401- scab1471 
double mutant. The metabolic profile of the mutant was analysed via LC-MS 
alongside of Δscab1401 mutant and the S. scabies wild type strain.  
LC-MS analyses of the scab1401 mutant supernatant unveiled the presence of a 
compound with the same molecular mass as pyochelin. The stereochemistry of the 
compound produced by S. scabies was also investigated. Comparison of the 
scab1401 mutant culture supernatant by LC-MS using chiral stationary phase with 
the authentic standards of pyochelin and ent-pyochelin proved that S. scabies 
produce pyochelin, not enantio-pyochelin. The LC-MS analysis of culture 
supernatants of a scab1401- scab1471 double mutant indicated no pyochelin 
production. These data indicate that pyochelin is produced by PBGC in S. scabies 
and Scab1401 represses transcription of pyochelin in iron-deficient conditions. The 
compound with the same mass as pyochelin was not consistently detected in the 
supernatants of wild type S. scabies when grown in iron-deficient conditions. It was 
postulated to be that it is due to that the pyochelin gene cluster in the wild type strain 
was not induced enough under the used growth conditions.  
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Plant assays were used (by Prof R. Loria’s group at Cornell University; Seipke et al., 
2011) to analyse the importance of pyochelin in plant pathogenicity. Incubation of 
scab1471 mutant (scab1471 encodes one of the NRPS enzymes from the pyochelin 
biosynthetic pathway) and of S. scabies wild type, both on potato tissue and radish 
seedlings, indicated that pyochelin is not required for pathogenicity of the potato 
tissue and radish. One conclusion that can be drawn from these results is that iron 
may have not been essential for S. scabies growth in the assays. The genome of S. 
scabies possesses several more biosynthetic gene clusters encoding other 
siderophores, such as putative genes for the biosynthesis of desferroxamines 
(scab57921–scab57951). To determine which iron-chelating metabolites produced 
by S. scabies are required for plant pathogenicity, analysis of desferrioxamine mutant 
and other siderophores mutants in S. scabies is needed as well as, in planta 
transcriptional analysis of the pyochelin, desferrioxamine and other putative 
siderophore biosynthetic gene clusters. 
6.1.2 Investigation of Scabichelin Biosynthetic Gene Cluster in S. scabies 
87.22. 
Mining of the S. scabies 87.22 genome has identified a gene cluster, which was 
predicted to encode the nonribosomal peptide synthetase multienzymes responsible 
for the biosynthesis of a novel iron-chelating metabolite named scabichelin. 
Bioinformatic analysis of a cryptic NRPS biosynthetic gene cluster, which include 
the protein coding sequences from scab85431 to scab85521 are homologous to 
proteins encoded for by genes within the coelichelin biosynthetic gene cluster from 
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S. coelicolor M145. Analysis of the culture supernatants of S. antibioticus, used by 
our collaborators, via HPLC and subsequent analysis by NMR indicated that these 
strains produce a tris-hydroxamate siderophore, which was named scabichelin. The 
aim was to establish whether the product of S. antibioticus is also the product of a 
cryptic NRPS encoded by the cryptic biosynthetic gene cluster in S. scabies 87.22. 
 
Bioinformatic analysis of the functional domains of the NRPS encoded for by 
scab85471 revealed it contains 17 enzymatic domains organized into 5 modules. 
Therefore, it was hypothesised that product of the scab85471 gene would be a 
pentapeptide, 
PCR analysis and sequencing confirmed the presence of apramycin cassette in 
scab85471::oriT-apr (W1000 mutant). The correct construction of the mutant was 
also confirmed by Southern blot hybridisation analysis.  
Comparative LC-MS/MS analyses of the W1000 mutant, S. scabies 87.22 wild type 
and scabichelin purified from S. antibioticus indicated that scabichelin is the 
metabolic product of the S. scabies 87.22 cryptic gene cluster. LC-MS analyses of 
culture supernatants of the 87.22 and W1000 strains grown in an iron-deficient 
medium, to which ferric iron was added before analysis, indicated the presence of a 
ferric complex that is produced by S. scabies 87.22, but not the W1000 mutant. LC-
MS retention time and MS/MS fragmentation pattern of ferri-scabichelin are the 
same for the S. scabies 87.22 compound and the authentic standard. 
Bioinformatic analysis of the scab85431-scab85521 gene cluster and LC-MS 
analysis of S. scabies 87.22 scabichelin indicated its potential function as an iron 
chelator. However, the essentiality of that metabolite for growth in iron-deficient 
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conditions has not yet been investigated. These findings may be helpful to establish 
the function of that siderophore in S. scabies and its potential role in plant 
pathogenicity. The further work with scabichelin would be conducted in 
collaboration with Dr.Bignell’s research group (former member of Prof. Loria’s 
group) and would involve the use of a plant assay to compare the necrotic effect of S. 
scabies 87.22 and the W1000 strains grown in parallel on tuber and root vegetables 
such as potato and radish, respectively. 
 
6.1.3 Desferrioxamine Production in S. scabies 
The PCR-targeting method was used to create a deletion of the desC gene within the 
des cluster of S. scabies (Gust et al., 2002). The desC gene in the S. scabies genome 
was replaced with an apramycin resistance cassette containing oriT. The constructed 
mutant was analysed via PCR and Southern blot hybridisation methods. 
LC-MS analysis of the S. scabies wild type strain and the S. scabies ΔdesC mutant 
strain liquid cultures was undertaken. Before analysis, the supernatants of the wild 
type and the mutant strain were incubated with ferric iron to obtain the ferric 
complexes with desferrioxamines, which were then examined via LC-MS. 
Chemical complementation was carried out to further analyse the function of the 
desC gene within the des cluster in S. scabies. 
The introduction of the desC copy from the pOSV556 vector into the ΔdesC mutant 
S. scabies genome was confirmed by PCR and LC-MS analyses. The results 
indicated that the wild type S. scabies produced desferrioxamines, whereas the 
ΔdesC mutant S. scabies strain did not, indicating that disruption of the desC gene in 
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S. scabies abolished desferrioxamine production. Chemical complementation using 
desferrioxamine pathway precursor N-hydroxy-N-succinylcadaverine (HSC) restored 
desferrioxamine B production in the S. scabies desC mutant, although to a lower 
level than in a wild type S. scabies strain. The lower level of desferrioxamine B 
production in S. scabies desC chemically complemented strain could have been due 
to the amount of HSC precursor added to ΔdesC mutant liquid culture. The 
concentration of HSC in ΔdesC mutant culture was only 1 µmol/ml. The reason for 
the small concentration of HSC was that it was not readily available during the 
experiment.  
The LC-MS of genetically complemented ΔdesC mutant strain indicated restoration 
of desferrioxamine biosynthesis. 
The further work with desC mutant would be conducted in collaboration with Prof. 
Rose Loria’s research group and would involve use of a plant assay to compare the 
necrotic effect of the S. scabies 87.22 wild type and ΔdesC mutant grown in parallel 
on root vegetables.  
6.2 Results and Discussion II: Investigation of Tetronate-like 
Biosynthetic Gene Cluster in S. scabies 87.22. 
6.2.1 Investigation of Tetronate-like Biosynthetic Gene Cluster in S. 
scabies 87.22. 
The S. scabies 87.22 genome was found to encode cryptic tetronate biosynthetic gene 
cluster, which is predicted to encode genes homologous to genes in the RK-682 
biosynthetic gene cluster, such as a type I polyketide synthase, an Acyl-CoA 
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synthetase/dehydrogenase, an Acyl carrier protein, a FabH-like protein, and a FkbH-
like protein. The aim of this work was to determine if the genes from the putative 
tetronate-like cluster in S. scabies are expressed under laboratory conditions. 
Currently, the metabolic product of this cluster has not been identified. To analyse 
the expression of the putative tetronate-like cluster in S. scabies, reverse transcriptase 
PCR (RT-PCR) was carried out on the total RNA isolated from the wild type S. 
scabies. 
The scab63021 gene has been proposed to be involved in the regulation of the 
tetronate-like biosynthetic gene cluster acting as a transcriptional activator. To prove 
this hypothesis, the attempt was made to disrupt the gene in S. scabies using PCR 
targeting protocol. Analysis of the wild type S. scabies and the putative scab63021 
mutant genomes has been carried out to allow for comparisons in the patterns of 
expression of the genes in the putative tetronate-like gene cluster. 
The transcriptional analysis of the S. scabies wild type RNA revealed that the cluster 
is expressed. Transcripts of some genes (listed in section 5.2) were obtained and 
confirmed by sequencing. The PCR analysis and sequencing of the Δscab63021 
mutant genomic DNA has confirmed the presence of the resistance cassette in the 
mutant genome. However, this did not enable us to conclude whether the cassette 
was in the correct position within the genome. The expression pattern does not 
illustrate any differences between the wild type strain and the Δscab63021 mutant 
indicating that scab63021 does not have any effect on the expression of genes within 
the putative tetronate biosynthetic gene cluster. 
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Further work would be to carry out the comparative analysis of the S. scabies wild 
type strain and the Δscab63021 mutant culture supernatants via LC-MS to find the 
putative tetronate product. If there would be no differences between the metabolic 
profiles of the two strains, the Δscab63021 mutant could be constructed again by 
another method. Alternatively, the deletion of the scab62941, encoding for a putative 
PKS within the S. scabies tetronate-like gene cluster could be obtained and the 
metabolic profile of the wild type strain and the mutant could be compared again via 
LC-MS in search of the cryptic tetronate metabolite.  
6.3 Significance 
Among actinomycetes, members of the genus Streptomyces are considered to be the 
major producers of secondary metabolites (Challis and Hopwood, 2003). They have 
evolved the ability to biosynthesize multiple biologically active compounds. These 
compounds are not made during the vegetative growth phase and their production is 
usually switched on at a point when nutrients needed for a primary metabolism are 
depleted and during the aerial mycelium growth phase and during spore growth 
initiation. Their biological functions include, among the others, killing of 
competitive microorganisms, regulation of bacterial metabolism and metal ion 
uptake. It was argued that possible reasons for the biosynthesis of secondary 
metabolites may be the selectional advantages these compounds confer to the 
producing organisms such as the defence mechanism against the environmental 
stresses (Stone and Williams, 1992).  
Siderophores are one class of secondary metabolites. They are produced by many 
bacteria to increase the solubility of iron from the soil. The analysis of several 
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Streptomyces species genomes were found to encode for the biosynthesis of multiple 
siderophores (Challis and Hopwood, 2003; Barona-Gomez et al., 2006), for example, 
S. coelicolor produces two hydroxamate siderophores: coelichelin and 
desferrioxamine. S. avermitilis produces desferrioxamine and is also predicted to 
produce the siderophore myxochelin (Ikeda et al., 2003). The reason for the 
production of more than one kind of iron-chelating metabolite is not exactly clear. 
However, it is known that many bacteria that do not produce desferrioxamine 
siderophore posses the uptake systems for it (Barona-Gomez et al., 2006). It was, 
therefore, hypothesized that streptomycetes, which produce desferrioxamine, also 
need to possess a biosynthetic gene cluster responsible for the production of another 
siderophore, which is not taken up into the cell by the ferroxamine uptake system 
(Challis and Hopwood, 2003). 
Multiple pathways for the assembly of various siderophores were also found in 
several plant pathogenic microorganisms (Franza and Expert, 2012). It is known that 
iron is essential for the development of bacterial infections in mammalian hosts (Cox 
et al 1981). However, the role of iron uptake in the invasion of plants by pathogenic 
bacteria has only been investigated in recent years (Franza and Expert, 2012). These 
investigations have provided some evidence for the role of iron acquisition in the 
virulence of Gram-negative plant pathogenic microorganisms. For example, Dickeya 
dadantii a soft-rotting Gram-negative soil bacterium is a plant pathogen of many 
plant species, including some vegetables. The two siderophores that it produces-
chrysobactin and achromobactin- are required for the development of infection 
symptoms in the plant tissues (Dellagi et al., 2005; Enard et al., 1988). Iron uptake is 
also required for infection by Erwinia amylovora, which causes fire blight in apple 
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flowers (Dellagi et al., 1998). Pseudomonas syringae pv. tabaci 6605 produces the 
siderophore pyoverdin, which is needed for development of wildfire disease on 
tobacco plants (Taguchi et al., 2010). As iron is often critical for the virulence of 
Gram-negative plant pathogens, it is suspected that siderophores are also important 
for iron uptake in pathogenic Streptomyces species. Streptomyces scabies causes 
disease in potatoes and root crops (Loria et al., 1998) and its genome encodes 
biosynthetic pathways directing biosynthesis of several siderophores, including 
pyochelin and desferrioxamines. The novel iron-chelating metabolite scabichelin was 
also isolated from this strain. Siderophore-mediated iron acquisition has not been yet 
confirmed to be a significant factor in pathogenicity of S. scabies. However, the 
investigations of the siderophore biosynthetic pathways in this strain will enable 
further elucidation of the role of iron acquisition in the virulence of plant pathogenic 
streptomycetes. Analysis of the S. scabies genome also unveiled the presence of a 
gene cluster encoding biosynthetic pathways for the production of secondary 
metabolites that are not associated with iron uptake but, which were reported to be 
present in other plant pathogens (Section 5). The investigation of these clusters and 
their metabolites will contribute to further elucidation of the molecular mechanism of 
S. scabies that are important for plant pathogenicity. 
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7.1 Materials 
7.1.1 Enzymes, Chemicals and Equipment 
Kits for DNA gel extraction and plasmid isolation from E. coli were purchased from 
Qiagen (USA). The kit for DNA ligation was obtained from Roche (Germany). 
Restriction enzymes were purchased from MBI Fermentas (Lithuania) and New 
England Biolabs (USA). Oligonucleotide primers were ordered from Sigma Genosys 
(USA). The gene synthesis was ordered from Genewiz. Taq polymerase was 
purchased from Fermentas and High Fidelity Polymerase from Roche. The 
ingredients for media preparation were purchased from Fisher BioReagents, Difco 
and Becton, Dickinson and co. The rest of chemicals were bought from Difco (USA), 
Sigma-Aldrich (USA), Fermentas (Lithuania), Fisher Scientific (UK), Biolab (New 
Zealand), Lonza (UK). 
The concentration of DNA and RNA was measured on a NanoDrop ND-1000 
Spectrophotometer. An Eppendorf Mastercycler Personal was used for PCR 
reactions. Agarose gel electrophoresis was performed on Bio-Rad Power Pac 300. A 
Bio-Rad Gene Pulser II with the Bio-Rad Pulse Controller Plus was used for 
electroporations. Thermo BioMate3 Spectrophotometer was used to check optical 
density of bacterial cell cultures. The aseptic work with Streptomyces was performed 
under Bassaire laminar flow hood. The microbial cell culture supernatants and 
extracts were analysed for secondary metabolite production by LC-MS (LC – 
Agilent 900, MS – Bruker HCT Plus) and Bruker MicroTOF mass spectrometer. For 
Southern blot hybridisation a UV Stratalinker 2400 from Stratagene was used for 
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DNA fixation to nylon membrane (Amersham). For hybridisation of probe to the 
DNA a TechHybridiser HB-1D was used. 
7.1.2 General Solutions, Buffers and Antibiotics 
All stock solutions (Table 7.1) were prepared according to Sambrook and Russel 
(2001). Distilled water was used for preparing all stock solutions. Autoclaving or 
filtration through a 0.2 µm filter (Stericon) was used to sterilise the solutions. 
Antibiotic stock solutions (Table 7.2) were dissolved in distilled water or other 
appropriate solution and sterilised by filtration through a 0.2 µm filter. 
 
Table 7.1General stock solutions. 
Chemical  Stock solution Solvent 
TBE ( 1000ML 5x) Trizma base- 53g 
Boric acid- 27.5g 
EDTA- 10mM, pH 8 
water 
TE buffer Tris –HCL pH 8 100mM 
EDTA – 10mM, pH 8 
water 
Tris-HCl (pH 8) 0.5M Water, pH adjusted with 
HCL 
Agarose gel loading dye Glycerol 50% 
Bromophenol blue 0.1% 
Xylene cyanol 0.1% 
water 
RNAse solution RNAse stock 50mg/ml water 
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Table 7.2 Antibiotics stock solutions. 
     
    Antibiotic 
 
    
Stock sol. 
 (mg/mL) 
 
 Solvent 
 
E. coli 
(μg/mL) 
S. scabies 
(μg/mL) 
overlay 
S. scabies 
(mg/plate) 
overlay 
ampicillin 100 water 100 - - 
apramycin 50 water 50 25 1.25 
chloramphenicol 25 ethanol 25 - - 
hygromycin 50 water 50 25 1.25 
kanamycin 50 water 50 100 5.0 
nalidixic acid 25 0.3M 
NaOH 
25 20 0.5 
7.1.3 Bacterial Strains 
Table 7.3 and table 7.4 list the bacterial strains used in this work. 
Table 7.3 The E. coli strains used. 
                                                        Escherichia coli strains 
Name Genotype Source 
  
DH5α 
F- endA1 glnV44 thi-1 relA1 
gyrA96 deoR nupG lacZdeltaM15 
hsdR17 
general cloning host 
(Woodcock et al., 
1989), lab stock 
 
MC1061 
araD139 Δ(ara-leu)7696 galE15 
galK16 Δ(lac)X74 rpsL(Strr) hsdR2 
(rK–mK+) mcrA mcrB1 
general cloning host, 
lab stock 
 
ET12567/pUZ8002 
Non-methylating host for transfer 
of DNA into Streptomyces spp. 
plasmid pUZ8002: tra, KanR, RP4 
23; Genome: dam, dcm, hsdS, 
CmR, TetR, JIC, Norwich 
 
JIC, Norwich 
(Gust et al., 2004) 
 
BW25113/pIJ790 
Temperature sensitive strain of E. 
coli, should be grown on rich 
 
Plant Bioscience 
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medium containing 
chloramphenicol (25 μg/ml) at 
30°C. Plasmid: pIJ790 [oriR101], 
[repA101(ts)], araBp-gam-be-exo. 
Chromosome: (Δ(araD-araB)567, 
ΔlacZ4787(::rrnB-4), lacIp-
4000(lacIQ), λ-, rpoS369(Am), 
rph-1, Δ(rhaD-rhaB)568, hsdR514; 
Datsenko and Wanner, 2000). 
Limited 
(Datsenko and Wanner, 
2000) 
 
 
Table 7.4 The S. scabies strains used 
Streptomyces scabies strains Source 
87.22 Wild type Rose Loria 
Cornell University 
Δscab1401 87.22 scab1401 null mutant Rose Loria 
Cornell University 
Δscab1471 87.22 scab1471 null mutant Rose Loria 
Cornell University 
Δscab1401- 
Δscab1471 
87.22 scab1401-scab1471 double mutant Rose Loria 
Cornell University 
Δscab desC S. scabies 87.22 scab57931 null mutant  
 
This study 
Δscab desC 
comp 
S. scabies 87.22, scab57931 null mutant 
complemented 
This study 
S. scabies 
W1000  
S. scabies  scab85471::apr mutant  This study 
Δscab63021 S. scabies  87.22 scab63021 ::apr mutant Lab stock 
PhD Thesis: Joanna Bicz                             Chapter 7: Materials and Methods 
160 
 
7.1.4 Plasmids and Cosmids  
Tables 7.5 list plasmids and cosmids used in this study. 
 
Table 7.5 Plasmids and cosmids used. 
Name Insert Source/Reference 
pKC1132 Plasmid to create disruption in 
scab85471, derived from pOJ260 
by deletion of the KpnI-SpeI 
fragment, contains oriT RK2 for 
conjugation from E. coli to 
Streptomyces, aac(3)IV 
Lab stock 
pOSV556 Contains: E. coli origin of 
replication, oriT, hygromycin 
resistance gene, ermE* promoter, 
pSAM2 integrase and 
corresponding attachement site. 
Pernodet Group, 
University of Paris- 
Sud, France 
pIJ773 Source of oriT-apr cassette for 
gene disruption (pBluescript KS(+), 
(aac3(IV)), oriT(RK2), FRT sites) 
Gust et al. 2004 
pUC57::scab63021 General cloning plasmid. Contains 
scab63021 and ampicillin 
resistance gene 
Genewiz Inc. 
S1757  Supercos1 derivative containing. 
scabies des cluster scab57921 to 
scab57981genes  
Rose Loria, 
Cornell University 
S57 Supercos1 derivative containing 
scab85251 to scab85521genes  
Rose Loria, 
Cornell University 
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7.1.5 Primers  
Oligonucleotide primers used in this study are listed in Table 7.6. 
 
Table 7.6 Oligonucleotide primers used. 
Name Sequence 5’→ 3’ Characteristic 
desCcomp_fw aaagggaagcttaggaggcgcggtat
gaccttca 
Primers to complement scab57931 
gene  
desCcomp_rv gggaaactcgaggcgtgatgagccg
ctcg 
supcosseq_fw 
 
aacaaataggggttccgc Primers for sequencing ends of 
scabichelin gene cluster insert in 
Supercos 1 supcosseq_rv 
 
gcctgtttttgtctctttcc  
replacement_fw cagggcgcgcacccgctgccggtgg
atgaactgctgccgattccggggatcc
gtcgacc 
PCR targeting primers to amplify 
oriT-apramycin cassette for 
scab85471 disruption 
replacement_rv gttcgagtggaagaacaggccctcct
ggagcggggcgagtgtaggctggag
ctgcttc 
Tr_fw 
 
cccggcccgcctccggcgctgccctc
cgcgccgcccggtattccggggatc 
cgtcgacc  
PCR targeting primers to amplify 
oriT-apramycin cassette for 
scab63021 disruption 
Tr_rv 
 
cggcgtcgctctcgccggccgtggcg
gcggggcgggccctgtaggctggag 
ctgcttc  
Test_fw 
 
cgccatccacctcctcatcc Used to confirm correct integration 
of S57::oriT-apr into the S. scabies 
87.22 genome   Test_rv 
 
aagcccggccagatccac 
desC_test_fw gacgtcgcccgcaactac Primers to test presence of oriT-
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 apramycin cassette in the place of 
scab57931 desC_test_rv 
 
gtgatgagccgctcgtgg 
Tr_test_fw 
 
cgggcgtggaagtaaccg Used to confirm correct integration 
of pUC57::oriT-apr into the S. 
scabies 87-22 genome   Tr_test_rv 
 
ctgcacgagcgtgtcctg 
apr_test_fw 
 
tacaccggaccttggagt 
 
Used to confirm the presence of 
oriT-apr cassette in the S. scabies 
87.22 genome   apr_test_rv 
 
gaccgactggaccttccttc 
 
 
Table 7.7 RT-PCR primers used. 
Name Sequence 5’→ 3’ Characteristic 
Scab62941_fw gctgcgccggctggagga primers to amplify internal 749 bp of 
scab62941 gene Scab62941_rv tcttggtgcggttgctgctc 
Scab62951_fw caacgaagagtggatcgacgt primers to amplify internal 615 bp of 
scab62951 gene Scab62951_fw tcgatggccttgtagtcctc 
Scab62971_fw ctcggtcgtcacctatctg primers to amplify internal 553 bp of 
scab62971 gene Scab62971_rv gatgatccggtggtcgaag 
Scab62981_fw gccgggaagctcaacctg primers to amplify internal 617 bp of 
scab62981 gene Scab62981_rv cagttggcggtgacctgc 
Scab62991_fw ggcatcgtcagcgtcaag primers to amplify internal 615 bp of 
scab62991 gene Scab62991_rv cggagcagtgaggtgatcag 
Scab63021_int
fw 
gagtacccgttgcgggagagcc primers to amplify internal 615 bp of 
scab63021 gene 
Scab63021_int
rv 
gatcaccgtgccctccgcgaag 
hrdB_fw gcgtgtcgagcacggagtgcagc primers to amplify internal 1317 bp 
of hrdB gene hrdB_rv ccgagtccgtctctgtcatggc 
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7.1.6 Growth Media 
Most growth media were prepared according to the manual by Kieser et al. (2000). 
All media were sterilised by autoclaving at 121°C. 
7.1.6.1 Recipes for Liquid Media 
LB Broth 
 
Luria-Bertani powder       25g/L 
 
H2O                                   to 1L 
2X YT 
 
Difco Bacto Tryptone          16g 
 
Difco Bacto Yeast extract    10g 
 
NaCl                                      5g 
 
H2O                                     to 1L 
 
SMM (Suplement Minimal Medium) 
MgSO4 .7H 2O (0.2M)                             25 mL 
TES Buffer (0.25M, pH 7.2)                  100 mL 
NaH 2 PO 4+ K 2HPO 4(50 mM each)      10 mL 
Trace Element Solution                              1 mL 
Casaminoacids (20%)                               10 mL 
H2O                                                          804 mL 
Glucose (20%)                                           50 mL 
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Each solution was sterilised by autoclaving or filtering and then added to sterile 
water. 
Trace Element Solution 
ZnSO 4 .7 H2O        0.1 g/L 
FeSO 4 .7 H2O        0.1 g/L 
MnCl 2 .4 H2O        0.1 g/L 
CaCl 2 .6 H2O         0.1 g/L 
NaCl                        0.1 g/L 
H2O                          to 1 L 
This solution is sterilised by filtration. 
 
Iron Deficient Medium (IDM; Barona-Gomez et. al., 2004) 
Salt concentration 
K2SO4                       2 g 
K2HPO4                    3 g 
NaCl                          1 g 
NH4Cl                        5 g 
H2O                        to 1 L 
Trace element concentration for IDM 
Thiamine                                    2 mg/L 
ZnSO4.7H2O                             2 mg/L 
CuSO4 (0.5 mg/mL)                    10 µL 
MnSO4.H2O (3.5mg/mL)            10 µL 
MgSO4 .H2O                            80 mg/L 
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Other solutions 
CaCl2                                                                 10 g/l 
Glucose                                      250 g/l 
Yeast extract                                 0.5% 
These solutions were filter sterilised after preparation. 
 
The 1 litre of the IDM solution was stirred with 50 g of Chelex-100 Sodium form                                                                          
(Sigma Aldrich) in a plastic  flask, covered with parafilm and left on the magnetic 
stirrer over night to let the Chelex resin remove the traces of iron. The Chelex was 
then filtered off on a funnel with filter paper (Whatmann) and the trace element 
solutions were added in the following amounts: 100 µl of thiamine and 100 µl of 
ZnSO4.7H2O stock solution, 10 µl of CuSO4 stock solution, 10 µl of MnSO4.H2O 
and 80mg of MgSO4.7H2O. The medium was then sterilised by autoclaving. Before 
starting the culture CaCl2, glucose and yeast extract stock solutions were added (500 
µl of stock solution per 50 ml media). 
7.1.6.2 Recipes for Solid Media 
Solid agar recipes used for Streptomyces growth. 
 
OBB (Oat Bran Broth; Johnson et al., 2007) 
Oatmeal                                18g 
Bacto Agar                           18g 
H2O                                    to 1L 
Trace element added after autoclaving. 
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SFM (Mannitol soya flour medium) 
Soya flour                            20g 
Mannitol                              20g  
Difco Bacto Agar                20g 
H2O                                 to 1L 
 
R5 medium 
Ingredients used before autoclaving 
Sucrose                             103 g 
K2SO4                              0.25 g 
MgCl2.6H2O                  10.12 g 
Glucose                              10 g 
Difco Casaminoacids           1 g 
Difco Yeast Extract              5 g 
TES Buffer                      5.73 g 
Agar                                   22 g 
H2O                                   to 1L 
All ingredients from the list above were mixed and medium was autoclaved. At the 
time of use the medium was melted and the ingredients from the list below were 
added. 
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After autoclaving ingredients/1L 
KH2PO4 (0.5%)                  10 mL 
CaCl2.2H2O (5M)                 4 mL 
L-proline (20%)                   15 mL 
NaOH (1N)                           7 mL 
Trace Element Solution          2 mL 
 
Solid agar recipes used for E. coli growth. 
LB Agar 
Luria-Bertani powder       25 g/L 
Difco Bacto Agar             15 g/L 
H2O                                   to 1L 
 
DNA (Difco nutrient agar) 
Difco Nutrient Agar          4.6 g 
H2O                                   to 1L 
7.2 Growth, Manipulation and Storage of E. coli 
The procedures used for growth, manipulation and storage of E. coli were taken from 
Sambrook and Russel (2001). 
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7.2.1 Growth Conditions of E. coli 
E. coli was cultured over night in LB broth (180 rpm, 37°C) or on LB agar plates at 
37°C. Antibiotic selection was used for plasmid-containing cells at the 
concentrations listed in Table 7.2. 
7.2.2 Preparation of Electrocompetent E. coli Cells 
E. coli was grown over night at 37°C in 10 ml LB shaking at 180 rpm. 100 µl of E. 
coli overnight culture was then inoculated into 10 ml LB and grown for 3-4 hours 
shaking at 200 rpm to an OD600 of ~ 0.4. The cells were then recovered by 
centrifugation at 3000 rpm for 10 min at 4°C. After decanting the medium the cell 
pellet was resuspended by mixing in 10 ml of ice-cold 10% glycerol. The cells were 
then centrifuged again and resuspended in 5 ml of ice-cold 10% glycerol, 
centrifuged, decanted and resuspended in the remaining ~100 µl 10% glycerol. 
7.2.3 Transformation of Electrocompetent E. coli Cells 
About 100 ng of DNA were added to 100 µl of E. coli cell suspension in a single 
transformation. Electroporation was done in a 0.2 cm ice-cold electroporation cuvette 
using a BioRad GenePulser II set to: 200 Ω, 25 μF and 2,5 kV and the expected time 
constant of 4.5 – 4.9 ms. Immediately after electroporation, 1 ml of ice cold LB was 
added to shocked cells. They were then incubated shaking for 1h at 37°C and spread 
onto LB agar plates containing appropriate antibiotic for the selection of 
transformants. 
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7.2.4 Storage of E. coli Cells 
E. coli overnight LB cultures were mixed with 70% glycerol to a final concentration 
of 20% and stored at -78 °C for a long term. 
7.3 Growth, Manipulation and Storage of Streptomyces 
The procedures used for growth, manipulation and storage of Streptomyces were 
described by Kieser et al. (2000). The protocol for genomic DNA extraction was 
taken from Pospiech and Neumann (1995). 
7.3.1 Spore Stock Collection from Agar Plates 
S. scabies spores were grown on oat bran broth (OBB) agar. Spores were collected 
from each plate by adding 3 ml of sterile water and scrapping the surface of the 
mycelia with a sterile loop. The spore suspension was then filtered through sterile 
cotton wool and centrifuged for 10 min at 3000 rpm. The supernatant was poured off 
and the spore pellet was resuspended in approximately 500 µl of the remaining 
water. The stock was then made by adding similar volume of 50% sterile glycerol to 
the spore suspension. The spores were stored at -20ºC. 
7.3.2 Liquid Cultures for Genomic DNA Extraction 
S. scabies spores for genomic DNA extraction were grown in 50 ml of TSB medium 
at 30ºC, 180 rpm for 72 hours. 
7.3.3 DNA Transfer from E. coli to S. scabies by Conjugation 
10μl of E. coli ET12567/pUZ8002 glycerol stock was added to 10 ml of a liquid LB 
medium containing kanamycin (25 μg/ml) and chloramphenicol (25 μg/ml) and the 
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culture was grown at 37ºC over night.Then, 100 μl of over night culture was added to 
10 ml LB and incubated for 6 hours with the same antibiotics and at the same 
conditions as above. After 6 hours the electrocompetent cells were prepared 
according to the procedure used earlier (section7.2.2), transformed with the oriT-
resistance cassette containing cosmid or plasmid clone (section 7.2.3) and selected 
for the incoming cosmid or plasmid by plating on LB agar with kanamycin (25 
μg/ml) and chloramphenicol (25 μg/ml) as well as antibiotic appropriate to the 
resistance of the cassette. One of the transformant colonies was inoculated into 10 ml 
LB liquid medium containing the same antibiotics as those used on LB plates and 
grown overnight at 37ºC. Then, 500 μl of overnight culture was inoculated into 50 
ml of fresh LB plus antibiotics as above and grown for 6 h at 37°C, shaking at 180 
rpm to an OD600 of 0.4. After 6 hours the cells were washed twice with 50 ml of LB 
to remove antibiotics (might inhibit Streptomyces), and resuspended in ~2 ml of LB. 
While washing the E. coli cells, 500μl (approximately 109) of freshly collected 
Streptomyces scabies 87.22 spores were added to 0.5ml 2 × YT broth, heat shocked 
at 50°C for 20 min, then cooled for 1 min on ice. Next, ~2 ml of E. coli cell 
suspension were mixed with 500 μl heat-shocked spores in 500 2xYT and then 
centrifuged briefly. The supernatant was then partially removed and the pellet was 
resuspended in the c.a. 500 μl residual liquid. This liquid was then plated out without 
diluting on several SFM agar + 10mM MgCl2 plates (without antibiotics) and 
incubated at 30°C for 16-20 h. The next day each plate was overlayed with 1 ml of 
water containing 0.5 mg nalidixic acid (20 μl of 25 mg/ml stock)  to selectively kill 
E. coli. The antibiotics in the appropriate concentrations were also added for the 
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selection of the exconjugant Streptomyces containing the plasmid or cosmid of 
interest. 
7.4 Extraction and Manipulation of DNA 
7.4.1 Isolation of Genomic DNA from S. scabies 
The S. scabies DNA was isolated according to the method by Pospiech and Neumann 
(1995). 
The cells of S. scabies 87.22 strain were grown in 50ml of TSB medium at 30°C for 
three days. The cells were harvested by centrifugation (10 min, 3000 rpm) and 
resuspended in 5 ml of SET (75 mM NaCl, 25 mM EDTA, 20 mM Tris, pH 7.5). 
Lysozyme was added to the cells to a concentration of 1 mg/ml and incubated at 
37°C for 0.5 h. Next, l/10 volume of 10% SDS and 0.5 mg/ml of proteinase K were 
added and the cells were incubated at 55°C with an occasional inversion for 2 h. 
After that l/3 volumes of 5 M sodium chloride and one volume of chloroform were 
added and the cells were incubated at room temperature for 0.5 h with frequent  
inversion. The cells were then centrifuged at 4500 g for 15 min; the aqueous phase 
was transferred to a new tube using a blunt-ended pipette tip. The DNA was 
precipitated by adding 1 volume of isopropanol and gently inverting the tube. The 
precipitated DNA was then transferred into a microfuge tube and rinsed with 70% 
ethanol, dried on air and dissolved in 1ml of TE buffer. The amount of DNA 
obtained was between 1-3 mg. 
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7.4.2 Plasmid/Cosmid Isolation from E. coli 
The E.coli cosmid or plasmid was isolated according to the method by Sambrook and 
Russell (2001). 
5 ml of liquid LB medium with added antibiotics was inoculated with E. coli cells 
and they were grown overnight at 37°C, 180 rpm. The cells were then centrifuged 
and the cell pellet was resuspended in 100 μl of solution I (50 mM Tris/HCl, pH 8; 
10 mM EDTA). Then, 200 μl solution II (200 mM NaOH; 1% SDS) was added to it 
and cells were mixed by inverting the tube several times. Then, 150 μl of solution III 
(3 M potassium acetate, pH 5.5) were added to the tube and it was mixed by 
inverting several times. The tube was centrifuged at a maximum speed in a 
microcentrifuge for 5 min at room temperature. Then, the supernatant was 
transferred to a new tube and 400 μl of phenol-chloroform-isoamyl alcohol (25:24:1) 
was added, vortexed 2 min and centrifuged at a full speed in a microcentrifuge for 5 
min, at room temperature. The upper phase was transferred to a new tube and 600 μl 
of ice cold isopropanol was added to it. The tube was left on ice for 10 min to 
precipitate the DNA, and the sample was centrifuged for 10 min at a full speed in a 
minicentrifuge at 4°C. The supernatant was removed and the pellet was washed with 
200 μl 70% ethanol, spinned in a microcentrifuge for 5 min at room temperature and 
left for 30 min at room temperature to air-dry. The pellet was then resuspended in a 
30 μl of sterile water with RNAse.  
7.4.3 Digestion of DNA with Restriction Enzymes 
Digestions by restriction enzymes were prepared following the manufacturer 
instructions. Restriction enzymes always occupied 10% of the total volume and 
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appropriate buffer also occupied 10% (all buffers were 10 x concentrated). If BSA 
had to be added, it also occupied 10% of the total volume. The rest of the total 
volume consisted of a DNA solution to be digested and, if necessary, water. 
Digestions of plasmid/cosmid were carried out in a total volume of 10 µl.  
7.4.4 Ligation of DNA into Plasmids 
DNA to be ligated into plasmid vectors was purified using the Fermentas gel 
extraction kit and eluted with 10 µl of distilled water. The concentration of vector 
and insert was then estimated by running 1µl of each DNA sample on an agarose gel 
along with a molecular size marker of a known DNA concentration. A molar ratio of 
vector: insert of 1:4 was generally used for ligation reactions. The ligation reactions 
were carried out in a 20 µl of a total volume for 30 min using Rapid Ligation kit 
from Roche. 
7.4.5 Agarose Gel Electrophoresis 
1x TBE buffer was used to prepare and run agarose gels. Different percentage 
agarose gels were prepared (0.8%, 1%, 1.5%) depending on the size of DNA 
fragments. 2 µl of Gel Red dye (Biotium) was added to the gel to visualize DNA 
under UV light. Electrophoresis was carried out for 40 min at 110 V. A. 1kb DNA 
molecular size marker (Fermentas) was used as a size standard. 
7.5 PCR Methods 
The High Fidelity Polymerase (Roche) was used to amplify a gene for PCR targeting 
or for cloning. The Taq polymerase (Fermentas) was used for analysis of constructs 
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or mutants. The PCR reactions were carried out in 50 µl total volume. The PCR 
reaction conditions are displayed in table 7.8. 
 
Table 7.8 PCR reaction conditions. 
              Solution       Volume           Concentration 
    Primers (100 pmoles/µl)          1 µl each       100 pmoles each 
          Template DNA           1 µl              ~ 50 ng 
            Buffer (10x)           5 µl      1x final concentration 
          dNTPs (5 mM)       2 µl each           100 µM each 
          DMSO (100%)          2.5 µl                  5% 
  DNA polymerase (2.5 U/µl)          0.5 µl              1.25 Units 
            Distilled water           37µl                   - 
            Total volume          50 µl                   - 
7.5.1 General PCR Method  
PCR conditions to amplify inserts for cloning and for analysis of constructs and 
mutants are displayed below. 
1) Denaturation:  94°C, 2 min 
2) Denaturation:  94°C, 45 s                  
3) Primer annealing:  55-67°C, 45 s      35 cycles 
4) Extension:   72°C, 90-240 s 
5) Final extension:  72°C, 10 min 
 
A primer annealing temperature is chosen to get the maximum copies of a product 
and the highest specificity. It is usually between 55-67°C. The extension time is 
chosen according to the rule 1 min of extension per 1kb of product. 
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7.5.2 PCR Amplification of the Gene Replacement Cassette. 
A PCR reaction (Gust et al., 2002) with designed primers was carried out to amplify 
the cassette from the digested pIJ773 vector. The conditions of the reaction are as 
follows: 
1) Denaturation:  94°C, 2 min 
2) Denaturation:  94°C, 45 s 
3) Primer annealing:  50°C, 45 sec        10 cycles 
4) Extension:   72°C, 90 sec 
5) Denaturation:  94°C, 45 sec 
6) Primer annealing:  55°C, 45 sec      25 cycles 
7) Extension:   72°C, 90 sec   
8) Final extension:  72°C, 5 min 
 
7.6 PCR Targeting in S. scabies 87.22 
PCR targeting technique was used to create in-frame deletions in S. scabies genome 
(Gust et al., 2002). 
7.6.1 Design of PCR Primers 
Two targeting primers were designed for the deletion in each gene according to the 
procedure described in section 3.1. The targeting primers are displayed in Table 7.6 
(Section 7.1.5). 
7.6.2 Purification of the Resistance Cassette 
Approximately 3 μg of plasmid DNA pIJ773 was digested with 50 U EcoRI (Roche) 
and 50 U HindIII (Roche), in 1 x buffer (Roche), in a 50 μl reaction for 1.5 hour at 
37° C. A 2938 bp vector fragment and a 1400 bp for the cassette were generated. The 
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digest was then run on a gel and then the band for the resistance cassette was cut out 
and purified by Qiagen gel extraction kit. The purified fragment was stored in a 30 μl 
of a sterile water, at –20°C.  
7.6.3 PCR Amplification of the Extended Resistance Cassette 
The purified resistance cassette was amplified by PCR with long targeting primers 
(Table 7.6) using the reaction mixture shown in Table 7.9. The Expand High Fidelity 
polymerase (Roche) was used in PCR reactions under the conditions described in 
section 7.5.2. 5 µl of the PCR reaction was analysed by electrophoresis on a 1% 
agarose gel for the presence of the cassette with the size of ~1476 bp. The rest of the 
PCR product was purified from the reaction mixture using the Qiagen PCR 
purification kit following the manufacturer’s instructions and eluted from the column 
with 30 µl of water. 
7.6.4 Introduction of Cosmid Clones into E. coli BW25113/pIJ790 by 
Electroporation 
pIJ790 vector contains the resistance marker cat (chloramphenicol resistance) and a 
temperature sensitive origin of replication (requires 30°C for replication). E. coli 
BW25113/pIJ790 cells were grown overnight at 30°C in a 10 ml LB containing 
chloramphenicol (25 μg/ml). 100 μl of E. coli BW25113/pIJ790 from the overnight 
culture were inoculated in a 10 ml LB containing 20 mM MgSO4 (200 μl of 1M 
stock) and chloramphenicol (25 μg/ml) and grown for 4 hours at 30°C, shaking at 
180 rpm to an OD600 of ~ 0.4. The competent cells were then prepared according to 
the section 7.2.2 and the 100 μl of the cell suspension was mixed with ~ 100 ng (1-2 
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μl) of a cosmid DNA. Electroporation was carried out as described in section 7.2.3 
and the cells were incubated on an orbital shaker at 180 rpm for 1h at 30°C. The 
culture was spread onto two plates of LB agar containing ampicillin (100 μg/ml), 
kanamycin (50 μg/ml) and chloramphenicol (25 μg/ml) and incubated overnight at 
30°C. The next day, the transformant colonies containing cosmid were observed. 
One isolated colony was transferred into 5 ml of liquid LB containing antibiotics as 
above and incubated overnight at 30°C. This culture was then used as a pre-culture 
for generating competent cells to be transformed with the extended resistance 
cassette.  
7.6.5 PCR Targeting of Cosmids  
10 ml of LB containing ampicillin (100 μg/ml), kanamycin (50 μg/ml) and 
chloramphenicol (25 μg/ml) was inoculated with 1% of the overnight culture of E. 
coli BW25113/pIJ790 and the cosmid. 100 μl of 1M L-arabinose stock solution was 
added to the culture to induce the red genes. Then, the culture was grown for 4 hours 
at 30°C shaking, at 180 rpm to an OD600 of ~ 0.4. Competent cells were prepared as 
described in section 7.2.2 and the 50 μl of the cell suspension was mixed with ~ 100 
ng (2 μl) of the extended resistance cassette PCR product. Electroporation was 
carried out (section 7.2.3) and the cells were incubated shaking at 180rpm for 1h at 
37°C (the temperature above 30°C causes degeneration and loss of pIJ790 plasmid). 
The culture was spread onto two plates of LB agar containing ampicillin (100 
μg/ml), kanamycin (50 μg/ml) and apramycin (50 μg/ml) and incubated overnight at 
37°C. After 16 hours growth at 37°C different colony sizes were observed. The small 
colonies were false positives and the larger the sizes of a colony, the more copies of 
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the mutagenised cosmids were present. Several large colonies were inoculated in 5 
ml LB liquid cultures containing ampicillin (100 μg/ml), kanamycin (50 μg/ml) and 
apramycin (50 μg/ml) and grown at 37°C, shaking at 180 rpm to a cell density OD600 
~ 0.1 – 0.3, for 6 h. After 6 hours, the cosmid DNA was isolated and tested by 
restriction analysis and PCR. 
About 2 µg (10 µl) of the wild type cosmid clone DNA and 2 µg (10 µl) of the 
mutagenised cosmid (with introduced extended apramycin cassette and OriT) were 
digested, each with BamHI or SacI restriction enzymes in a total volume of 30 µl. 
Both digestions were left for a 3 hours at 37°C and then 5 µl of each digestion was 
analysed on an agarose gel (1% agarose). The digested wild type and mutagenised 
cosmid gave distinct patterns of bands. The expected digestion pattern for the 
mutagenised cosmid was confirmed by an in silico prediction using program, such as 
Clone Manager or NEB cutter. If the digestion pattern agreed with the program 
prediction then the integration of the disruption cassette into cosmid was also 
confirmed using PCR with suitable test primers (Table 7.6) priming within ~ 100 bp 
upstream and downstream of the region, which recombined with the PCR product of 
the extended OriT-apramycin resistance cassette. The PCR reaction was performed 
under the conditions listed in the section 7.5.2. The mutagenised cosmid was 
introduced into a non-methylating E. coli host ET12567/pUZ8002 by electroporation 
(section 7.3.3). 
7.6.6 Transfer of the Mutant Cosmids into Streptomyces scabies  
The procedure for conjugal transfer of the engineered cosmid from E. coli 
ET12567/pUZ8002 into S. scabies is described in section 7.3.3. After several days of 
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incubation the grey, hydrophobic Streptomyces colonies were present on each plate. 
Several colonies were picked and transferred onto DNA plates (Difco Nutrient Agar) 
containing nalidixic acid (25µg/ml) and apramycin (50µg/ml) with and without 
kanamycin (50µg/ml). Double cross-over exconjugants were kanamycin sensitive 
(the cosmid backbone containing kanamycin resistance gene has been lost during 
cross over) and apramycin resistant (cassette contains apramycin). The kanamycin 
sensitive clones were picked from DNA plates and plated out on oat bran broth (the 
solid medium used for growing of S. scabies). The spores were then collected; 
genomic DNA isolated and analysed for the desired mutation by PCR (section 7.5.1) 
with the test primers (section 7.1.5) and also by Southern blot hybridisation (section 
7.7). 
7.7 Southern Blot Hybridisation 
DIG High Prime DNA Labelling and Detection Starter Kit (Roche) was used to carry 
out Southern blot hybridisation. 
7.7.1 Probe Labeling 
1µg of cosmid DNA (5 µl) was added to a final volume of 16 µl of autoclaved miliQ 
distilled water and denatured by boiling at 100°C for 10 min. The sample was then 
rapidly cooled on ice, mixed with 4 µl of DIG High Prime solution and incubated 
over night in 37°C water bath. Then, the labeling reaction was stopped by adding 2 
µl of 0.2 M EDTA (pH 8.0) and then by heating to 65°C for 10 min. 
7.7.2 Genomic DNA Digestion 
20 µg of genomic DNA for each strain was digested with BamHI or SacI over night 
at 37°C. The samples were then loaded on 0.7% agarose gel and run over night at 25 
PhD Thesis: Joanna Bicz                             Chapter 7: Materials and Methods 
180 
 
V. The gel was then exposed to UV light for 5 minutes to help denature the DNA. 
Then, the gel was rinsed in distilled water and washed twice 15 minutes in 
denaturation buffer (2 x 15 min shaking at room temperature). After denaturation the 
gel was rinsed again in distilled water and twice with neutralisation buffer (2x 15 
shaking). 
7.7.3 Capillary Transfer and DNA Fixation 
A glass plate was placed across a plastic tray containing 20xSSC buffer. One sheet of 
3mm Whatmann filter paper soaked in 20xSSC buffer was placed on the glass plate. 
The ends of the filter paper touched the buffer in the container. On the top of this 
filter paper another soaked piece of paper was put and on that the treated gel with the 
wells side down. The piece of a nylon membrane with a positive charge cut to the 
size of the gel was placed on the top of it. The gel was wrapped around on the edges 
with a tape to prevent ‘short cirquiting.’ Then, three pieces of Whatmann 3 mm 
paper the size of gel were placed on the top of a nylon membrane; after that, the 5 cm 
high layer of paper towels and finally on that a glass plate with 2 litres flask half-
filled with water as a weight. The movement of the DNA to the membrane was 
carried out by capillary transfer over night. The next day the membrane was removed 
from the gel, placed on the piece of Whatmann 3mm paper soaked in 10xSSC buffer 
and UVcross-linked to fix the DNA (auto-crosslinking on UV Stratalinker 2400 from 
Stratagene). 
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7.7.4 Hybridisation 
The membrane with the DNA transferred to it was prehybridised in a hybridisation 
tube in a 20 ml of DIG Easy Hyb solution ( DIG Easy Hyb granules mixed with 64 
ml of sterile water for 10 min at 37°C) rotating for 2 hours at 42°C. The membrane 
was then incubated in the hybridisation solution over night rotating at 42°C. The 
hybridisation solution was prepared by adding the 20 µl of denatured DIG labeled 
DNA probe (5µg/µl) into 7 ml of preheated DIG Easy Hyb solution. The probe was 
denatured by boiling for 5 min at 98°C and then rapidly cooled on ice. The next day 
the hybridization solution was removed and the membrane was washed 2x 5 minutes 
in 50 ml preheated 2x SSC, 0.1% SDS rotating at 25°C; then 2x 15 min in 50 ml 
preheated 0.5x SSC, 0.1% SDS at 58°C. The membrane was then washed in 30 ml of 
washing buffer for 5 min at room temperature. Then, it was incubated at 50 ml of 
blocking solution at room temperature; under constant rotation in the hybridisation 
oven. After 30 minutes the blocking solution was replaced with a 30 ml of the fresh 
blocking solution, mixed with a 3 µl of the anti-DIG antibody conjugate and the 
membrane was incubated with it for another 30 min. Then, the antibody solution was 
removed and the membrane was washed twice in 50 ml of washing buffer (2x15 min 
rotating) and then equilibrated for 5 min in 20 ml of a detection buffer. 
7.7.5 Detection 
The wet membrane was placed with the DNA side up in a hybridisation bag and 2 ml 
of chemiluminescence substrate CSPD (from DIG High Prime kit, Roche) was 
applied onto it. The membrane was then immediately covered with the second sheet 
of the development bag so that the CSPD substrate was spread evenly without an air 
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bubbles over the membrane. The edges of the hybridisation bag were then sealed and 
the membrane was incubated in the development folder in the dark. After 5 min the 
membrane was placed inside a new hybridisation bag, sealed and incubated at 37°C 
for 15 min to enhance the luminescence reaction. The membrane was then exposed 
to film over night. The film was then developed according to standard procedures. 
7.8 RNA Methods 
7.8.1 Total RNA Isolation from S. scabies 
The wild type S. scabies were grown on an oat bran broth plates at 30°C for 3, 5, 7 
and 14 days. After the incubation, the mycelia from each plate were collected by a 
plastic loop and ground in a mortar with the addition of a liquid nitrogen. The frozen 
ground mycelium was transferred into a 1.5 ml Eppendorf tube containing 350 µl of 
resuspension buffer RA1 from NucleoSpin RNA II kit (Macherey-Nagel) and 3.5 µl 
of mercapthoethanol. The sample was then vortexed vigorously for 3 minutes to help 
the cell wall breakage. The sample was processed further using NucleoSpin RNA II 
kit. The RNA was finally eluted on the column with 60 µl of RNAse free distilled 
sterile water. The RNA was always handled in gloves. All pipette tips and Eppendorf 
tubes were autoclaved twice. The bench area and pipettes were wiped with the 
RNAse inhibitor agent (RNaseZAP, Sigma Aldrich). The RNA was analysed using 
agarose gel elecrophoresis on a 1% agarose gel. 1µl of RNA was mixed with the 4 µl 
of the loading dye (Fermentas) and run on a gel with 50 V current for 1hour. The 
RNA was then visualised under the UV light. The presence of the two sharp bands 
and the third lower and more faded was indicating that the RNA is not degraded and 
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it is suitable for downstream applications, such as PCR. The RNA samples were then 
treated with DNAse (TurboDnase, Ambion) to remove any traces of genomic DNA. 
They were then analysed using standard PCR method (section 7.5.1) with Taq 
polymerase to ensure that no genomic DNA was present in the samples. The purified 
RNA was then used as a template in reverse transcriptase PCR reactions (section 
7.8.2) to analyse expression of the genes from the putative tetronate biosynthetic 
gene cluster.  
7.8.2 Reverse Transcriptase PCR Method 
The Qiagen One Step PCR Kit was used for performing of PCR reactions. 
Polymerase from that kit is a mix of reverse transcriptase (RT) polymerases 
(Omniscript Reverse Transcriptase, Sensiscript ReverseTranscriptase) and the Taq 
DNA polymerase (Hotstar Taq polymerase). The RT polymerase converts messenger 
RNA (mRNA) into a complementary DNA (cDNA) in the initial part of the PCR 
reaction carried out at 50°C in 30 minutes. In the next step, the temperature of the 
reaction was raised to 95°C to activate the Taq DNA polymerase, deactivate the 
reverse transcriptases and denature the cDNA. The cDNA template was then 
amplified by the Taq polymerase in a standard PCR reaction. 
 
 
 
 
 
 
PhD Thesis: Joanna Bicz                             Chapter 7: Materials and Methods 
184 
 
The PCR reaction conditions are displayed in the following table: 
Table 7.9 RT-PCR reaction conditions 
               Solution       Volume              Amount 
             Primers (1x)    0.5-1 µl each         0.5-1 µM each 
           Template RNA          1-2 µl              1pg-2µg 
5x QIAGEN OneStep RT-PCR       
Buffer 
          10 µl      1x final concentration 
           dNTPs (10 mM)        2 µl each           400 µM each 
QIAGEN OneStep RT-PCR 
Enzyme Mix (5 U/µl) 
           2 µl              2.5 Units 
         RNase-free water         variable                    - 
            Total volume            50 µl                    - 
 
Thermal cycler conditions for RT-PCR: 
1) Reverse transcription:                  50°C, 30min 
2) Initial PCR activation step:          95°C, 15 min 
3-step cycling: 
1) Denaturation:        94°C, 1 min   
2) Annealing :                   50-68°C, 45 s 35 cycles  
3) Extension:                   72°C, 1 min/kb 
4) Final extension                         72°C, 10 min 
PhD Thesis: Joanna Bicz                             Chapter 7: Materials and Methods 
185 
 
7.9 Growth of Streptomyces scabies; Extraction of Metabolites and 
Analysis of Metabolite Production 
7.9.1 Pyochelin 
7.9.1.1 Culturing of S. scabies in Iron Deficient Medium  
S. scabies 87.22 and and the ΔScab1401 and ΔScab1401–ΔScab1471 mutants were 
cultured in Iron Deficient Medium for a detection of pyochelin. 50 ml of sterilised 
IDM in each 250 ml sterile plastic Erlenmeyer flask were inoculated with 10 µl of 
fresh spore stock of each S. scabies pyochelin mutant and wild type S. scabies strain. 
The liquid cultures were incubated at 30°C shaking at 180 rpm for 4-5 days. 1 ml of 
each cell culture was then taken to 1.5 ml Eppendorf tubes and centrifuged in a table 
microfuge at 13000 rpm for 5 minutes at room temperature. Supernatant was placed 
in 1 ml HPLC tubes. The samples were analysed using LC-MS. 
7.9.1.2 LC-MS Analysis  
Liquid chromatography –Mass Spectrometry (LC-MS) was used to analyse the 
supernatants of the S. scabies 87.22 and the ΔScab1401 and ΔScab1401–ΔScab1471 
mutants. LC-MS analysis of the reaction mixture was carried out using Eclipse 
XDB-C18 column (150 x 4.6mm, 5μm, Agilent) connected to an Agilent 1100 
HPLC instrument. The outflow was connected via a splitter (10% flow to MS, 90 % 
flow to waste) to a Bruker HCT+ mass spectrometer fitted with an electrospray 
source in positive ion mode with parameters: nebulizer flow 40 psi, dry gas flow 10.0 
L/min, dry temperature 300 ºC, capillary – 4 kV, skimmer 40V, capillary exit 106 V, 
ion charge control target (ICC) 100,000, spectral averages 3. Absorbance was 
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monitored at 210 nm and 280 nm. The elution profile is displayed in the table below, 
with a 1 ml/min flow rate. The retention time for pyochelin was 23 minutes.  
 
Table 7.10 Gradient elution profile used in LC-MS analyses of pyochelin production. 
 Time (min) Water + 0.1% formic acid Methanol + 0.1% formic acid 
          0                100                  0 
          5                100                  0 
         25                  0                100 
         30                  0                100 
         35                100                  0 
7.9.1.3 Extraction of Pyochelin and High Resolution Mass Spectrometry 
S. scabies 87.22 and the ΔScab1401 and ΔScab1401–ΔScab1471 mutants were 
grown in an iron-deficient medium (Barona-Gomez et al., 2004) for 4 days. The 
cultures were centrifuged for 10 min at 4000 r.p.m. at 4°C. The supernatants were 
lyophilised,  
resuspended in 5 ml of methanol and analysed using a Dionex Ultimate 3000RS 
instrument fitted with Supelco Acentis Express C18 column (15062.1 mm, 2.7 mm); 
coupled to a Bruker MaXis mass spectrometer with parameters: ESI in positive 
mode; full scan 50–1500 m/z; End plate offset, 2500 V; Capillary, 24500 V; 
Nebulizer gas (N2), 1.6 bar; Dry gas (N2), 8 l min21; Dry Temperature, 180 uC. The 
elution profile is displayed in the table. The flow rate was 0.2 ml per minute. 
Absorbance was monitored at 210 and 280 nm. The High Resolution Mass 
spectrometry analyses were performed by our collaborator Dr. Lijiang Song 
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Table 7.11 Gradient elution profile used in High Resolution MS analyses of 
pyochelin production. 
 Time (min) Water + 0.1% formic acid Methanol + 0.1% formic acid 
          0                100                    0 
          5                100                    0 
        30                  0                  100 
         35                  0                  100 
         40                100                    0 
         55                100                    0 
 
Pyochelin and enantio-pyochelin (ent-pyochelin) standard solutions (both 10 µl, 10 
µg/ml in methanol) and concentrated culture supernatant from the ΔScab1401 mutant 
were analysed using a homochiral stationary phase using an Agilent 1100 HPLC 
coupled to a Bruker HCT plus mass spectrometer with parameters: ESI in positive 
mode; full scan 50–1500 m/z; End plate offset, 2500 V; Capillary, 24500 V; 
Nebulizer gas (N2), 40 p.s.i.; Dry gas (N2), 10 l min21; Dry Temperature, 300 uC. 
The eluents and elution conditions are described in Table 7.11. The flow rate was 1 
ml/min. All High Resolution Mass Spectrometry analyses for pyochelin and 
scabichelin, as well as, chiral HPLC analyses, were carried out with the assistance of 
our collaborator on the project Dr. Lijiang Song. 
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7.9.2 Scabichelin 
7.9.2.1 LC-MS Analysis  
S. scabies 87.22 and W1000 were grown in iron deficient medium (Barona-Gomez et 
al., 2004) according to the same protocol as in section 7.9.1.1. 1 ml of supernatants 
from each of 50 ml cultures of S. scabies 87.22 and W1000 were analysed by high 
resolution LC-MS on a Sigma Ascentis Express column (C18, 150 x 2.1mm, 2.7μm) 
attached to a Dionex 3000RS UHPLC coupled to a Bruker MaXis ESI-Q-TOF mass 
spectrometer. The mobile phases were water containing 0.1% formic acid (eluent A) 
and methanol containing 0.1% formic acid (eluent B). A gradient of 5% B to 100% B 
in 15 minutes was used with a flow rate of 0.2ml/min. Absorbance at 210nm was 
monitored. The mass spectrometer was operated in a positive ion mode with a scan 
range 50-2,000 m/z. Source conditions were: end plate offset at -500V; capillary at -
4500V; nebulizer gas (N2) at 1.6bar; dry gas (N2) at 8L/min; dry Temperature at 180 
°C. Ion tranfer conditions were: ion funnel RF at 200Vpp; multiple RF at 200Vpp; 
quadruple low mass at 55 m/z; collision energy at 5.0 eV; collision RF at 600 Vpp; 
ion cooler RF at 50-350 Vpp; transfer time at 121μs; pre-Pulse storage time at 1 μs.  
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7.9.3 Desferrioxamines 
7.9.3.1 Growing S. scabies in Supplemented Minimal Medium (SMM) and LC-
MS Analysis 
50 ml of sterilised SMM in each 250 ml sterile plastic Erlenmeyer flask was 
inoculated with 10 µl of fresh spore stock of S. scabies ΔdesC mutant and wild type 
S. scabies strain. The liquid cultures were then incubated at 30°C incubator, shaking 
at 180 rpm for 3-4 days. 1 ml of each cell culture was then taken to 1.5 ml Eppendorf 
tubes and 2µl of FeCl3 was added to them. The samples were incubated for 30 min at 
room temperature and then centrifuged in a table microfuge at 13000 rpm for 5 
minutes at room temperature. Supernatant was taken to 1 ml HPLC tubes. The 
samples were then analysed using LC-MS. The LC-MS equipment and analysis 
conditions were same as described for pyochelin LC-MS analysis (Section 7.9.1.2). 
The absorbance was monitored at 435 nm.  
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